{
  "metadata": {
    "timestamp": "2025-12-17T22:13:47.757536",
    "genes": [
      "PAM",
      "ADAMTS9-AS2",
      "ITPR1",
      "MEF2A",
      "EPAS1",
      "P4HA1",
      "GBE1",
      "PFKP",
      "ARRDC3",
      "VEGFA",
      "BNIP3L",
      "CA12",
      "ZNF395",
      "PDK1",
      "IGFBP5",
      "AKAP12",
      "INSIG2",
      "ABCA1",
      "SLC6A6",
      "SLC2A3",
      "SLC2A1",
      "EGLN3",
      "ENO2",
      "NDRG1",
      "LUCAT1",
      "FNDC3B",
      "ADM",
      "TRIM2",
      "ESYT2",
      "ERO1A",
      "AL136131.3",
      "OSMR-AS1",
      "OXR1",
      "ANGPTL4",
      "ANXA2",
      "ANKRD28",
      "PRELID2",
      "ARL4C",
      "PYGL",
      "DNAH11",
      "SLC16A1",
      "C4ORF47",
      "HILPDA",
      "MIR210HG",
      "PLOD2",
      "SORCS3",
      "NRP1",
      "PGK1",
      "AC097534.2",
      "YBX3",
      "MSRA",
      "IRS2",
      "CAV1",
      "SYTL2",
      "CEBPD",
      "SPNS2",
      "LYST",
      "SSBP2",
      "CAST",
      "ARHGEF10",
      "CA9",
      "PFKFB4",
      "SCARB1",
      "BACE2",
      "SLC39A14",
      "BHLHE40",
      "SLC22A23",
      "TRIO",
      "MYOF",
      "TRIM9",
      "SERPINE1",
      "NPAS2",
      "ADCY8",
      "EYA2",
      "MT1X",
      "PRUNE2",
      "CALD1",
      "DLG1",
      "LGALS3",
      "NOL3",
      "DPYD",
      "PCOLCE2",
      "ATP13A3",
      "RASSF8",
      "HK2",
      "AC107021.1",
      "GRB10",
      "AC098829.1",
      "FAM20C",
      "FKBP5",
      "IMMP2L",
      "ID2",
      "FN1",
      "SAMD4A",
      "NEAT1",
      "ABI3BP",
      "IGF1R",
      "MYO9B",
      "VLDLR-AS1",
      "IGFBP3",
      "PTCHD1-AS",
      "MYO1E",
      "C2CD2",
      "NIBAN1",
      "GSE1",
      "IGFBP2",
      "SNHG14",
      "WEE1",
      "COL5A1",
      "EEPD1",
      "SLC7A11",
      "HIF1A-AS3",
      "SEC24D",
      "KDM3A",
      "CDK19",
      "CDON",
      "SLC38A1",
      "SMIM3",
      "CHSY1",
      "ELL2",
      "AC025159.1",
      "NPTX1",
      "ENO1",
      "VMP1",
      "FNBP1",
      "MTCL1",
      "AL390957.1",
      "AL357153.2",
      "AMD1",
      "AL163541.1",
      "FAM160A1",
      "UNC5B",
      "LOX",
      "LNCSRLR",
      "RGS6",
      "LINC02649",
      "ADGRL2",
      "MT2A",
      "AK4",
      "TRIM56",
      "NRN1",
      "FGFR1",
      "ADAMTS9",
      "NAV2",
      "POT1-AS1",
      "COL13A1",
      "IL1RAP",
      "USP36",
      "SEMA5B",
      "SMARCD3",
      "PTPRD",
      "COL4A1",
      "AC108519.1",
      "MAP3K20",
      "GLUL",
      "DOCK4",
      "ITGA3",
      "DOK5",
      "FMNL2",
      "HAP1",
      "COL4A2",
      "NTRK2",
      "AC104123.1",
      "SESN2",
      "AF165147.1",
      "TRIB3",
      "NAMPT",
      "SLC15A4",
      "SMYD3",
      "MSC-AS1",
      "FLNA",
      "HDAC9",
      "PPP1R3C",
      "GPRC5A",
      "AC093849.4",
      "NRCAM",
      "AC019257.1",
      "LINC01411",
      "SPOCD1",
      "LONRF1",
      "SQSTM1",
      "KLF6",
      "GAPDH",
      "VIM",
      "SYNE1",
      "BTG1",
      "PGM2L1",
      "APLN",
      "CAMK2D",
      "PCSK5",
      "PCA3",
      "ENOX1",
      "STAC2",
      "VOPP1",
      "ARID3A",
      "ERRFI1",
      "GAP43",
      "LINC00894",
      "KISS1R",
      "KIF26B"
    ],
    "context": "Astrocytoma",
    "provider": "perplexity",
    "model": "sonar-deep-research",
    "source": "scripts/run_deepsearch.py",
    "preset": null,
    "template": null,
    "custom_prompt_used": false,
    "provider_override": null,
    "model_override": null,
    "reasoning_effort_override": null,
    "search_recency_override": null,
    "timeout_seconds": 180,
    "effective_provider": "offline",
    "effective_model": "offline",
    "project": "Astrocytoma_nmf",
    "query": "Cluster_11",
    "source_tag": "deepsearch",
    "resolve_citations": true,
    "citation_flags": {
      "validate": true,
      "scrape": false,
      "pdf": true,
      "topic_validation": false
    }
  },
  "deepsearch_raw": {
    "markdown": "<think>\nThis is a complex request asking me to perform a comprehensive literature analysis of 136 genes in the context of astrocytoma (a type of brain tumor). I need to:\n\n1. Analyze each gene's functional role, particularly in the context of astrocytes and astrocytoma\n2. Identify gene clusters/programs that work together\n3. Provide evidence from the search results and my knowledge\n4. Output findings as both a narrative report (10,000+ words) AND a structured JSON document\n\nLet me first review the search results provided:\n- Most results are from NCBI gene database pages with limited information (JavaScript required)\n- Some Nature articles with relevant content about cancer metabolism, glycolysis, glioblastoma, autophagy, BBB function, neuroinflammation, etc.\n- Articles about specific pathways (HIF-1α, VEGF, metabolic reprogramming, angiogenesis)\n- One article specifically about astrocyte activation post-TBI\n- One about microRNA-mediated neuronal detargeting\n\nThe search results are quite limited and mostly from NCBI gene databases. I'll need to supplement with my knowledge about these genes and their roles in astrocytoma.\n\nLet me organize my analysis:\n\n**Gene programs I should identify:**\n\n1. **Hypoxia-Inducible Factor (HIF) signaling & Metabolic Reprogramming**\n   - EPAS1 (HIF-2α), HIF1A-AS3, CA9, CA12, PDK1, PFKP, PFKFB4, ENO1, ENO2, PGK1, HK2, NDRG1, EGLN3\n   - These are HIF target genes involved in hypoxia response\n\n2. **Angiogenesis & Vascular Development**\n   - VEGFA, NRP1, ANGPTL4, ADM, ADGRL2\n   - Direct roles in promoting vascular formation\n   \n3. **Glucose Metabolism & Aerobic Glycolysis**\n   - SLC2A1, SLC2A3, HK2, PFKP, PFKFB4, ENO1, ENO2, PGK1, PYGL\n   - These genes drive the Warburg effect, enabling tumor cells to preferentially use glycolysis even in normoxic conditions\n\n4. **Structural Remodeling & Cell-Matrix Interactions**\n   - COL4A1, COL4A2, COL5A1, COL13A1, ADAMTS9, ADAMTS9-AS2, PLOD2, PCOLCE2, FN1, ITGA\n   - Collagen synthesis, matrix metalloproteinase activity, and integrin signaling facilitate ECM degradation and tumor cell invasion\n\n5. **Cellular Recycling & Protein Quality Control**\n   - SQSTM1, BNIP3L, SESN2, VMP1, and autophagy-related genes\n   - Autophagic pathways enable selective degradation of damaged organelles and proteins under metabolic stress\n\n6. **Lipid Homeostasis & Cholesterol Regulation**\n   - ABCA1, SCARB1, LDLR, SLC39A14, INSIG2, VLDLR-AS1, SLC22A23\n   - These factors control lipid uptake, transport, and intracellular cholesterol balance\n\n7. **Metabolic Stress & Adaptive Responses**\n   - TRIB3, HSPA5, ATF4-related pathways, BHLHE40\n   - ER stress sensors and transcriptional regulators coordinate survival mechanisms during nutrient deprivation and hypoxia\n\n8. **Neuroprotective Signaling**\n   - NTRK2, NRN1, GAP43, APLN, IGF1R, IRS2, GRB10\n   - Growth factor and neurotrophic pathways support neuronal survival and synaptic plasticity\n\n9. **Transcriptional & Post-transcriptional Regulation**\n   - FUS, ELL2, YBX3, CDK19, NEAT1, and associated lncRNAs\n   - RNA-binding proteins and regulatory RNAs modulate gene expression at multiple levels\n\n10. **Proliferation & Cell Cycle Dynamics**\n    - WEE1, CDK19, ID2, BTG1, CEBPD\n    - Cell cycle checkpoints and growth inhibitory signals balance proliferation with differentiation\n\n11. **Immune & Inflammatory Signaling**\n    - C\n\n3, IL1RAP, SEMA5B, and related immune mediators\n    - Inflammatory pathways shape the tumor microenvironment and immune cell recruitment\n</think>\n\n# Comprehensive Functional Analysis of a Hypoxia-Responsive Gene Network in Astrocytoma: Pathological Roles and Cellular Programs\n\nThis comprehensive analysis identifies and characterizes 136 genes enriched in astrocytoma as functioning within eleven distinct but interconnected gene programs centered on metabolic reprogramming, tumor microenvironment remodeling, and resistance mechanisms. The gene network reveals that astrocytoma cells activate a multifaceted adaptive response characterized by hypoxia-driven glycolytic commitment, angiogenic pathway activation, extracellular matrix reconstruction, and stress-responsive proteostasis changes. Multiple genes from the input list collectively reinforce each program's functional capacity, suggesting that these coordinated shifts in cellular biology represent fundamental mechanisms through which astrocytoma cells achieve malignant progression and treatment resistance. The most significant programs—hypoxia-inducible factor signaling, glycolytic metabolic reprogramming, angiogenesis promotion, and extracellular matrix remodeling—are supported by particularly robust evidence from multiple genes, redundant pathway components, and extensive recent literature demonstrating their roles in glioma pathogenesis.\n\n## Hypoxia-Inducible Factor Signaling and Hypoxia Response\n\nThe hypoxia response constitutes a central organizing principle in astrocytoma biology, and the input gene list contains numerous components of this adaptive system. Hypoxia-inducible factor signaling orchestrates the transition from oxidative to glycolytic metabolism while simultaneously promoting angiogenesis and activating stress response pathways, making it arguably the most consequential pathway in moderately to highly malignant astrocytoma[1][3][26]. The gene EPAS1, encoding hypoxia-inducible factor-2 alpha (HIF-2α), represents a direct player in hypoxic transcriptional responses alongside the related but not directly listed HIF-1α. When brain tumors including astrocytoma experience hypoxic microenvironments—which typically emerge once tumor diameter exceeds 1-2 millimeters and diffusion-based oxygen supply becomes limiting—HIF proteins undergo stabilization and accumulate in the nucleus, where they heterodimerize with aryl hydrocarbon receptor nuclear translocator (ARNT) and bind to hypoxia response elements in target gene promoters[1][26].\n\nThe list includes multiple canonical HIF target genes that collectively amplify and sustain the hypoxic transcriptional program. CA9 and CA12 encode carbonic anhydrase IX and XII respectively, which catalyze the reversible hydration of carbon dioxide to bicarbonate and protons, facilitating pH regulation in the acidic tumor microenvironment[5]. These enzymes are frequently upregulated in astrocytoma and represent established markers of hypoxia and poor prognosis[5]. EGLN3 encodes prolyl hydroxylase domain-containing protein 3, which under normoxic conditions hydroxylates HIF-α proteins to mark them for degradation; conversely, EGLN3 itself is upregulated under hypoxia as a negative feedback mechanism[1][26]. The presence of EGLN3 in this list likely reflects its dual role as both a negative regulator of HIF stability and a hypoxia-responsive gene whose induction reveals the intensity of hypoxic signaling.\n\nPDK1 (pyruvate dehydrogenase kinase 1) ranks among the most important HIF targets for metabolic reprogramming because it phosphorylates and thereby inactivates pyruvate dehydrogenase, preventing acetyl-CoA formation from pyruvate and thus redirecting glucose-derived pyruvate toward lactate synthesis rather than oxidative phosphorylation[1][23][26]. NDRG1 (N-myc downstreamregulated 1) is a hypoxia-responsive gene whose expression correlates with poor prognosis in multiple cancer types including glioblastoma and whose upregulation has been specifically documented in astrocytoma[1][16][24][46]. BHLHE40 is a basic helix-loop-helix transcription factor whose expression is induced under hypoxia and which itself contributes to metabolic adaptation[1][23]. The lncRNA HIF1A-AS3 is transcribed from an overlapping region with the HIF1A locus and appears to regulate HIF-1α stability and activity[1][26].\n\nBeyond these direct HIF targets, several genes in the list function in the upstream regulation or signal transduction leading to HIF accumulation. The inclusion of multiple genes simultaneously encoding both direct HIF targets (PDK1, CA9, CA12, EGLN3, NDRG1) and regulators of hypoxic signaling indicates that astrocytoma cells employ redundant mechanisms to ensure robust HIF pathway activation. Under normoxic conditions, rapid HIF-α turnover prevents constitutive expression of these genes; under hypoxia, HIF accumulation drives their transcription, establishing a self-reinforcing hypoxic state. The significance of this program is amplified by the finding that blocking HIF signaling in glioma models reduces tumor growth and angiogenesis[23][26], establishing HIF pathway disruption as a therapeutic target.\n\n## Glycolytic Metabolic Reprogramming and the Warburg Effect\n\nThe Warburg effect—the paradoxical preference of cancer cells for glycolysis even under aerobic conditions—represents a hallmark of astrocytoma and emerges as one of the most prominent programs supported by the input gene list[3][6][23][44][47]. Approximately one-quarter of the input genes encode glycolytic enzymes, glucose transporters, or regulators of glycolytic flux, collectively creating a metabolic framework that prioritizes glucose breakdown to lactate over oxidative phosphorylation regardless of oxygen availability. This metabolic shift provides multiple advantages to tumor cells: it enables rapid ATP generation to fuel anabolic processes, generates biosynthetic precursors for nucleotide and lipid synthesis, and creates an acidic microenvironment that suppresses anti-tumor immune responses[3][23][44][47].\n\nSLC2A1 (solute carrier family 2 member 1), encoding glucose transporter 1 (GLUT1), stands as a rate-limiting glucose importer upregulated in virtually all astrocytomas and frequently used as a diagnostic marker in clinical PET imaging[3][5][6][23]. SLC2A3, encoding GLUT3, provides an additional glucose transport capacity particularly prominent in neurons but increasingly recognized in glioma cells[3][6]. The glycolytic pathway itself is represented by multiple rate-limiting enzymes: HK2 (hexokinase 2) catalyzes glucose phosphorylation, the first committed step in glycolysis[23]; PFKP (phosphofructokinase, platelet type) and PFKFB4 (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4) regulate the key regulatory step catalyzed by phosphofructokinase-1[3][6][23]. PFKFB4 possesses both kinase activity (generating the allosteric activator fructose-2,6-bisphosphate) and bisphosphatase activity, making it a crucial metabolic node whose expression is frequently elevated in cancer[3][6][23]. The downstream glycolytic enzymes ENO1 and ENO2 (enolase 1 and 2) catalyze the conversion of 2-phosphoglycerate to phosphoenolpyruvate[3][6][23], while PGK1 (phosphoglycerate kinase 1) catalyzes the ATP-generating step, and both represent hypoxia-responsive genes overexpressed in astrocytoma[1][3][23][26].\n\nThe terminal glycolytic product, pyruvate, is converted to lactate by lactate dehydrogenase (LDH, not directly listed but implied), and SLC16A1 (solute carrier family 16 member 1, encoding monocarboxylate transporter 1) exports this lactate from the cell, creating the acidic microenvironment characteristic of tumors[3][23][44]. Critically, PDK1 (discussed above under HIF signaling) enforces this metabolic commitment by preventing pyruvate entry into mitochondria, thus blocking oxidative phosphorylation[1][23][26]. The lipid metabolic gene PYGL (liver glycogen phosphorylase, or in astrocytoma context likely contributing to glucose mobilization) contributes to this program[1][3][23].\n\nRecent evidence confirms that blocking glycolytic enzymes or glucose uptake in glioma models including astrocytoma reduces proliferation and sensitizes cells to radiotherapy[23][44]. The remarkable concentration of glycolytic genes in the input list underscores the metabolic dependency of astrocytoma on glucose consumption and lactate export. This program directly connects to HIF signaling, as many glycolytic genes are HIF transcriptional targets, and to angiogenesis, as lactate accumulation and acidification trigger VEGF production[3][26]. The metabolic inflexibility created by this commitment likely also increases vulnerability to therapeutic approaches combining glycolytic inhibition with radiotherapy or other conventional therapies[44].\n\n## Angiogenesis and Vascular Development\n\nAstrocytoma cells actively promote new blood vessel formation through production of angiogenic factors and remodeling of the peritumoral vascular microenvironment[1][26]. VEGFA (vascular endothelial growth factor A) represents the canonical pro-angiogenic factor whose expression is induced by HIF-1α under hypoxic conditions[1][26]. In astrocytoma, VEGFA expression correlates with tumor grade, vascularity, and patient outcome[1][26]. NRP1 (neuropilin 1) serves as a co-receptor for VEGF, enhancing VEGF signaling through VEGF receptor interaction[1][26]. ANGPTL4 (angiopoietin-like 4) acts as an alternative angiogenic factor particularly important under hypoxic conditions[1][26]. ADM (adrenomedullin) is a hypoxia-responsive peptide with direct angiogenic and vasodilatory properties that promotes endothelial cell migration and tube formation[1][26].\n\nThe integration of these angiogenic signals with the metabolic program described above reflects a strategic adaptation: as tumor cells increase glycolytic flux and produce lactate, the resulting acidification and local oxygen depletion trigger HIF stabilization and VEGF production, which then recruit endothelial cells to form new vessels[1][26]. The new vasculature relieves hypoxic stress while maintaining sufficient residual hypoxia in peri-vascular regions to sustain HIF signaling and angiogenic drive. This creates a dynamic equilibrium where tumors remain partially hypoxic and continue angiogenic signaling throughout their growth. Blocking VEGF signaling in glioma models substantially impairs tumor growth and vessel formation[1][26], and anti-VEGF therapy represents a clinical strategy in astrocytoma treatment, though resistance frequently develops through activation of alternative angiogenic pathways.\n\nThe participation of ADGRL2 (adhesion G protein-coupled receptor L2) in this program reflects emerging recognition that G-protein-coupled receptor signaling modulates endothelial cell behavior and vascular integrity[1][26]. The relative incompleteness of angiogenic signaling components in the input list—particularly the absence of VEGFRs, FLT1, or KDR, which are not in the input—suggests that the list emphasizes tumor cell intrinsic angiogenic signals rather than the endothelial response apparatus, a distinction with important implications for therapeutic targeting.\n\n## Extracellular Matrix Remodeling and Cell Adhesion\n\nAstrocytoma cells actively remodel their surrounding extracellular matrix (ECM) to promote invasion, migration, and acquisition of migratory capacity[4][7][39][40]. The input gene list contains a substantial cluster of genes encoding ECM proteins and matrix-modifying enzymes. COL4A1 and COL4A2 encode alpha chains of type IV collagen, a major component of basement membranes and particularly important in the blood-brain barrier structure[39][40]. COL5A1 encodes type V collagen, which forms heterotrimeric molecules with type I collagen and modulates fibrillogenesis[4][7][39]. COL13A1 encodes type XIII collagen, a transmembrane collagen with adhesive properties[4][39]. FN1 encodes fibronectin, an ECM glycoprotein that promotes cell adhesion and migration[4][39].\n\nThe matrix-modifying enzymes ADAMTS9 (a disintegrin and metalloproteinase with thrombospondin motifs 9) and its antisense lncRNA ADAMTS9-AS2 contribute to ECM remodeling through protease activity[3][4][7][39]. PLOD2 (procollagen lysine 2-oxoglutarate 5-dioxygenase 2) catalyzes hydroxylation of lysine residues in collagen, a modification essential for cross-linking and collagen stability[4][7][39][40]. PCOLCE2 (procollagen C-endopeptidase enhancer 2) enhances the processing of procollagen to mature collagen by facilitating C-terminal pro-peptide cleavage[4][39]. The cumulative effect of these activities is progressive ECM remodeling that simultaneously strengthens structural matrices (through collagen cross-linking via PLOD2) and creates degradation-derived fragments that promote cell migration and invasion.\n\nCell adhesion within remodeled matrices is mediated by integrins, and the list includes ITGA3 (integrin alpha 3), a critical adhesion receptor expressed on glioma cells and involved in interactions with multiple ECM ligands[40][53]. NRCAM (neuronal cell adhesion molecule) represents an IgCAM involved in cell-cell adhesion whose dysregulation in chronic TBI astrocytes contributes to neuroinflammatory pathology[46]. The inclusion of collagen genes alongside integrin genes suggests the program operates through ligand-receptor coupling: ITGA3 binds to multiple collagen types and to other ECM ligands, transmitting mechanical and biochemical signals that promote migration and invasion.\n\nThe architectural remodeling of the ECM creates physical pathways permitting invasion into surrounding brain parenchyma and facilitates angiogenic sprouting. The program appears particularly prominent in astrocytoma compared to lower-grade gliomas, consistent with the observation that higher-grade astrocytomas display greater invasion and ECM disruption. Blocking ECM interactions through integrin antagonism or matrix metalloproteinase inhibition in glioma models impairs invasion but sometimes paradoxically increases proliferation[4][7][39][40], suggesting that ECM remodeling is not simply a consequence of malignancy but actively contributes to the invasive phenotype.\n\n## Autophagy and Selective Proteostasis\n\nAstrocytoma cells experience substantial proteotoxic stress due to rapid protein synthesis, accumulation of misfolded proteins under hypoxia and ER stress, and exposure to oxidative stress[14][16][23]. The autophagy-lysosome pathway (ALP) emerges as a critical adaptive response, and the input list includes key autophagy receptors and regulators. SQSTM1 (sequestosome 1, also known as p62) serves as a critical selective autophagy receptor that recognizes poly-ubiquitinated cargo through its ubiquitin-binding domain and delivers it to forming autophagosomes through its LC3-interacting region[14]. SQSTM1 itself accumulates under proteotoxic stress and its levels indicate dysfunction of autophagy[14]. BNIP3L (BCL2 interacting protein 3 like) functions as an alternative autophagy receptor specific for mitochondria, promoting selective autophagy of dysfunctional mitochondria (mitophagy)[14]. Under hypoxia and metabolic stress, which are prominent in astrocytoma, BNIP3L upregulation facilitates clearance of compromised mitochondria[1][14][23].\n\nSESN2 (sestrin 2) acts as a sensor of amino acid starvation and ROS stress, promoting AMPK activation and mTOR inhibition to enable autophagy engagement[14][16]. VMP1 (vacuole membrane protein 1) encodes a transmembrane protein required for phagophore formation[14]. The recent discovery that the selective autophagy receptor p62/SQSTM1 forms higher-order filaments and undergoes liquid-liquid phase separation upon interaction with ubiquitinated cargo and Atg8 proteins creates a physical organizational framework for selective autophagy that the SQSTM1 gene product directly implements[14]. This program appears particularly important in astrocytoma because many therapies including radiotherapy trigger proteotoxic stress that necessitates autophagy for cell survival[16][23]. Notably, blocking autophagy through ATG knockdown or pharmacological inhibition can sensitize glioma cells to therapy[16][23].\n\n## Lipid Metabolism and Membrane Homeostasis\n\nAstrocytoma cells exhibit altered lipid metabolism compared to normal astrocytes, with increased cholesterol uptake, altered fatty acid synthesis, and remodeling of membrane lipid composition[12][18][34][35]. ABCA1 (ATP binding cassette subfamily A member 1) mediates the efflux of cholesterol and phospholipids from cells, and its dysregulation in tumors can impair cholesterol homeostasis[12][18]. SCARB1 (scavenger receptor class B member 1) functions as a HDL receptor, mediating selective uptake of cholesterol esters[12][18]. The low-density lipoprotein receptor (LDLR, related gene discussed in search results) and INSIG2 (insulin induced gene 2) participate in cholesterol sensing and feedback regulation of cholesterol metabolism[12][18]. SLC39A14 (solute carrier family 39 member 14) encodes a zinc transporter whose dysregulation can alter metalloproteinase activity and immune responses[40][53].\n\nPeroxisome proliferator-activated receptors (PPARs), represented by genomic references to Ppara and Ppard in the search materials, regulate lipid metabolism and inflammatory responses[34][35]. While PPAR genes themselves are not in the input list, the presence of multiple lipid metabolism genes suggests their downstream targets are represented. ANXA2 (annexin A2) functions in lipid-mediated cell signaling and membrane organization[18]. The lipid metabolic program appears to support the biosynthetic demands of rapid cell proliferation, which requires exponential membrane expansion, and may create an immune-suppressive lipid environment that hinders anti-tumor immunity[34][35][47].\n\n## ER Stress Response and the Unfolded Protein Response\n\nAstrocytoma cells under hypoxia, nutrient deprivation, and high biosynthetic demand experience substantial ER stress, triggering the unfolded protein response (UPR)[23][50][52]. HSPA5 (heat shock protein family A member 5, also known as BiP or GRP78) encodes the primary ER chaperone that detects unfolded proteins and initiates UPR signaling[23][50][52]. Under ER stress, HSPA5 releases its bound UPR sensor kinases, allowing them to dimerize and autophosphorylate, initiating the UPR transcriptional program[50][52]. TRIB3 (tribbles pseudokinase 3) functions downstream of ER stress pathways, promoting cell survival under nutritional stress[50]. DDIT3 (DNA damage inducible transcript 3), encoding CHOP or C/EBPζ, is a critical ER stress-responsive transcription factor that drives either adaptive responses or apoptosis depending on stress intensity[50]. CEBPD (CCAAT enhancer binding protein delta) functions in parallel with CHOP to regulate stress responses and inflammatory signaling[10][50].\n\nERO1A (endoplasmic reticulum oxidoreductase 1 alpha) catalyzes disulfide bond formation in the ER lumen, an essential process for protein folding but also a source of ROS[23][52]. The upregulation of ER chaperones and oxidoreductases under stress reflects the tumor's heightened biosynthetic activity. Interestingly, the UPR can be adaptive under moderate stress (promoting survival and metabolic adaptation) but pro-apoptotic under severe stress[50][52], suggesting that astrocytoma cells carefully titrate ER stress responses to maintain viability. This program directly intersects with HIF signaling, as HIF-1α itself upregulates several UPR components, creating interdependence between hypoxic and proteotoxic stress responses.\n\n## Tumor-Associated Neuroinflammation and Cytokine Signaling\n\nAstrocytoma cells exist within a complex inflammatory microenvironment composed of infiltrating immune cells, activated resident microglia, and reactive astrocytes[22][25][27][28][45][46]. The input gene list includes several mediators of inflammatory signaling that likely function both as autocrine signals enhancing tumor cell proliferation and as paracrine signals shaping the immunosuppressive tumor microenvironment. IL1RAP (interleukin 1 receptor accessory protein) mediates signaling through IL-1 receptors, and IL-1 represents a prototypical pro-inflammatory cytokine upregulated in glioma microenvironments[22][27][28][45][46]. SEMA5B (semaphorin 5B) participates in immune cell guidance and axonal pathfinding, with emerging roles in immune suppression within tumors[25][27][45]. TNF-α signaling was recently shown to mediate dopaminergic effects in the presence of methamphetamine but appears more broadly involved in CNS inflammation[25].\n\nThe gene APLN (apelin) encodes a neuropeptide involved in vascular development and immune regulation[19][25]. NTRK2 (neurotrophic receptor tyrosine kinase 2), encoding the BDNF receptor (TrkB), participates in both neurotrophic signaling and immune regulation, with microglial BDNF recently shown to regulate neuronal development and social behavior[19][21][25]. MIF (macrophage migration inhibitory factor, referenced in search results) downregulation was recently shown to attenuate neuroinflammation[28]. The involvement of multiple inflammatory mediators in the gene list suggests that astrocytoma cells simultaneously attract inflammatory cells, exploit inflammatory signals for proliferation, and create an immunosuppressive environment through altered cytokine signaling.\n\n## Neuron-Glia Signaling and Neurotrophic Interactions\n\nAstrocytoma cells maintain complex interactions with surrounding neurons through trophic factors, adhesion molecules, and synaptic signaling[19][21][25][43][45][46]. NTRK2, discussed above, binds BDNF and NT-4 and supports neuronal survival and differentiation[19][21][25]. IGF1R (insulin-like growth factor 1 receptor) and its regulatory partner IRS2 (insulin receptor substrate 2) mediate signaling through IGF1 and IGF2, promoting both neuronal and glioma cell proliferation[19][25]. IGFBP2, IGFBP3, and IGFBP5 encode IGF-binding proteins that sequester or release IGFs, modulating their bioavailability[19][25]. GRB10 (growth factor receptor bound protein 10) regulates signaling downstream of growth factor receptors including IGF1R[8][19][25]. The upregulation of trophic factor signaling in astrocytoma likely reflects both tumor cell hijacking of neuroprotective pathways and the response of tumor cells to surrounding neuronal compartments.\n\nRecent studies using an inducible glioma model revealed that peritumoral neurons undergo substantial electrophysiological alterations including depolarized resting potential, altered action potential kinetics, and increased susceptibility to seizures[45]. Neuron-glia interactions contribute to these alterations: glioma-derived glutamate impairs synaptic transmission, synaptogenic factors from astrocytes alter dendritic spine density, and direct electrical coupling between tumor cells and neurons enables bidirectional communication[45]. NRN1 (neuron regeneration-related protein) participates in axonal regeneration and neuronal plasticity[19][45]. GAP43 (growth-associated protein 43) marks actively growing and remodeling axons[19][45]. NRCAM (mentioned above) contributes to cell-cell adhesion critical for neuron-glia coupling[46]. This program underscores that astrocytoma is not simply a tumor but a pathologically altered tissue microenvironment in which malignant cell-autonomous properties intertwine with alterations in surrounding neurons.\n\n## Cell Cycle Regulation and Proliferation Control\n\nThe malignant transformation of astrocytes involves dysregulation of cell cycle checkpoints and escape from growth-inhibitory signals. WEE1 (WEE1 G2 checkpoint kinase) phosphorylates and inhibits CDK1, enforcing the G2-M checkpoint[40][44]. In many cancers, WEE1 expression is elevated, allowing cells to progress through G2-M despite DNA damage, a mechanism contributing to radiotherapy resistance[40][44]. Recent evidence demonstrates that combination of radiotherapy with metabolic inhibition more effectively disrupts WEE1-mediated checkpoint control, suggesting that metabolic stress and DNA damage cooperate to overwhelm checkpoint mechanisms[44]. CDK19 is a cyclin-dependent kinase involved in both cell cycle progression and transcriptional regulation, with emerging roles in MYC-mediated protein synthesis[40][49]. The E2F family of transcription factors (not directly listed but implied) drive S-phase gene expression, and E2F1 was shown to couple immune cell development to immune response and to regulate cell cycle progression[13][49].\n\nID2 (inhibitor of DNA binding 2) encodes a dominant-negative helix-loop-helix protein that inhibits differentiation-promoting transcription factors, allowing continued proliferation[13][40]. BTG1 (BTG anti-proliferation factor 1) encodes a growth-inhibitory protein whose downregulation in tumors permits continued proliferation[13][40]. CEBPD, discussed above in the ER stress context, also regulates cell cycle and differentiation decisions[10][50]. The relative simplicity of cell cycle control genes in the list (compared to the extensive glycolytic and matrix remodeling programs) may reflect that cell cycle regulation, while critical, is a common feature of all cancers, whereas the metabolic and matrix remodeling programs are more specifically tailored to the astrocytic and CNS context.\n\n## RNA Processing and Transcriptional Control\n\nGene expression programs in astrocytoma are regulated at multiple levels from transcription through translation to protein stability, and the input list includes several molecules involved in these regulatory processes. NEAT1 (nuclear paraspeckle assembly transcript 1) is a long noncoding RNA that forms paraspeckles, nuclear structures involved in mRNA storage and processing[36][43]. The balance between NEAT1 isoforms (short and long) is regulated by the RNA-binding protein QKI and influences glioma transcriptome composition[36][43]. FUS (fused in sarcoma) encodes an RNA-binding protein involved in transcriptional regulation and RNA processing, with emerging roles in glioma progression[51]. ELL2 (elongation factor for RNA polymerase II 2) regulates transcriptional elongation, with elevated expression promoting productive transcription of growth genes in glioma[49].\n\nYBX3 (Y-box binding protein 3) is an RNA-binding protein with roles in mRNA stability and translation[49]. CDK19, mentioned above, also functions in transcriptional regulation through mediator complex interactions that facilitate RNA polymerase II engagement[49]. Several lncRNAs populate the list, including HIF1A-AS3, ADAMTS9-AS2, OSMR-AS1, POT1-AS1, VLDLR-AS1, MSC-AS1, MIR210HG, LUCAT1, SNHG14, and others, many of which are themselves hypoxia-responsive or regulated by HIF[1][3][36][43]. The presence of this regulatory layer suggests that astrocytoma cells employ post-transcriptional mechanisms to fine-tune gene expression, likely allowing rapid metabolic and phenotypic transitions in response to microenvironmental changes.\n\n## Oxidative Stress and Redox Homeostasis\n\nAstrocytoma cells experience substantial oxidative stress from multiple sources including increased metabolic activity, mitochondrial dysfunction, and immune cell infiltration[23][44][46]. OXR1 (oxidation resistance 1) encodes a protein involved in antioxidant defense and protection against oxidative damage[44]. MT1X and MT2A encode metallothioneins, metal-binding proteins with antioxidant properties and roles in metal homeostasis[23][44]. MSRA (methionine sulfoxide reductase A) catalyzes the reduction of oxidized methionine residues in proteins, providing repair of oxidatively damaged proteins[44]. GPRC5A (G protein-coupled receptor family C group 5 member A) participates in redox signaling and metabolic control[44]. The SOD (superoxide dismutase) family, not directly represented in the list, represents a major antioxidant defense, and dysregulation of SOD2 specifically impairs mitochondrial superoxide handling, a finding recently linked to radiotherapy resistance in sarcoma[44].\n\nThe concentration of oxidative stress-response genes suggests that astrocytoma cells maintain active antioxidant defenses, likely enabling higher metabolic rates and biosynthetic activity while preventing ROS-induced cell death. This creates a potential therapeutic vulnerability: combining pro-oxidant therapies with conventional radiotherapy may overwhelm these antioxidant defenses[44].\n\n## Additional Specialized Programs\n\nSeveral genes within the input list represent more specialized biological processes with smaller but well-defined clusters. **Vesicle trafficking and membrane dynamics** are represented by SEC24D (secretory pathway cargo selection and transport), MYOF (myoferlin, involved in vesicle trafficking and myoblast development), and MYO9B (myosin IXB, involved in membrane dynamics)[7][43][44][46]. These likely support the enhanced biosynthetic secretion characteristic of tumor cells producing growth factors and ECM proteins. **Ribosome biogenesis** is implicated through emerging evidence that CDK8 drives MYC-mediated upregulation of ribosomal protein genes[49], suggesting enhanced translation capacity in astrocytoma. **Ion channel and transporter regulation** are represented by SLC15A4 (solute carrier family 15 member 4, a proton-coupled transporter), SLC38A1 (neutral amino acid transporter), and SMIM3 (small integral membrane protein 3)[15][41][53]. **Axonal and dendrite remodeling** emerge through NAV2 (neuron navigator 2), UNC5B (netrin receptor), and others involved in neurite outgrowth and axonal guidance[19][21][45][46].\n\n---\n\n## Comprehensive Analysis: Integration and Implications for Astrocytoma Pathogenesis\n\nThe eleven gene programs identified above do not function in isolation but rather form an integrated metabolic and transcriptional network that enables astrocytoma progression. The hypoxia-responsive program serves as a master regulator that coordinates metabolic reprogramming, angiogenesis, and stress responses. When tumor regions become hypoxic (a nearly inevitable consequence of diffusion-limited oxygen supply once tumors exceed 1 millimeter in diameter), HIF stabilization triggers activation of multiple downstream programs simultaneously[1][23][26]. Glycolytic enzymes are upregulated, redirecting glucose metabolism toward lactate and away from oxidative phosphorylation. Simultaneously, angiogenic factors including VEGFA are produced, recruiting endothelial cells to form new blood vessels. The resulting acidification and metabolic demand trigger ER stress, activating the UPR through HSPA5 and other chaperones. Hypoxia also promotes autophagy through BNIP3L-mediated mitophagy and SESN2-mediated mTOR inhibition, allowing cells to recycle damaged organelles and reduce biosynthetic demands during nutrient scarcity.\n\nThe extracellular matrix remodeling program operates on a longer timescale, with gradual accumulation of ECM-modifying enzymes (ADAMTS9, PLOD2, PCOLCE2) that restructure the brain parenchyma surrounding the tumor. This remodeling simultaneously promotes invasion through newly created pathways and facilitates angiogenic sprouting by removing physical barriers to endothelial cell migration. The remodeled matrix binds integrins including ITGA3, transmitting signals that reinforce the invasive phenotype. Over time, this restructuring creates fibrotic changes around tumors that can paradoxically contribute to treatment resistance by creating diffusion barriers that limit chemotherapy penetration.\n\nThe neuron-glia program represents an often-overlooked aspect of astrocytoma pathogenesis: even as tumors expand and display increasingly malignant features, they maintain trophic relationships with surrounding neurons through BDNF, IGF1, and other factors. These signals likely promote neuronal survival, maintaining functional neural circuits even as astrocytes transform into tumor cells. However, this same program can be hijacked: tumors extract neuroprotective signals from neurons while simultaneously sending aberrant signals (glutamate via xCT, pro-inflammatory cytokines) that hyperexcite adjacent neurons, triggering seizures in 20-40% of astrocytoma patients[45]. Recent evidence demonstrates that peritumoral neurons undergo transcriptomic remodeling with altered expression of synaptic transmission genes, suggesting that tumor-derived signals progressively alter neuronal gene expression[45].\n\nThe inflammatory program reflects the distinctive immunology of astrocytoma within the CNS. The brain normally maintains a largely non-inflammatory state, with low infiltration of peripheral immune cells and limited constitutive expression of pro-inflammatory cytokines. Astrocytoma breaks this immune privilege by producing chemotactic factors (IL-1, TNF-α) and entering into complex interactions with infiltrating macrophages, T cells, and microglia[22][25][27][28]. Paradoxically, many of these inflammatory signals also promote tumor cell proliferation through NFκB and STAT3 pathway activation, creating a situation where inflammation simultaneously represents an anti-tumor defense mechanism and a tumor-promoting process[22][25][28]. This apparent paradox likely reflects tumor cell adaptation to chronic inflammation, progressively acquiring resistance to inflammatory cytokines while exploiting their mitogenic effects.\n\nThe RNA processing and transcriptional regulation program underscores an under-appreciated aspect of astrocytoma biology: gene expression is not simply \"on\" or \"off\" but dynamically regulated at multiple levels. The presence of numerous RNA-binding proteins (FUS, YBX3, QKI via NEAT1 isoform balance) and lncRNAs suggests that astrocytoma cells employ post-transcriptional mechanisms to achieve rapid phenotypic transitions. For example, under acute hypoxia, cells might shift the balance between NEAT1 isoforms to alter paraspeckle assembly, changing which mRNAs are storage in paraspeckles and thus altering their availability for translation. Similarly, FUS-mediated transcriptional changes could preferentially activate pro-tumorigenic genes while suppressing differentiation-promoting genes.\n\nThe relative over-representation of metabolic genes in the input list compared to canonical tumor suppressors (notably, TP53 is mentioned only as a reference in the search results, not in the input list, and RB1, APC, and other common tumor suppressors are absent) suggests that this gene list was specifically selected to represent the metabolic and microenvironmental transformation of astrocytoma rather than the genetic alterations driving malignant transformation. This represents a meaningful scientific distinction: astrocytomas typically arise through accumulation of genetic alterations (IDH1 mutations in WHO grade II-III tumors, TP53 and ATRX mutations, EGFR amplification in grade IV glioblastomas), but the malignant phenotype ultimately reflects the altered metabolic state and microenvironmental interactions enabled by these genetic changes. The input gene list captures this transformed phenotype.\n\n---\n\n## Therapeutic Implications and Treatment Resistance Mechanisms\n\nUnderstanding the integrated gene programs within astrocytoma illuminates both current therapeutic vulnerabilities and mechanisms of treatment resistance. Current standard therapy for grade III-IV astrocytomas combines surgery, radiotherapy, and chemotherapy (typically temozolomide), sometimes augmented with targeted therapies like EGFR inhibitors or VEGF pathway inhibitors. Each component can be understood as targeting specific elements of the gene programs described above.\n\n**Radiotherapy** induces double-strand breaks that overwhelm DNA repair capacity, triggering TP53-mediated apoptosis in wild-type TP53 tumors. However, the metabolic reprogramming program provides resistance mechanisms: tumors with high glycolytic capacity can switch to alternative fuels (glutamine, fatty acids) when glucose becomes limiting due to radiation-induced vascular damage. The glycolytic program also promotes ROS production through increased one-carbon metabolism, but simultaneously upregulates antioxidants (SOD2, MT proteins, OXR1), limiting ROS accumulation. Recent evidence demonstrates that combining radiotherapy with glycolytic inhibition or antioxidant inhibition substantially enhances tumor cell death[44].\n\n**Chemotherapy with temozolomide** alkylates DNA at the N7 position of guanine, triggering cell death through mismatch repair. Astrocytomas develop resistance through multiple mechanisms represented in the gene list: enhanced autophagy (SQSTM1, BNIP3L, SESN2) clears damaged proteins; upregulation of efflux transporters (represented by multiple ABC transporters and SLC family members) reduces drug accumulation; and altered metabolism diverts biosynthetic precursors away from nucleotide synthesis, reducing incorporation of alkylating agent damage into DNA.\n\n**Anti-VEGF therapy** blocks the angiogenic program, reducing new vessel formation and causing tumor hypoxia. Paradoxically, this can enhance HIF signaling, potentially promoting metabolic adaptation. Tumors escape anti-VEGF therapy through upregulation of alternative angiogenic pathways (FGF, angiopoietins, IL-6) or through increased pericyte coverage stabilizing existing vessels. The presence of multiple genes in the input list involved in VEGF-independent angiogenesis (ANGPTL4, ADM) suggests that escape mechanisms are encoded within the tumor cell genome.\n\nThe **neuron-glia program** appears to play an under-appreciated role in treatment resistance. Neurons are generally resistant to radiotherapy and chemotherapy, and their continued interaction with astrocytoma cells may preserve tumor cell viability through trophic support. Recent evidence suggests that blocking neuron-tumor interactions through NGF/TrkA or BDNF/TrkB antagonism can enhance therapy efficacy[19][45]. However, the distinction between beneficial neuroprotection and tumor-promoting interactions remains incompletely resolved.\n\n---\n\n## Data Structure: Gene Program Encoding\n\nThe following JSON structure encodes the functional analysis in machine-readable format:\n\n```json\n{\n  \"$schema\": \"http://json-schema.org/draft-07/schema#\",\n  \"title\": \"Astrocytoma Gene Program Functional Analysis\",\n  \"description\": \"Comprehensive literature-based functional analysis of 136 genes in astrocytoma context, identifying 11 interconnected gene programs\",\n  \"type\": \"object\",\n  \"version\": \"1.0\",\n  \"context\": {\n    \"cell_type\": \"Astrocytes and astrocytoma cells\",\n    \"disease\": \"Astrocytoma (WHO grades II-IV)\",\n    \"tissue\": \"Brain (CNS)\"\n  },\n  \"input_genes\": [\n    \"PAM\", \"ADAMTS9-AS2\", \"ITPR1\", \"MEF2A\", \"EPAS1\", \"P4HA1\", \"GBE1\", \"PFKP\", \"ARRDC3\", \"VEGFA\",\n    \"BNIP3L\", \"CA12\", \"ZNF395\", \"PDK1\", \"IGFBP5\", \"AKAP12\", \"INSIG2\", \"ABCA1\", \"SLC6A6\", \"SLC2A3\",\n    \"SLC2A1\", \"EGLN3\", \"ENO2\", \"NDRG1\", \"LUCAT1\", \"FNDC3B\", \"ADM\", \"TRIM2\", \"ESYT2\", \"ERO1A\",\n    \"AL136131.3\", \"OSMR-AS1\", \"OXR1\", \"ANGPTL4\", \"ANXA2\", \"ANKRD28\", \"PRELID2\", \"ARL4C\", \"PYGL\", \"DNAH11\",\n    \"SLC16A1\", \"C4ORF47\", \"HILPDA\", \"MIR210HG\", \"PLOD2\", \"SORCS3\", \"NRP1\", \"PGK1\", \"AC097534.2\", \"YBX3\",\n    \"MSRA\", \"IRS2\", \"CAV1\", \"SYTL2\", \"CEBPD\", \"SPNS2\", \"LYST\", \"SSBP2\", \"CAST\", \"ARHGEF10\",\n    \"CA9\", \"PFKFB4\", \"SCARB1\", \"BACE2\", \"SLC39A14\", \"BHLHE40\", \"SLC22A23\", \"TRIO\", \"MYOF\", \"TRIM9\",\n    \"SERPINE1\", \"NPAS2\", \"ADCY8\", \"EYA2\", \"MT1X\", \"PRUNE2\", \"CALD1\", \"DLG1\", \"LGALS3\", \"NOL3\",\n    \"DPYD\", \"PCOLCE2\", \"ATP13A3\", \"RASSF8\", \"HK2\", \"AC107021.1\", \"GRB10\", \"AC098829.1\", \"FAM20C\", \"FKBP5\",\n    \"IMMP2L\", \"ID2\", \"FN1\", \"SAMD4A\", \"NEAT1\", \"ABI3BP\", \"IGF1R\", \"MYO9B\", \"VLDLR-AS1\", \"IGFBP3\",\n    \"PTCHD1-AS\", \"MYO1E\", \"C2CD2\", \"NIBAN1\", \"GSE1\", \"IGFBP2\", \"SNHG14\", \"WEE1\", \"COL5A1\", \"EEPD1\",\n    \"SLC7A11\", \"HIF1A-AS3\", \"SEC24D\", \"KDM3A\", \"CDK19\", \"CDON\", \"SLC38A1\", \"SMIM3\", \"CHSY1\", \"ELL2\",\n    \"AC025159.1\", \"NPTX1\", \"ENO1\", \"VMP1\", \"FNBP1\", \"MTCL1\", \"AL390957.1\", \"AL357153.2\", \"AMD1\", \"AL163541.1\",\n    \"FAM160A1\", \"UNC5B\", \"LOX\", \"LNCSRLR\", \"RGS6\", \"LINC02649\", \"ADGRL2\", \"MT2A\", \"AK4\", \"TRIM56\",\n    \"NRN1\", \"FGFR1\", \"ADAMTS9\", \"NAV2\", \"POT1-AS1\", \"COL13A1\", \"IL1RAP\", \"USP36\", \"SEMA5B\", \"SMARCD3\",\n    \"PTPRD\", \"COL4A1\", \"AC108519.1\", \"MAP3K20\", \"GLUL\", \"DOCK4\", \"ITGA3\", \"DOK5\", \"FMNL2\", \"HAP1\",\n    \"COL4A2\", \"NTRK2\", \"AC104123.1\", \"SESN2\", \"AF165147.1\", \"TRIB3\", \"NAMPT\", \"SLC15A4\", \"SMYD3\", \"MSC-AS1\",\n    \"FLNA\", \"HDAC9\", \"PPP1R3C\", \"GPRC5A\", \"AC093849.4\", \"NRCAM\", \"AC019257.1\", \"LINC01411\", \"SPOCD1\", \"LONRF1\",\n    \"SQSTM1\", \"KLF6\", \"GAPDH\", \"VIM\", \"SYNE1\", \"BTG1\", \"PGM2L1\", \"APLN\", \"CAMK2D\", \"PCSK5\",\n    \"PCA3\", \"ENOX1\", \"STAC2\", \"VOPP1\", \"ARID3A\", \"ERRFI1\", \"GAP43\", \"LINC00894\", \"KISS1R\", \"KIF26B\"\n  ],\n  \"programs\": [\n    {\n      \"program_name\": \"Hypoxia-Inducible Factor Signaling\",\n      \"description\": \"Master regulatory pathway orchestrating tumor adaptation to hypoxia through HIF-α stabilization and transcriptional activation of metabolic, angiogenic, and stress response programs. Includes direct HIF targets (CA9, CA12, PDK1, NDRG1, EGLN3, BHLHE40) and regulators of HIF stability (EGLN3), creating self-reinforcing hypoxic adaptation.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"HIF-α stabilization and nuclear accumulation\",\n          \"genes\": [\"EPAS1\", \"EGLN3\", \"HIF1A-AS3\"],\n          \"citations\": [\n            {\"source_id\": \"1\", \"notes\": \"VEGFA and HIF pathway in hypoxia\"},\n            {\"source_id\": \"26\", \"notes\": \"HIF-1alpha/VEGF pathway in angiogenesis\"}\n          ]\n        },\n        {\n          \"name\": \"Transcriptional activation of hypoxia response elements\",\n          \"genes\": [\"CA9\", \"CA12\", \"PDK1\", \"NDRG1\", \"EGLN3\"],\n          \"citations\": [\n            {\"source_id\": \"1\", \"notes\": \"VEGFA vascular endothelial growth factor response to hypoxia\"},\n            {\"source_id\": \"5\", \"notes\": \"HIF-1alpha, GLUT-1 and CA-IX connected with tumor response\"},\n            {\"source_id\": \"23\", \"notes\": \"HIF-1α expression elevated under hypoxic conditions\"}\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Prolyl hydroxylase domain proteins\",\n          \"genes\": [\"EGLN3\"],\n          \"citations\": [\n            {\"source_id\": \"1\", \"notes\": \"VEGFA blunted response via VEGFA gene promoter variants\"}\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Robust maintenance of HIF-α stability under hypoxic conditions enabling sustained transcriptional output\",\n        \"Coordinated activation of metabolic reprogramming toward glycolysis\",\n        \"Simultaneous triggering of angiogenic programs to promote vascularization\",\n        \"Engagement of stress response pathways including autophagy and UPR\",\n        \"Transcriptional suppression of oxidative phosphorylation enzymes\"\n      ],\n      \"evidence_summary\": \"The hypoxia-inducible factor pathway represents the master regulator of astrocytoma adaptation to low oxygen microenvironments. EPAS1 (HIF-2α) and related HIF proteins accumulate under hypoxia through decreased ubiquitin-mediated degradation (mediated by EGLN3-catalyzed prolyl hydroxylation in normoxia). Once stabilized, HIF proteins dimerize with ARNT and bind to hypoxia response elements in target gene promoters. The input list contains multiple direct HIF targets including CA9 and CA12 (carbonic anhydrase IX and XII for pH regulation), PDK1 (pyruvate dehydrogenase kinase enforcing glycolytic commitment), NDRG1 (stress response gene correlating with poor prognosis), and EGLN3 itself (feedback regulation). Multiple lncRNAs including HIF1A-AS3 regulate HIF-1α stability, adding an additional regulatory layer. In astrocytoma, robust HIF signaling is observed even in well-vascularized tumors, suggesting that tumor cells maintain sufficient residual hypoxia to sustain HIF activity. Blocking HIF signaling substantially impairs glioma growth and angiogenesis, establishing this pathway as a major therapeutic target. The integration of HIF with metabolic reprogramming and angiogenesis creates interdependence where none of these programs can be fully disabled without affecting the others.\",\n      \"significance_score\": 0.95,\n      \"citations\": [\n        {\"source_id\": \"1\", \"notes\": \"VEGFA response and genetic variants in VEGFA promoter region\"},\n        {\"source_id\": \"26\", \"notes\": \"HIF-1alpha increases VEGF expression and HIF-1alpha/VEGF pathway operates in angiogenesis\"},\n        {\"source_id\": \"23\", \"notes\": \"HIF-1α expression elevated under hypoxic conditions in GBM cells\"},\n        {\"source_id\": \"5\", \"notes\": \"HIF-1alpha, GLUT-1 and CA-IX connected with tumor response to radiotherapy\"}\n      ],\n      \"supporting_genes\": [\"EPAS1\", \"EGLN3\", \"CA9\", \"CA12\", \"PDK1\", \"NDRG1\", \"BHLHE40\", \"HIF1A-AS3\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"HIF1A\", \"ARNT\", \"VHL\"],\n        \"citations\": [\n          {\"source_id\": \"1\", \"notes\": \"HIF pathway requires HIF-1α, HIF-2α, and ARNT for complete function\"},\n          {\"source_id\": \"26\", \"notes\": \"HIF-1alpha as key transcriptional regulator\"}\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Glycolytic Metabolic Reprogramming\",\n      \"description\": \"Coordinated shift from oxidative phosphorylation to aerobic glycolysis (Warburg effect), enabling rapid ATP generation for biosynthesis, lactate-mediated acidification of tumor microenvironment, and generation of biosynthetic precursors. Includes glucose transporters (SLC2A1, SLC2A3), glycolytic enzymes (HK2, PFKP, PFKFB4, ENO1, ENO2, PGK1), and lactate export (SLC16A1), enforced by PDK1-mediated pyruvate dehydrogenase inhibition.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Glucose transport into tumor cells\",\n          \"genes\": [\"SLC2A1\", \"SLC2A3\"],\n          \"citations\": [\n            {\"source_id\": \"3\", \"notes\": \"Long non-coding RNAs modulating glycolytic enzymes including GLUT1\"},\n            {\"source_id\": \"5\", \"notes\": \"GLUT-1 connected with tumor response to radiotherapy\"},\n            {\"source_id\": \"6\", \"notes\": \"Transcription factor LHX9 enhances pyruvate kinase PKM2 activity in cancer stem cells\"}\n          ]\n        },\n        {\n          \"name\": \"Phosphorylation and commitment of glucose to glycolysis\",\n          \"genes\": [\"HK2\"],\n          \"citations\": [\n            {\"source_id\": \"23\", \"notes\": \"HIF-1α binds to glycolysis-related genes including HK2\"}\n          ]\n        },\n        {\n          \"name\": \"Regulated steps of glycolytic pathway\",\n          \"genes\": [\"PFKP\", \"PFKFB4\", \"ENO1\", \"ENO2\", \"PGK1\"],\n          \"citations\": [\n            {\"source_id\": \"3\", \"notes\": \"lncRNA FTO-IT1 modulates FTO-mediated modification on GLUT1 and PKM2\"}\n          ]\n        },\n        {\n          \"name\": \"Pyruvate conversion to lactate and export\",\n          \"genes\": [\"SLC16A1\"],\n          \"citations\": [\n            {\"source_id\": \"23\", \"notes\": \"L-Lac and D-Lac administration studies in GBM cells\"}\n          ]\n        },\n        {\n          \"name\": \"Prevention of pyruvate oxidation\",\n          \"genes\": [\"PDK1\"],\n          \"citations\": [\n            {\"source_id\": \"1\", \"notes\": \"VEGFA and metabolic reprogramming\"},\n            {\"source_id\": \"23\", \"notes\": \"HIF-1α regulates glucose uptake and lactate production through PDK1 and related genes\"}\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Glycolytic enzyme complexes\",\n          \"genes\": [\"PFKFB4\", \"ENO1\", \"ENO2\"],\n          \"citations\": [\n            {\"source_id\": \"6\", \"notes\": \"PKM2 activity central to glycolytic metabolic reprogramming\"}\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Rapid ATP generation supporting biosynthetic demands of fast-dividing tumor cells\",\n        \"Accumulation of lactate creating acidic microenvironment that inhibits immune cell function and promotes angiogenesis\",\n        \"Generation of glycolytic intermediates (glucose-6-phosphate, glyceraldehyde-3-phosphate) supporting nucleotide and lipid biosynthesis\",\n        \"Metabolic inflexibility creating vulnerability to glucose starvation or glycolytic enzyme inhibition\",\n        \"Reduced reliance on oxidative phosphorylation minimizing ROS generation through electron transport chain\",\n        \"Coordination with hypoxic signaling through HIF-1α-mediated PFKFB4 upregulation\"\n      ],\n      \"evidence_summary\": \"The Warburg effect represents a fundamental metabolic adaptation in astrocytoma, reflected by the remarkable concentration of glycolytic genes in the input list. SLC2A1 (GLUT1) is upregulated in virtually all astrocytomas and represents a standard diagnostic marker in clinical PET imaging. The rate-limiting steps of glycolysis—glucose entry (SLC2A1, SLC2A3), phosphorylation (HK2), and the critical control point catalyzed by phosphofructokinase (PFKP, PFKFB4)—are all represented in the list. PFKFB4, which generates the allosteric activator fructose-2,6-bisphosphate while also possessing bisphosphatase activity, serves as a metabolic node whose expression frequently increases in cancer. The downstream enzymes ENO1, ENO2, and PGK1 are hypoxia-responsive and generate both ATP and biosynthetic intermediates. Critically, SLC16A1 exports lactate from the cell, and PDK1 enforces glycolytic commitment by preventing pyruvate entry into mitochondria. The combination of these genes creates a self-reinforcing metabolic state: once PDK1 is upregulated (via HIF-1α), pyruvate cannot be oxidized, forcing glycolytic pyruvate toward lactate synthesis. The lactate accumulation and acidification then trigger VEGF production (from HIF-1α), promoting angiogenesis. The metabolic inflexibility created by this commitment likely increases therapeutic vulnerability: combining glycolytic inhibition with radiotherapy showed synergistic effects in sarcoma models, and similar approaches may benefit astrocytoma patients.\",\n      \"significance_score\": 0.98,\n      \"citations\": [\n        {\"source_id\": \"3\", \"notes\": \"lncRNAs as critical regulators of cancer metabolism and glycolysis\"},\n        {\"source_id\": \"23\", \"notes\": \"SUCLG2 knockdown affects glucose uptake, lactate production, and metabolic parameters through HIF-1α signaling\"},\n        {\"source_id\": \"44\", \"notes\": \"Metabolic flexibility and tumor cell metabolism in response to complex I inhibition\"}\n      ],\n      \"supporting_genes\": [\"SLC2A1\", \"SLC2A3\", \"HK2\", \"PFKP\", \"PFKFB4\", \"ENO1\", \"ENO2\", \"PGK1\", \"SLC16A1\", \"PDK1\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"LDHA\", \"LDHB\", \"GCK\", \"PKLR\"],\n        \"citations\": [\n          {\"source_id\": \"23\", \"notes\": \"HIF-1α binds to glycolysis-related genes including LDHA and PKM2\"}\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Angiogenesis and Vascular Promotion\",\n      \"description\": \"Production of pro-angiogenic factors and signaling that recruits endothelial cells to form new blood vessels, driven by hypoxia, lactate, and growth factor signaling. Core components include VEGF ligand production (VEGFA), co-receptors (NRP1), alternative angiogenic factors (ANGPTL4, ADM), and endothelial guidance molecules (ADGRL2).\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"VEGF ligand production and secretion\",\n          \"genes\": [\"VEGFA\"],\n          \"citations\": [\n            {\"source_id\": \"1\", \"notes\": \"VEGF blunted response to high-altitude hypoxia\"},\n            {\"source_id\": \"26\", \"notes\": \"HIF-1alpha expression results in increased VEGF expression and HIF-1alpha/VEGF pathway in angiogenesis\"}\n          ]\n        },\n        {\n          \"name\": \"VEGF co-receptor signaling enhancement\",\n          \"genes\": [\"NRP1\"],\n          \"citations\": [\n            {\"source_id\": \"1\", \"notes\": \"VEGF pathway components in angiogenesis\"}\n          ]\n        },\n        {\n          \"name\": \"Alternative angiogenic factor production\",\n          \"genes\": [\"ANGPTL4\", \"ADM\"],\n          \"citations\": [\n            {\"source_id\": \"1\", \"notes\": \"VEGF pathway and angiogenic responses\"}\n          ]\n        },\n        {\n          \"name\": \"Endothelial cell guidance and adhesion\",\n          \"genes\": [\"ADGRL2\"],\n          \"citations\": [\n            {\"source_id\": \"1\", \"notes\": \"Endothelial cell response to angiogenic signals\"}\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Vascular endothelial growth factor ligand-receptor complexes\",\n          \"genes\": [\"VEGFA\", \"NRP1\"],\n          \"citations\": [\n            {\"source_id\": \"1\", \"notes\": \"VEGFA vascular endothelial growth factor\"}\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Recruitment of endothelial cells to tumor microenvironment through VEGF and alternative angiogenic signals\",\n        \"Formation of new blood vessels that relieve hypoxic stress while maintaining residual peri-vascular hypoxia\",\n        \"Enhanced oxygen delivery enabling further tumor expansion\",\n        \"Creation of nutrient-rich vascular niche supporting sustained proliferation\",\n        \"Vascular co-evolution that permits metastatic dissemination through blood vessels\",\n        \"Resistance to anti-VEGF therapy through upregulation of alternative pathways (ANGPTL4, ADM)\"\n      ],\n      \"evidence_summary\": \"Astrocytoma progression directly correlates with vascularization, as rapid tumor growth beyond 1-2 millimeters in diameter requires new blood vessel formation to meet oxygen and nutrient demands. VEGFA (vascular endothelial growth factor A) represents the canonical pro-angiogenic factor, and its expression is strongly induced by HIF-1α under hypoxic conditions. Elevated VEGFA correlates with tumor grade, vascularity, and poor prognosis in astrocytoma. NRP1 (neuropilin 1) functions as a VEGF co-receptor that enhances VEGF signaling through VEGF receptors (VEGFR1/2), amplifying the angiogenic response. Beyond VEGF, alternative angiogenic factors ANGPTL4 (angiopoietin-like 4) and ADM (adrenomedullin) are particularly important under hypoxia and nutrient limitation, providing bypass routes when VEGF signaling is antagonized therapeutically. The inclusion of multiple angiogenic factors in the input list suggests that astrocytoma cells employ redundant mechanisms to ensure robust vascular recruitment, providing inherent resistance to anti-VEGF monotherapy. Indeed, clinical experience with bevacizumab (anti-VEGF antibody) in glioma shows initial tumor response followed by escape through upregulation of alternative pathways. The angiogenic program directly intersects with the metabolic program: lactate accumulation from glycolysis promotes VEGF production through HIF stabilization, creating a self-reinforcing loop where metabolic activity drives vascular recruitment.\",\n      \"significance_score\": 0.88,\n      \"citations\": [\n        {\"source_id\": \"1\", \"notes\": \"VEGFA in response to hypoxia and genetic variants\"},\n        {\"source_id\": \"26\", \"notes\": \"HIF-1alpha drives increased VEGF expression and pathway operates in angiogenesis\"}\n      ],\n      \"supporting_genes\": [\"VEGFA\", \"NRP1\", \"ANGPTL4\", \"ADM\", \"ADGRL2\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"VEGFR1\", \"VEGFR2\", \"FGFR1\", \"FGF2\", \"TIE2\", \"ANG1\", \"ANG2\"],\n        \"citations\": [\n          {\"source_id\": \"1\", \"notes\": \"VEGF receptor and ligand interactions in angiogenesis\"}\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Extracellular Matrix Remodeling and Invasion\",\n      \"description\": \"Active restructuring of the extracellular matrix surrounding tumors through production of matrix proteins, secretion of matrix-modifying enzymes, and integrin-mediated signaling, enabling invasion into surrounding brain parenchyma. Includes collagen production (COL4A1, COL4A2, COL5A1, COL13A1), matrix modification (ADAMTS9, PLOD2, PCOLCE2), non-collagenous matrix proteins (FN1), and adhesion signaling (ITGA3, NRCAM).\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Type IV collagen production and incorporation into basement membranes\",\n          \"genes\": [\"COL4A1\", \"COL4A2\"],\n          \"citations\": [\n            {\"source_id\": \"4\", \"notes\": \"COL1A1 regulates invasion and metastasis of cholangiocarcinoma cells\"},\n            {\"source_id\": \"39\", \"notes\": \"Tight junction proteins and adherens junction proteins including collagen interactions\"}\n          ]\n        },\n        {\n          \"name\": \"Type V collagen production modulating fibrillogenesis\",\n          \"genes\": [\"COL5A1\"],\n          \"citations\": [\n            {\"source_id\": \"4\", \"notes\": \"Matrix metalloproteinase-mediated COL1A1 synthesis\"}\n          ]\n        },\n        {\n          \"name\": \"Type XIII collagen production with adhesive properties\",\n          \"genes\": [\"COL13A1\"],\n          \"citations\": [\n            {\"source_id\": \"4\", \"notes\": \"Collagen regulation in tumor invasion and metastasis\"}\n          ]\n        },\n        {\n          \"name\": \"Fibronectin production and deposition\",\n          \"genes\": [\"FN1\"],\n          \"citations\": [\n            {\"source_id\": \"4\", \"notes\": \"Extracellular matrix components in cell adhesion and migration\"}\n          ]\n        },\n        {\n          \"name\": \"Matrix metalloproteinase-mediated proteolysis\",\n          \"genes\": [\"ADAMTS9\"],\n          \"citations\": [\n            {\"source_id\": \"7\", \"notes\": \"Matrix metalloproteinase-1 decorated polymersomes potentiate collagen degradation\"}\n          ]\n        },\n        {\n          \"name\": \"Collagen lysine hydroxylation enabling cross-linking\",\n          \"genes\": [\"PLOD2\"],\n          \"citations\": [\n            {\"source_id\": \"4\", \"notes\": \"Matrix metalloproteinase inducing COL1A1 synthesis and ECM remodeling\"}\n          ]\n        },\n        {\n          \"name\": \"Procollagen C-terminal processing\",\n          \"genes\": [\"PCOLCE2\"],\n          \"citations\": [\n            {\"source_id\": \"4\", \"notes\": \"Extracellular matrix processing and maturation\"}\n          ]\n        },\n        {\n          \"name\": \"Integrin-mediated adhesion and migration signaling\",\n          \"genes\": [\"ITGA3\"],\n          \"citations\": [\n            {\"source_id\": \"40\", \"notes\": \"Tight junction proteins regulated by microRNA mediated mechanisms\"},\n            {\"source_id\": \"53\", \"notes\": \"Integrin α3 critical for proper neuron-glia cell adhesion\"}\n          ]\n        },\n        {\n          \"name\": \"Cell-cell adhesion through neural CAMs\",\n          \"genes\": [\"NRCAM\"],\n          \"citations\": [\n            {\"source_id\": \"46\", \"notes\": \"NRCAM downregulation associated with chronic TBI astrocyte alterations\"}\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Type IV collagen fibrils in basement membranes\",\n          \"genes\": [\"COL4A1\", \"COL4A2\"],\n          \"citations\": [\n            {\"source_id\": \"39\", \"notes\": \"Tight junction-associated proteins and basement membrane components\"}\n          ]\n        },\n        {\n          \"name\": \"Fibronectin matrix networks\",\n          \"genes\": [\"FN1\"],\n          \"citations\": [\n            {\"source_id\": \"4\", \"notes\": \"Extracellular matrix protein networks\"}\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Progressive degradation and remodeling of surrounding brain parenchyma ECM\",\n        \"Creation of invasion corridors enabling tumor cell infiltration into normal brain tissue\",\n        \"Deposition of tumor-derived collagen creating fibrotic tissue barriers\",\n        \"Integrin-mediated signaling promoting migratory phenotype\",\n        \"Cross-linking of collagen through PLOD2 activity creating mechanically stiff tumors\",\n        \"Activation of cryptic matrix epitopes promoting further proteolysis\",\n        \"Enabling of angiogenic sprouting through matrix reorganization\"\n      ],\n      \"evidence_summary\": \"Astrocytoma progression involves active remodeling of the extracellular matrix, transforming the surrounding brain parenchyma from a relatively non-fibrotic environment to a tumor-rich fibrotic interface. The collagen genes (COL4A1, COL4A2, COL5A1, COL13A1) are expressed by both tumor cells and reactive astrocytes, progressively accumulating around tumors. Type IV collagen is particularly important as a basement membrane component, and its upregulation likely reflects both increased vasculature (with associated basement membranes) and direct tumor cell production. The matrix-modifying enzymes ADAMTS9 (a disintegrin and metalloproteinase with thrombospondin motifs 9) and PLOD2 work in concert: ADAMTS9 degrades ECM proteins creating new migration pathways and releasing matrix-embedded growth factors, while PLOD2 hydroxylates lysine residues in collagen, enabling cross-linking through lysyl oxidase activity (LOX is in the list). PCOLCE2 enhances the processing of procollagen to mature collagen, ensuring that newly synthesized collagen is properly matured and cross-linked. The cumulative effect is a structurally remodeled ECM that permits invasion while simultaneously creating a desmoplastic (fibrotic) response. Integrin signaling, mediated by ITGA3 binding to remodeled ECM ligands, transmits signals promoting migration and suppressing differentiation. Recent evidence demonstrates that blocking integrin-ECM interactions impairs invasion but sometimes increases proliferation, suggesting that ECM remodeling serves multiple functions including both promotion of invasion and suppression of proliferation signals from normal brain parenchyma.\",\n      \"significance_score\": 0.92,\n      \"citations\": [\n        {\"source_id\": \"4\", \"notes\": \"Matrix metalloproteinase-mediated COL1A1 synthesis and ECM invasion\"},\n        {\"source_id\": \"7\", \"notes\": \"Matrix metalloproteinase-1 function in collagen degradation\"},\n        {\"source_id\": \"39\", \"notes\": \"Extracellular matrix components in BBB integrity\"},\n        {\"source_id\": \"40\", \"notes\": \"microRNA-mediated regulation of tight junction and adhesion proteins\"}\n      ],\n      \"supporting_genes\": [\"COL4A1\", \"COL4A2\", \"COL5A1\", \"COL13A1\", \"FN1\", \"ADAMTS9\", \"ADAMTS9-AS2\", \"PLOD2\", \"PCOLCE2\", \"ITGA3\", \"NRCAM\", \"LOX\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"MMP1\", \"MMP2\", \"MMP9\", \"TIMP1\", \"TIMP2\", \"LOX\"],\n        \"citations\": [\n          {\"source_id\": \"4\", \"notes\": \"Matrix metalloproteinase-2 inducing COL1A1 synthesis\"},\n          {\"source_id\": \"7\", \"notes\": \"Matrix metalloproteinase-1 and related proteases\"}\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Selective Autophagy and Proteostasis\",\n      \"description\": \"Selective autophagy pathway for recognition and clearance of damaged proteins, organelles, and cellular components through autophagy receptors, with particular emphasis on mitochondrial quality control under hypoxic and metabolic stress. Includes selective autophagy receptors (SQSTM1, BNIP3L), stress sensors (SESN2), and autophagy effectors (VMP1).\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Recognition of polyubiquitinated cargo by autophagy receptors\",\n          \"genes\": [\"SQSTM1\"],\n          \"citations\": [\n            {\"source_id\": \"14\", \"notes\": \"p62/SQSTM1 recognizes poly-ubiquitinated cargo and delivers to autophagosome\"}\n          ]\n        },\n        {\n          \"name\": \"Selective mitochondrial autophagy (mitophagy)\",\n          \"genes\": [\"BNIP3L\"],\n          \"citations\": [\n            {\"source_id\": \"1\", \"notes\": \"Metabolic reprogramming and hypoxia responses affecting mitochondrial function\"}\n          ]\n        },\n        {\n          \"name\": \"Stress sensing and AMPK activation\",\n          \"genes\": [\"SESN2\"],\n          \"citations\": [\n            {\"source_id\": \"14\", \"notes\": \"Proteostasis and autophagy pathway regulation\"}\n          ]\n        },\n        {\n          \"name\": \"Phagophore formation and membrane dynamics\",\n          \"genes\": [\"VMP1\"],\n          \"citations\": [\n            {\"source_id\": \"14\", \"notes\": \"VMP1 required for phagophore formation\"}\n          ]\n        },\n        {\n          \"name\": \"SQSTM1 filament formation and phase separation\",\n          \"genes\": [\"SQSTM1\"],\n          \"citations\": [\n            {\"source_id\": \"14\", \"notes\": \"p62/SQSTM1 forms higher-order filaments and undergoes liquid-liquid phase separation\"}\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Autophagy receptor complexes with Atg8 proteins\",\n          \"genes\": [\"SQSTM1\", \"BNIP3L\"],\n          \"citations\": [\n            {\"source_id\": \"14\", \"notes\": \"Selective autophagy receptors with LC3-interacting regions\"}\n          ]\n        },\n        {\n          \"name\": \"p62 filamentous structures and condensates\",\n          \"genes\": [\"SQSTM1\"],\n          \"citations\": [\n            {\"source_id\": \"14\", \"notes\": \"p62 forms discontinuous coat around cargo\"}\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Clearance of protein aggregates and misfolded proteins produced under hypoxia and ER stress\",\n        \"Selective elimination of dysfunctional mitochondria through BNIP3L-mediated mitophagy\",\n        \"Restoration of cellular ATP through selective organelle clearance and recycling\",\n        \"Reduction of ROS through removal of damaged mitochondria with electron transport chain dysfunction\",\n        \"Rapid adaptation to nutrient starvation through amino acid recycling\",\n        \"Resistance to therapeutic-induced proteotoxic stress\"\n      ],\n      \"evidence_summary\": \"Astrocytoma cells experience substantial proteotoxic stress from rapid protein synthesis, hypoxia-induced misfolding, and ER stress, necessitating active autophagy pathways for cell survival. SQSTM1 (sequestosome 1, also known as p62) serves as a selective autophagy receptor that recognizes poly-ubiquitinated cargo through its ubiquitin-binding domain and delivers cargo to autophagosomes through its LC3-interacting region. Recent structural studies revealed that p62 forms filaments and undergoes liquid-liquid phase separation when interacting with ubiquitinated cargo, creating a physical organizational framework that concentrates autophagy machinery at cargo-rich sites. BNIP3L (BCL2 interacting protein 3 like) functions as an alternative autophagy receptor specific for mitochondria, permitting selective autophagy of damaged mitochondria (mitophagy) particularly under hypoxic conditions. Under hypoxia and metabolic stress, which are hallmarks of astrocytoma, mitochondria become dysfunctional and accumulate ROS, necessitating their selective clearance. SESN2 (sestrin 2) acts as a sensor of amino acid starvation and oxidative stress, promoting AMPK activation and mTOR inhibition to engage autophagy. VMP1 (vacuole membrane protein 1) encodes a transmembrane protein required for phagophore formation, providing a critical structural component of the autophagy machinery. The convergence of multiple autophagy signals in the input list suggests that astrocytoma cells are under constant proteotoxic stress and maintain constitutively elevated autophagy. Blocking autophagy through ATG knockdown or pharmacological inhibition can sensitize glioma cells to radiotherapy and chemotherapy, establishing autophagy as both a survival mechanism and a potential therapeutic target.\",\n      \"significance_score\": 0.85,\n      \"citations\": [\n        {\"source_id\": \"14\", \"notes\": \"Structural organization of p62 filaments and liquid-liquid phase separation in autophagy\"},\n        {\"source_id\": \"16\", \"notes\": \"Autophagy-lysosome pathway dysregulation in neurodegeneration\"},\n        {\"source_id\": \"23\", \"notes\": \"Metabolic stress triggering autophagy responses\"}\n      ],\n      \"supporting_genes\": [\"SQSTM1\", \"BNIP3L\", \"SESN2\", \"VMP1\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"ATG5\", \"ATG7\", \"ATG12\", \"LC3\", \"ULK1\", \"mTOR\", \"AMPK\"],\n        \"citations\": [\n          {\"source_id\": \"14\", \"notes\": \"Core autophagy machinery including ATG and LC3 proteins\"}\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Lipid Metabolism and Membrane Homeostasis\",\n      \"description\": \"Dysregulation of cholesterol and lipid homeostasis supporting biosynthetic demands of rapid proliferation and creating immunosuppressive lipid microenvironment. Includes cholesterol efflux (ABCA1), cholesterol uptake (SCARB1), cholesterol sensing (INSIG2), and lipid metabolism regulation through peroxisome proliferator-activated receptors.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Cholesterol and phospholipid efflux from tumor cells\",\n          \"genes\": [\"ABCA1\"],\n          \"citations\": [\n            {\"source_id\": \"12\", \"notes\": \"Low-density lipoprotein receptor required for cholesteryl ester transfer protein\"},\n            {\"source_id\": \"18\", \"notes\": \"PI3K/Akt signaling with growth factor pathways\"}\n          ]\n        },\n        {\n          \"name\": \"HDL-mediated cholesterol ester uptake\",\n          \"genes\": [\"SCARB1\"],\n          \"citations\": [\n            {\"source_id\": \"12\", \"notes\": \"Lipid and cholesterol metabolism regulation\"}\n          ]\n        },\n        {\n          \"name\": \"Cholesterol sensing and negative feedback regulation\",\n          \"genes\": [\"INSIG2\"],\n          \"citations\": [\n            {\"source_id\": \"12\", \"notes\": \"Cholesterol metabolism and feedback control\"}\n          ]\n        },\n        {\n          \"name\": \"Zinc-dependent membrane transport\",\n          \"genes\": [\"SLC39A14\"],\n          \"citations\": [\n            {\"source_id\": \"40\", \"notes\": \"Ion channel and transporter regulation\"}\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Lipid rafts and membrane microdomains\",\n          \"genes\": [\"ABCA1\", \"SCARB1\"],\n          \"citations\": [\n            {\"source_id\": \"12\", \"notes\": \"Cholesterol and lipid membrane organization\"}\n          ]\n        },\n        {\n          \"name\": \"ABC transporter complexes\",\n          \"genes\": [\"ABCA1\"],\n          \"citations\": [\n            {\"source_id\": \"12\", \"notes\": \"ATP binding cassette transporter family\"}\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Enhanced membrane biogenesis supporting exponential cell division and organelle proliferation\",\n        \"Altered membrane fluidity and lipid raft composition affecting growth factor receptor signaling\",\n        \"Creation of immunosuppressive lipid microenvironment through altered cholesterol metabolism\",\n        \"Support for increased biosynthetic capacity through sterol delivery to ER\",\n        \"Potential metabolic vulnerability to lipid pathway inhibitors\"\n      ],\n      \"evidence_summary\": \"Rapidly proliferating astrocytoma cells require exponential increases in membrane surface area to accommodate cell division and organelle biogenesis. This biosynthetic demand necessitates elevated cholesterol and phospholipid synthesis and uptake. ABCA1 (ATP binding cassette subfamily A member 1) mediates the efflux of cholesterol and phospholipids from cells, and its dysregulation in tumors can impair cholesterol homeostasis. SCARB1 (scavenger receptor class B member 1) functions as an HDL receptor, mediating selective uptake of cholesterol esters from circulating HDL particles. INSIG2 (insulin induced gene 2) participates in cholesterol sensing and feedback regulation of cholesterol metabolism, enabling cells to adjust lipid biosynthesis based on current cholesterol levels. SLC39A14 encodes a zinc transporter whose function extends beyond simple metal transport to regulating metalloproteinase activity and immune responses. Altered lipid metabolism is not simply a consequence of biosynthetic demand but actively contributes to tumor progression: oxidized lipids accumulate in tumors and promote anti-tumor immune suppression, while altered membrane cholesterol composition can impair immune cell recruitment. The presence of multiple lipid metabolism genes in the input list suggests that lipid homeostasis represents an actively dysregulated program contributing to both tumor growth and immune evasion.\",\n      \"significance_score\": 0.72,\n      \"citations\": [\n        {\"source_id\": \"12\", \"notes\": \"Low-density lipoprotein receptor and cholesterol metabolism\"},\n        {\"source_id\": \"34\", \"notes\": \"Peroxisome proliferator-activated receptor delta suppressing CD8+ T cell cytotoxicity\"},\n        {\"source_id\": \"35\", \"notes\": \"Peroxisome proliferator-activated receptor alpha in contextual fear extinction\"}\n      ],\n      \"supporting_genes\": [\"ABCA1\", \"SCARB1\", \"INSIG2\", \"SLC39A14\", \"ANXA2\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"SREBP1\", \"SREBP2\", \"HMGCR\", \"ACAT1\", \"ACAT2\"],\n        \"citations\": [\n          {\"source_id\": \"12\", \"notes\": \"Sterol regulatory element-binding proteins in cholesterol homeostasis\"}\n        ]\n      }\n    },\n    {\n      \"program_name\": \"ER Stress Response and Unfolded Protein Response\",\n      \"description\": \"Adaptive response to endoplasmic reticulum stress triggered by hypoxia, nutrient limitation, and biosynthetic burden, including ER chaperone induction, integrated stress response transcription factors, and pro-survival or pro-apoptotic branching. Includes ER chaperones (HSPA5), stress-responsive kinases (DDIT3, CEBPD), and stress sensors (TRIB3).\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"ER stress-mediated chaperone induction\",\n          \"genes\": [\"HSPA5\"],\n          \"citations\": [\n            {\"source_id\": \"23\", \"notes\": \"ER stress components in metabolic adaptation\"},\n            {\"source_id\": \"50\", \"notes\": \"HSPA5 as BiP/GRP78 chaperone involved in ER stress response\"},\n            {\"source_id\": \"52\", \"notes\": \"ER chaperone BiP and unfolded protein response\"}\n          ]\n        },\n        {\n          \"name\": \"Integrated stress response transcription factor activation\",\n          \"genes\": [\"DDIT3\"],\n          \"citations\": [\n            {\"source_id\": \"50\", \"notes\": \"DDIT3 (CHOP) as ER stress-responsive transcription factor\"}\n          ]\n        },\n        {\n          \"name\": \"ER oxidoreductase-mediated disulfide bond formation\",\n          \"genes\": [\"ERO1A\"],\n          \"citations\": [\n            {\"source_id\": \"23\", \"notes\": \"ER oxidoreductase in oxidative protein folding\"}\n          ]\n        },\n        {\n          \"name\": \"Nutritional stress sensing\",\n          \"genes\": [\"SESN2\"],\n          \"citations\": [\n            {\"source_id\": \"14\", \"notes\": \"SESN2 as amino acid stress sensor\"}\n          ]\n        },\n        {\n          \"name\": \"CCAAT/enhancer binding protein family transcriptional regulation\",\n          \"genes\": [\"CEBPD\", \"DDIT3\"],\n          \"citations\": [\n            {\"source_id\": \"10\", \"notes\": \"CEBPD supports inflammatory signaling activation\"},\n            {\"source_id\": \"50\", \"notes\": \"ER stress regulation through CHOP and related factors\"}\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"ER lumen chaperone machinery\",\n          \"genes\": [\"HSPA5\", \"ERO1A\"],\n          \"citations\": [\n            {\"source_id\": \"52\", \"notes\": \"ER chaperone and oxidoreductase complexes\"}\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Enhanced protein folding capacity accommodating increased biosynthetic burden\",\n        \"Activation of pro-survival autophagy under moderate ER stress\",\n        \"Engagement of pro-apoptotic pathways under severe ER stress\",\n        \"Metabolic adaptation to hypoxia and nutrient limitation\",\n        \"Coordination with HIF signaling to integrate hypoxic and proteotoxic stress\",\n        \"Potential resistance to chemotherapy through upregulation of drug efflux pumps\"\n      ],\n      \"evidence_summary\": \"Astrocytoma cells under hypoxia, nutrient deprivation, and high biosynthetic demand experience substantial endoplasmic reticulum (ER) stress. HSPA5 (heat shock protein family A member 5), commonly known as BiP or GRP78, serves as the primary ER chaperone that detects accumulation of unfolded proteins and initiates the unfolded protein response (UPR) transcriptional program. Under ER stress, HSPA5 releases its bound UPR sensor kinases (PERK, IRE1, ATF6), allowing them to dimerize and autophosphorylate, initiating downstream signaling cascades. DDIT3 (DNA damage inducible transcript 3), encoding CHOP (C/EBP homologous protein), represents a critical ER stress-responsive transcription factor that drives either adaptive responses promoting cell survival or pro-apoptotic programs depending on stress intensity and duration. CEBPD (CCAAT enhancer binding protein delta) functions in parallel with CHOP to regulate stress responses and inflammatory signaling. ERO1A (endoplasmic reticulum oxidoreductase 1 alpha) catalyzes disulfide bond formation in the ER lumen, an essential process for protein folding but also a source of reactive oxygen species. TRIB3 functions downstream of ER stress pathways to promote cell survival under nutritional stress. The cumulative upregulation of ER stress-response genes in the input list indicates that astrocytoma cells are under constant proteotoxic stress and have adapted to sustain viability despite these challenges. Importantly, the UPR can be adaptive under moderate stress but becomes pro-apoptotic under severe stress, suggesting that therapeutic approaches combining ER stressors (such as proteasome inhibitors or IRE1-selective inhibitors) with conventional therapy might overcome adaptation mechanisms.\",\n      \"significance_score\": 0.80,\n      \"citations\": [\n        {\"source_id\": \"23\", \"notes\": \"ER stress and HIF-1α interaction in metabolic regulation\"},\n        {\"source_id\": \"50\", \"notes\": \"ER stress enhancement of proinflammatory signaling\"},\n        {\"source_id\": \"52\", \"notes\": \"ER chaperone BiP and unfolded protein response in human models\"}\n      ],\n      \"supporting_genes\": [\"HSPA5\", \"ERO1A\", \"DDIT3\", \"CEBPD\", \"TRIB3\", \"SESN2\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"PERK\", \"IRE1\", \"ATF6\", \"ATF4\", \"XBP1\"],\n        \"citations\": [\n          {\"source_id\": \"50\", \"notes\": \"UPR sensor kinases and transcription factors\"},\n          {\"source_id\": \"52\", \"notes\": \"Integrated unfolded protein response components\"}\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Tumor-Associated Neuroinflammation\",\n      \"description\": \"Inflammatory cytokine signaling and immune cell recruitment creating a tumor-promoting immunosuppressive microenvironment. Includes IL-1 signaling (IL1RAP), TNF-α signaling, semaphorin immune guidance (SEMA5B), and cytokine receptors (APLN). Astrocytoma cells simultaneously attract immune cells, exploit inflammatory signals for proliferation, and create immunosuppressive conditions.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"IL-1 receptor signaling pathway activation\",\n          \"genes\": [\"IL1RAP\"],\n          \"citations\": [\n            {\"source_id\": \"22\", \"notes\": \"Hypoxia-mediated signaling in glioma invasion\"},\n            {\"source_id\": \"27\", \"notes\": \"IL6 modulates immune status in tumor microenvironment\"},\n            {\"source_id\": \"46\", \"notes\": \"Pro-inflammatory cytokines in acute TBI astrocyte response\"}\n          ]\n        },\n        {\n          \"name\": \"TNF-α signaling and immune activation\",\n          \"genes\": [],\n          \"citations\": [\n            {\"source_id\": \"25\", \"notes\": \"TNF-α signaling mediates dopaminergic effects and neuroinflammation\"}\n          ]\n        },\n        {\n          \"name\": \"Semaphorin-mediated immune cell guidance\",\n          \"genes\": [\"SEMA5B\"],\n          \"citations\": [\n            {\"source_id\": \"25\", \"notes\": \"Cytokine and chemokine signaling in neuroimmune responses\"}\n          ]\n        },\n        {\n          \"name\": \"Apelin-mediated immune and vascular regulation\",\n          \"genes\": [\"APLN\"],\n          \"citations\": [\n            {\"source_id\": \"19\", \"notes\": \"BDNF from microglia regulating neuronal development and social behavior\"}\n          ]\n        },\n        {\n          \"name\": \"CEBPD-mediated inflammatory signaling\",\n          \"genes\": [\"CEBPD\"],\n          \"citations\": [\n            {\"source_id\": \"10\", \"notes\": \"CEBPD supports inflammatory signaling through TLR4 gene activation\"}\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"IL-1 receptor signaling complexes\",\n          \"genes\": [\"IL1RAP\"],\n          \"citations\": [\n            {\"source_id\": \"27\", \"notes\": \"IL6 and related cytokine receptor signaling\"}\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Recruitment of infiltrating macrophages and T lymphocytes through chemotactic signals\",\n        \"Activation of resident microglia through DAMPs and inflammatory signals\",\n        \"Establishment of tumor-promoting IL-1 and IL-6 signaling loops\",\n        \"Creation of immunosuppressive metabolic microenvironment through lactate and adenosine\",\n        \"Paradoxical promotion of tumor growth through inflammatory mitogenic signals\",\n        \"Impaired anti-tumor T cell responses through immune checkpoint molecule expression\"\n      ],\n      \"evidence_summary\": \"Astrocytoma exists within a complex inflammatory microenvironment composed of infiltrating immune cells, activated resident microglia, and reactive astrocytes producing inflammatory cytokines. IL1RAP (interleukin 1 receptor accessory protein) mediates signaling through IL-1 receptors, and IL-1 represents a prototypical pro-inflammatory cytokine upregulated in glioma microenvironments. IL-1 signaling promotes NFκB activation in both tumor and immune cells, creating a tumor-promoting feed-forward loop. SEMA5B (semaphorin 5B) participates in immune cell guidance and axonal pathfinding, with emerging roles in immune suppression within tumors through altered immune cell recruitment or function. APLN (apelin) encodes a neuropeptide involved in vascular development and immune regulation, suggesting pleiotropic roles in coordinating vascular and immune aspects of the tumor microenvironment. CEBPD (CCAAT enhancer binding protein delta) regulates inflammatory signaling through multiple pathways including TLR4 activation. The recent discovery that TNF-α mediates dopaminergic effects in the CNS extends our understanding of how inflammatory cytokines impact neural circuitry, a distinction particularly important for understanding tumor-associated seizures. The involvement of multiple inflammatory mediators in the gene list suggests that astrocytoma cells simultaneously attract inflammatory cells through chemotactic signals, exploit inflammatory signals for proliferation through STAT3 and NFκB pathway activation, and create an immunosuppressive environment through altered cytokine signaling and metabolic factors (lactate, adenosine). This apparent paradox likely reflects tumor cell adaptation to chronic inflammation: initial inflammatory responses are anti-tumoral, but persistent inflammation selects for tumor cells capable of exploiting inflammatory signals while suppressing effective anti-tumor immunity.\",\n      \"significance_score\": 0.76,\n      \"citations\": [\n        {\"source_id\": \"22\", \"notes\": \"NF-κB signaling in glioma invasion and hypoxia\"},\n        {\"source_id\": \"25\", \"notes\": \"TNF-α signaling and neuroimmune interactions\"},\n        {\"source_id\": \"27\", \"notes\": \"IL6 modulates tumor microenvironment immune status\"},\n        {\"source_id\": \"28\", \"notes\": \"MIF downregulation attenuates neuroinflammation\"},\n        {\"source_id\": \"46\", \"notes\": \"Pro-inflammatory cytokines in astrocyte activation post-TBI\"}\n      ],\n      \"supporting_genes\": [\"IL1RAP\", \"SEMA5B\", \"APLN\", \"CEBPD\", \"NTRK2\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"TNF\", \"IL1A\", \"IL1B\", \"IL6\", \"TLR4\", \"NFκB\"],\n        \"citations\": [\n          {\"source_id\": \"22\", \"notes\": \"TNF-α and NF-κB signaling in tumor progression\"},\n          {\"source_id\": \"25\", \"notes\": \"Cytokine signaling pathways\"}\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Neuron-Glia Signaling and Neurotrophic Interactions\",\n      \"description\": \"Maintenance of complex interactions between tumor cells and surrounding neurons through trophic factor signaling, adhesion molecules, and synaptic communication. Includes neurotrophic receptors (NTRK2, IGF1R), IGF binding proteins (IGFBP2, IGFBP3, IGFBP5), adhesion molecules (NRCAM), and axonal markers (GAP43, NRN1). These interactions maintain neuronal survival while potentially promoting tumor cell adaptation.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"BDNF-mediated neurotrophic signaling\",\n          \"genes\": [\"NTRK2\"],\n          \"citations\": [\n            {\"source_id\": \"19\", \"notes\": \"BDNF from microglia regulates neuronal development in medial prefrontal cortex\"},\n            {\"source_id\": \"21\", \"notes\": \"14,15-EET-mediated production of astrocyte-derived BDNF\"},\n            {\"source_id\": \"25\", \"notes\": \"BDNF receptor signaling in dopamine and neuroimmune responses\"}\n          ]\n        },\n        {\n          \"name\": \"IGF1 signaling pathway activation\",\n          \"genes\": [\"IGF1R\", \"IRS2\", \"GRB10\"],\n          \"citations\": [\n            {\"source_id\": \"8\", \"notes\": \"PI3K/AKT signaling pathway regulation by microRNA\"},\n            {\"source_id\": \"19\", \"notes\": \"IGF receptor signaling in neuronal and glial development\"}\n          ]\n        },\n        {\n          \"name\": \"IGF bioavailability regulation\",\n          \"genes\": [\"IGFBP2\", \"IGFBP3\", \"IGFBP5\"],\n          \"citations\": [\n            {\"source_id\": \"19\", \"notes\": \"IGF-binding proteins in growth factor signaling\"}\n          ]\n        },\n        {\n          \"name\": \"Neuron-glia cell-cell adhesion\",\n          \"genes\": [\"NRCAM\"],\n          \"citations\": [\n            {\"source_id\": \"46\", \"notes\": \"NRCAM downregulation in chronic TBI astrocytes\"}\n          ]\n        },\n        {\n          \"name\": \"Axonal growth and plasticity\",\n          \"genes\": [\"GAP43\", \"NRN1\"],\n          \"citations\": [\n            {\"source_id\": \"19\", \"notes\": \"GAP43 marking actively growing and remodeling axons\"},\n            {\"source_id\": \"21\", \"notes\": \"Neuronal development and astrocyte interactions\"}\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Tyrosine kinase receptor complexes\",\n          \"genes\": [\"NTRK2\", \"IGF1R\"],\n          \"citations\": [\n            {\"source_id\": \"19\", \"notes\": \"Growth factor receptor signaling complexes\"}\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Maintenance of peritumoral neuronal viability through trophic factor support\",\n        \"Potential tumor cell exploitation of neuroprotective pathways for proliferation\",\n        \"Bidirectional communication between tumor and neurons enabling metabolic coupling\",\n        \"Neuronal plasticity and synaptogenic changes in response to tumor presence\",\n        \"Altered action potential firing and synaptic transmission in peritumoral neurons\",\n        \"Potential therapeutic vulnerability through NTRK or IGF signaling antagonism\"\n      ],\n      \"evidence_summary\": \"Astrocytoma cells maintain complex interactions with surrounding neurons through trophic factors, adhesion molecules, and electrical coupling. NTRK2 (neurotrophic receptor tyrosine kinase 2), encoding the BDNF receptor (TrkB), represents a canonical neurotrophic signal whose upregulation in tumor microenvironments suggests either neuronal response to tumor-derived BDNF or tumor cell exploitation of BDNF signaling. Recent evidence demonstrates that microglial BDNF regulates neuronal development and social behavior, extending the neurotrophic signaling network beyond direct neuron-neuron interactions to include glial components. IGF1R (insulin-like growth factor 1 receptor) and its regulatory partner IRS2 (insulin receptor substrate 2) mediate signaling through IGF1 and IGF2, promoting both neuronal and glioma cell proliferation. The IGF-binding proteins IGFBP2, IGFBP3, and IGFBP5 sequester or release IGFs, modulating their bioavailability and creating a dynamic equilibrium of growth factor activity. GRB10 (growth factor receptor bound protein 10) regulates signaling downstream of growth factor receptors including IGF1R. NRCAM (neuronal cell adhesion molecule) participates in cell-cell adhesion critical for neuron-glia coupling, and its downregulation in chronic traumatic brain injury astrocytes is associated with neuroinflammatory pathology. Recent studies using inducible glioma models revealed that peritumoral neurons undergo substantial electrophysiological alterations including depolarized resting potential, altered action potential kinetics, and increased seizure susceptibility. Neuron-glia interactions directly contribute to these alterations: glioma-derived glutamate impairs synaptic transmission, synaptogenic factors from astrocytes alter dendritic spine density, and direct electrical coupling between tumor cells and neurons enables bidirectional communication. The presence of multiple neurotrophic pathway components in the input list suggests that tumor cells maintain trophic relationships with neurons despite transformation, potentially preserving neuronal function even as astrocytes malignantly transform.\",\n      \"significance_score\": 0.81,\n      \"citations\": [\n        {\"source_id\": \"19\", \"notes\": \"BDNF and neurotrophic receptor signaling\"},\n        {\"source_id\": \"21\", \"notes\": \"BDNF in astrocyte-mediated neuroprotection\"},\n        {\"source_id\": \"45\", \"notes\": \"Neuronal alterations in peritumoral cortex underlying seizure pathophysiology\"},\n        {\"source_id\": \"46\", \"notes\": \"NRCAM and neural adhesion in chronic neurodegeneration\"}\n      ],\n      \"supporting_genes\": [\"NTRK2\", \"IGF1R\", \"IRS2\", \"GRB10\", \"IGFBP2\", \"IGFBP3\", \"IGFBP5\", \"NRCAM\", \"GAP43\", \"NRN1\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"BDNF\", \"IGF1\", \"IGF2\", \"NGF\", \"GDNF\"],\n        \"citations\": [\n          {\"source_id\": \"19\", \"notes\": \"Brain-derived neurotrophic factor signaling\"},\n          {\"source_id\": \"21\", \"notes\": \"Neurotrophic factor production in astrocytes\"}\n        ]\n      }\n    },\n    {\n      \"program_name\": \"Cell Cycle Checkpoint Control and Proliferation Escape\",\n      \"description\": \"Dysregulation of cell cycle checkpoints permitting continued proliferation despite DNA damage, enabling radiotherapy resistance. Includes G2-M checkpoint kinase (WEE1), cyclin-dependent kinases (CDK19), inhibitors of differentiation (ID2), and growth-inhibitory proteins (BTG1). This program enables malignant transformation through escape from growth-inhibitory signals.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"G2-M checkpoint regulation through WEE1-mediated CDK1 inhibition\",\n          \"genes\": [\"WEE1\"],\n          \"citations\": [\n            {\"source_id\": \"40\", \"notes\": \"WEE1 G2 checkpoint kinase regulation of mitotic inhibitor\"},\n            {\"source_id\": \"44\", \"notes\": \"Metabolic inhibition and checkpoint regulation in response to radiotherapy\"}\n          ]\n        },\n        {\n          \"name\": \"Cyclin-dependent kinase transcriptional functions\",\n          \"genes\": [\"CDK19\"],\n          \"citations\": [\n            {\"source_id\": \"49\", \"notes\": \"CDK8 regulates transcription of ribosomal genes and protein synthesis\"}\n          ]\n        },\n        {\n          \"name\": \"Inhibition of differentiation through helix-loop-helix antagonism\",\n          \"genes\": [\"ID2\"],\n          \"citations\": [\n            {\"source_id\": \"13\", \"notes\": \"E2F1 couples immune cell development to immune response\"}\n          ]\n        },\n        {\n          \"name\": \"Growth-inhibitory signaling suppression\",\n          \"genes\": [\"BTG1\"],\n          \"citations\": [\n            {\"source_id\": \"13\", \"notes\": \"Cell cycle and immune response regulation\"}\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"CDK-cyclin complexes at G2-M transition\",\n          \"genes\": [\"WEE1\"],\n          \"citations\": [\n            {\"source_id\": \"40\", \"notes\": \"Mitotic regulation by WEE1\"}\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Escape from G2-M checkpoint despite DNA damage from radiotherapy\",\n        \"Continued proliferation under genotoxic stress\",\n        \"Suppression of differentiation even under anti-proliferative signals\",\n        \"Enhanced ribosome biogenesis supporting increased protein synthesis\",\n        \"Resistance to conventional radiotherapy and chemotherapy\",\n        \"Potential vulnerability to combined checkpoint and metabolic inhibition\"\n      ],\n      \"evidence_summary\": \"Malignant transformation of astrocytes involves dysregulation of cell cycle checkpoints, enabling proliferation despite DNA damage or anti-proliferative signals. WEE1 (WEE1 G2 checkpoint kinase) phosphorylates and inhibits CDK1, enforcing the G2-M checkpoint and preventing cells from entering mitosis with unrepaired DNA damage. In many cancers, elevated WEE1 expression paradoxically permits G2-M progression despite DNA damage, likely through enhanced checkpoints that can be easily overcome by additional oncogenic signals. Recent evidence demonstrates that radiotherapy combined with metabolic inhibition more effectively disrupts WEE1-mediated checkpoint control, suggesting that metabolic stress and DNA damage cooperate to overwhelm checkpoint mechanisms. CDK19 is a cyclin-dependent kinase involved in both cell cycle progression and transcriptional regulation, with emerging roles in MYC-mediated protein synthesis and ribosome biogenesis. The presence of CDK19 in the input list alongside metabolic genes suggests integration of cell cycle and biosynthetic programs: CDK8/19 directly upregulates ribosomal protein genes through mediator complex phosphorylation, ensuring that G1-S progression is coupled to enhanced ribosome capacity. ID2 (inhibitor of DNA binding 2) encodes a dominant-negative helix-loop-helix protein that inhibits differentiation-promoting transcription factors, allowing continued proliferation rather than lineage differentiation. BTG1 (BTG anti-proliferation factor 1) encodes a growth-inhibitory protein whose downregulation in tumors permits continued proliferation. The relative simplicity of cell cycle control genes compared to the extensive metabolic program may reflect that cell cycle dysregulation is a common feature of all cancers, while the metabolic and matrix remodeling programs are more specifically tailored to astrocytoma.\",\n      \"significance_score\": 0.74,\n      \"citations\": [\n        {\"source_id\": \"40\", \"notes\": \"WEE1 regulation of mitotic checkpoint\"},\n        {\"source_id\": \"44\", \"notes\": \"Metabolic and checkpoint control coordination in radiotherapy resistance\"},\n        {\"source_id\": \"49\", \"notes\": \"CDK8 regulation of ribosome biogenesis and protein synthesis\"}\n      ],\n      \"supporting_genes\": [\"WEE1\", \"CDK19\", \"ID2\", \"BTG1\", \"CEBPD\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"CDK1\", \"Cyclin B\", \"E2F\", \"TP53\", \"RB1\"],\n        \"citations\": [\n          {\"source_id\": \"40\", \"notes\": \"Core cell cycle checkpoint components\"},\n          {\"source_id\": \"44\", \"notes\": \"Checkpoint and TP53 signaling\"}\n        ]\n      }\n    },\n    {\n      \"program_name\": \"RNA Processing and Transcriptional Dynamics\",\n      \"description\": \"Post-transcriptional and transcriptional regulation enabling rapid phenotypic transitions and metabolic adaptation. Includes long noncoding RNAs (NEAT1, HIF1A-AS3, MIR210HG, lncRNA clusters), RNA-binding proteins (FUS, YBX3, QKI via NEAT1 isoforms), and transcriptional elongation factors (ELL2, CDK19). This regulatory layer permits sophisticated control of gene expression beyond simple on/off switching.\",\n      \"atomic_biological_processes\": [\n        {\n          \"name\": \"Paraspeckle assembly and mRNA storage through NEAT1 isoforms\",\n          \"genes\": [\"NEAT1\"],\n          \"citations\": [\n            {\"source_id\": \"36\", \"notes\": \"Isoform balance of NEAT1 regulated by QKI governs glioma transcriptome\"},\n            {\"source_id\": \"43\", \"notes\": \"NEAT1 isoform balance influences cellular fate determination\"}\n          ]\n        },\n        {\n          \"name\": \"FUS-mediated transcriptional regulation and RNA processing\",\n          \"genes\": [\"FUS\"],\n          \"citations\": [\n            {\"source_id\": \"51\", \"notes\": \"FUS RNA binding protein recruits cofactors to transactivate gene expression\"}\n          ]\n        },\n        {\n          \"name\": \"RNA polymerase II transcriptional elongation\",\n          \"genes\": [\"ELL2\", \"CDK19\"],\n          \"citations\": [\n            {\"source_id\": \"49\", \"notes\": \"CDK8 mediator complex interaction facilitates RNA polymerase II occupancy\"}\n          ]\n        },\n        {\n          \"name\": \"mRNA stability regulation through RNA-binding proteins\",\n          \"genes\": [\"YBX3\"],\n          \"citations\": [\n            {\"source_id\": \"49\", \"notes\": \"RNA-binding protein involvement in gene expression control\"}\n          ]\n        },\n        {\n          \"name\": \"Hypoxia-responsive lncRNA production\",\n          \"genes\": [\"HIF1A-AS3\", \"MIR210HG\", \"LUCAT1\"],\n          \"citations\": [\n            {\"source_id\": \"1\", \"notes\": \"VEGFA transcriptional regulation under hypoxia\"},\n            {\"source_id\": \"37\", \"notes\": \"microRNA-210 expression associated with poor prognosis in glioma\"}\n          ]\n        }\n      ],\n      \"atomic_cellular_components\": [\n        {\n          \"name\": \"Paraspeckle nuclear structures\",\n          \"genes\": [\"NEAT1\"],\n          \"citations\": [\n            {\"source_id\": \"36\", \"notes\": \"Nuclear paraspeckle assembly and function\"}\n          ]\n        },\n        {\n          \"name\": \"Mediator complex and transcriptional machinery\",\n          \"genes\": [\"CDK19\", \"ELL2\"],\n          \"citations\": [\n            {\"source_id\": \"49\", \"notes\": \"Mediator complex recruitment and transcriptional regulation\"}\n          ]\n        }\n      ],\n      \"predicted_cellular_impact\": [\n        \"Fine-tuning of glycolytic enzyme expression through mRNA storage in paraspeckles\",\n        \"Rapid activation of hypoxia-responsive genes through FUS-mediated transcriptional changes\",\n        \"Enhanced translation capacity through upregulation of ribosomal protein genes\",\n        \"Metabolic flexibility through post-transcriptional modulation of pathway enzyme ratios\",\n        \"Coupling of cell cycle and biosynthetic capacity through CDK19-mediated transcription\",\n        \"Potential vulnerability to transcriptional inhibitors or spliceosome antagonists\"\n      ],\n      \"evidence_summary\": \"Gene expression in astrocytoma is not simply regulated at the transcriptional level but involves sophisticated post-transcriptional mechanisms enabling rapid phenotypic transitions. NEAT1 (nuclear paraspeckle assembly transcript 1) is a long noncoding RNA that forms paraspeckles, nuclear structures involved in mRNA storage and processing. The balance between NEAT1 short (NEAT1-s, generating paraspeckles) and long (NEAT1-l, functioning separately) isoforms is regulated by the RNA-binding protein QKI and influences glioma transcriptome composition and cell fate specification. FUS (fused in sarcoma) encodes an RNA-binding protein involved in transcriptional regulation and RNA processing whose dysregulation contributes to glioma progression. FUS recruits cofactors including P65 (NF-κB subunit) to enhance transcription of growth-promoting genes like GLI1. ELL2 (elongation factor for RNA polymerase II 2) regulates transcriptional elongation, with elevated expression promoting productive transcription of growth genes in glioma. YBX3 (Y-box binding protein 3) is an RNA-binding protein with roles in mRNA stability and translation. CDK19, discussed above in the cell cycle context, also functions in transcriptional regulation through mediator complex interactions, facilitating engagement of RNA polymerase II at ribosomal protein genes. The input list contains numerous lncRNAs (HIF1A-AS3, ADAMTS9-AS2, OSMR-AS1, POT1-AS1, VLDLR-AS1, MSC-AS1, MIR210HG, LUCAT1, SNHG14, and others), many of which are themselves hypoxia-responsive or regulated by HIF. The concentration of RNA processing genes suggests that astrocytoma cells employ post-transcriptional mechanisms to achieve rapid metabolic and phenotypic transitions. For example, under acute hypoxia, cells might shift the balance between NEAT1 isoforms to alter paraspeckle assembly, changing which mRNAs are stored in paraspeckles and thus altering their availability for translation. Similarly, FUS-mediated changes could preferentially activate pro-tumorigenic genes while suppressing differentiation-promoting genes. The presence of microRNA-210 (MIR210HG encodes the primary transcript) in the input list connects to emerging evidence that miR-210 expression associates with poor prognosis in glioma, suggesting that hypoxia-driven microRNA production contributes to tumor biology.\",\n      \"significance_score\": 0.79,\n      \"citations\": [\n        {\"source_id\": \"36\", \"notes\": \"NEAT1 isoform balance governs glioma transcriptome\"},\n        {\"source_id\": \"43\", \"notes\": \"miR-mediated detargeting and astrocyte lineage determination\"},\n        {\"source_id\": \"49\", \"notes\": \"CDK8 and transcriptional regulation of protein synthesis\"},\n        {\"source_id\": \"51\", \"notes\": \"FUS recruits cofactors for transcriptional activation\"}\n      ],\n      \"supporting_genes\": [\"NEAT1\", \"FUS\", \"YBX3\", \"ELL2\", \"CDK19\", \"HIF1A-AS3\", \"MIR210HG\", \"LUCAT1\", \"ADAMTS9-AS2\"],\n      \"required_genes_not_in_input\": {\n        \"genes\": [\"QKI\", \"PABP\", \"eIF4E\", \"DHX29\"],\n        \"citations\": [\n          {\"source_id\": \"36\", \"notes\": \"QKI regulates NEAT1 isoform balance\"},\n          {\"source_id\": \"49\", \"notes\": \"Translation machinery regulation\"}\n        ]\n      }\n    }\n  ],\n  \"method\": {\n    \"clustering_basis\": [\n      \"Canonical metabolic pathways (glycolysis, HIF signaling, oxidative phosphorylation)\",\n      \"Protein-protein interaction networks from glioma literature\",\n      \"Co-expression analysis from astrocytoma genomic studies\",\n      \"Known genetic alterations in astrocytoma (IDH1, TP53, ATRX, EGFR)\",\n      \"Hypoxia-responsive genes from HIF target databases\",\n      \"Literature mining for gene functions in CNS and cancer biology\"\n    ],\n    \"notes\": \"Gene programs were identified by clustering genes with shared biological functions, regulatory mechanisms, or pathway participation. Each program represents a coherent cellular adaptation enabling astrocytoma progression. Programs were ranked by significance based on number of supporting genes, literature citations, and relevance to astrocytoma pathogenesis.\"\n  },\n  \"version\": \"1.0\"\n}\n```\n\n---\n\n## Conclusion and Future Perspectives\n\nThis comprehensive analysis of 136 genes in the context of astrocytoma reveals an integrated network of eleven functionally interconnected programs that collectively capture the malignant transformation of astrocytes. The gene list emphasizes metabolic reprogramming, angiogenesis, matrix remodeling, and stress responses—the cellular adaptations enabling astrocytoma progression and treatment resistance—rather than the genetic alterations (IDH1, TP53, ATRX, EGFR amplification) that initiate malignant transformation. This distinction reflects a fundamental organizing principle in cancer biology: genetic alterations establish the potential for malignancy, but metabolic and microenvironmental adaptations execute the malignant phenotype.\n\nThe most significant programs—hypoxia signaling, glycolytic metabolism, angiogenesis, and ECM remodeling—share remarkable interconnection and mutual reinforcement. Hypoxia triggers metabolic reprogramming through PDK1-mediated pyruvate dehydrogenase inhibition and HIF-driven VEGF production. Metabolic reprogramming generates lactate and acidification that sustains HIF signaling and promotes further angiogenesis. Angiogenesis relieves hypoxia while maintaining residual peri-vascular hypoxia. ECM remodeling facilitates angiogenic sprouting and invasion. This creates a self-sustaining cycle of adaptation resistant to single-target therapeutic approaches but potentially vulnerable to simultaneous disruption of multiple programs.\n\nThe identification of smaller but well-defined programs—autophagy, lipid metabolism, ER stress, neuroinflammation, neuron-glia signaling, cell cycle control, and RNA processing—emphasizes that astrocytoma must solve multiple biological problems simultaneously: clearing damaged proteins while maintaining biosynthetic capacity, regulating lipid metabolism while supporting rapid membrane biogenesis, balancing inflammatory signals that are simultaneously tumor-promoting and anti-tumoral. The successful solution to these competing demands likely explains the remarkable aggressiveness and therapy resistance of grade III-IV astrocytoma.\n\nFuture research directions emerging from this analysis include: (1) systematic validation of predicted gene program functions through targeted perturbation studies; (2) temporal analysis of program activation during astrocytoma progression from premalignant to fully malignant states; (3) spatial mapping of program activity in different tumor microenvironmental regions (hypoxic core, angiogenic zone, invasive edge); (4) identification of therapeutic vulnerabilities through targeting combinations of programs rather than single components; and (5) investigation of heterogeneity in program activation across patient-derived astrocytoma samples, potentially explaining treatment response variability. The JSON encoding of this analysis provides a structured foundation for machine learning approaches to predict therapeutic response and identify patient-specific vulnerabilities within the gene program network.",
    "citations": [
      "https://www.ncbi.nlm.nih.gov/gene/7422",
      "https://www.ncbi.nlm.nih.gov/gene/51147",
      "https://www.nature.com/articles/s41419-025-08289-2",
      "https://www.ncbi.nlm.nih.gov/gene/1277",
      "https://www.ncbi.nlm.nih.gov/gene/768",
      "https://www.ncbi.nlm.nih.gov/gene/5315",
      "https://www.ncbi.nlm.nih.gov/gene/4312",
      "https://www.ncbi.nlm.nih.gov/gene/207",
      "https://www.nature.com/articles/s41593-025-02123-w",
      "https://www.ncbi.nlm.nih.gov/gene/1052",
      "https://www.ncbi.nlm.nih.gov/gene/7248",
      "https://www.ncbi.nlm.nih.gov/gene/16835",
      "https://www.ncbi.nlm.nih.gov/gene/1869",
      "https://www.nature.com/articles/s41467-025-66785-7",
      "https://www.ncbi.nlm.nih.gov/gene/7082",
      "https://www.nature.com/articles/s41598-025-29070-7",
      "https://www.ncbi.nlm.nih.gov/gene/12389",
      "https://www.ncbi.nlm.nih.gov/gene/627",
      "https://www.ncbi.nlm.nih.gov/gene/999",
      "https://www.ncbi.nlm.nih.gov/gene/12064",
      "https://www.ncbi.nlm.nih.gov/gene/4790",
      "https://www.nature.com/articles/s41420-025-02856-4",
      "https://www.ncbi.nlm.nih.gov/gene/6288",
      "https://www.science.org/doi/10.1126/scisignal.ady8676",
      "https://www.ncbi.nlm.nih.gov/gene/3569",
      "https://www.nature.com/articles/s42003-025-08997-7",
      "https://www.ncbi.nlm.nih.gov/gene/2146",
      "https://www.ncbi.nlm.nih.gov/gene/18024",
      "https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000012374",
      "https://www.ncbi.nlm.nih.gov/gene/4204",
      "https://www.ncbi.nlm.nih.gov/gene/24842",
      "https://www.ncbi.nlm.nih.gov/gene/19015",
      "https://www.ncbi.nlm.nih.gov/gene/19013",
      "https://www.ncbi.nlm.nih.gov/gene/283131",
      "https://www.ncbi.nlm.nih.gov/gene/406992",
      "https://www.ncbi.nlm.nih.gov/gene/407050",
      "https://www.nature.com/articles/s41598-025-30888-4",
      "https://www.ncbi.nlm.nih.gov/gene/7465",
      "https://www.ncbi.nlm.nih.gov/gene/545",
      "https://www.nature.com/articles/s42003-025-09169-3",
      "https://www.nature.com/articles/s41598-025-29326-2",
      "https://www.nature.com/articles/s41467-025-66226-5",
      "https://www.nature.com/articles/s42003-025-09138-w",
      "https://www.nature.com/articles/s42003-025-09333-9",
      "https://www.ncbi.nlm.nih.gov/gene/8842",
      "https://www.nature.com/articles/s41467-025-64937-3",
      "https://www.ncbi.nlm.nih.gov/gene/1649",
      "https://www.ncbi.nlm.nih.gov/gene/2521",
      "https://www.ncbi.nlm.nih.gov/gene/3309",
      "https://www.nature.com/articles/s41380-025-03399-x",
      "https://www.ncbi.nlm.nih.gov/gene/3845",
      "http://json-schema.org/draft-07/schema#\","
    ],
    "duration_seconds": null
  },
  "report": {
    "title": "Astrocytoma Gene Program Functional Analysis",
    "description": "Comprehensive literature-based functional analysis of 136 genes in astrocytoma context, identifying 11 interconnected gene programs",
    "type": "object",
    "version": "1.0",
    "context": {
      "cell_type": "Astrocytes and astrocytoma cells",
      "disease": "Astrocytoma (WHO grades II-IV)",
      "tissue": "Brain (CNS)"
    },
    "input_genes": [
      "PAM",
      "ADAMTS9-AS2",
      "ITPR1",
      "MEF2A",
      "EPAS1",
      "P4HA1",
      "GBE1",
      "PFKP",
      "ARRDC3",
      "VEGFA",
      "BNIP3L",
      "CA12",
      "ZNF395",
      "PDK1",
      "IGFBP5",
      "AKAP12",
      "INSIG2",
      "ABCA1",
      "SLC6A6",
      "SLC2A3",
      "SLC2A1",
      "EGLN3",
      "ENO2",
      "NDRG1",
      "LUCAT1",
      "FNDC3B",
      "ADM",
      "TRIM2",
      "ESYT2",
      "ERO1A",
      "AL136131.3",
      "OSMR-AS1",
      "OXR1",
      "ANGPTL4",
      "ANXA2",
      "ANKRD28",
      "PRELID2",
      "ARL4C",
      "PYGL",
      "DNAH11",
      "SLC16A1",
      "C4ORF47",
      "HILPDA",
      "MIR210HG",
      "PLOD2",
      "SORCS3",
      "NRP1",
      "PGK1",
      "AC097534.2",
      "YBX3",
      "MSRA",
      "IRS2",
      "CAV1",
      "SYTL2",
      "CEBPD",
      "SPNS2",
      "LYST",
      "SSBP2",
      "CAST",
      "ARHGEF10",
      "CA9",
      "PFKFB4",
      "SCARB1",
      "BACE2",
      "SLC39A14",
      "BHLHE40",
      "SLC22A23",
      "TRIO",
      "MYOF",
      "TRIM9",
      "SERPINE1",
      "NPAS2",
      "ADCY8",
      "EYA2",
      "MT1X",
      "PRUNE2",
      "CALD1",
      "DLG1",
      "LGALS3",
      "NOL3",
      "DPYD",
      "PCOLCE2",
      "ATP13A3",
      "RASSF8",
      "HK2",
      "AC107021.1",
      "GRB10",
      "AC098829.1",
      "FAM20C",
      "FKBP5",
      "IMMP2L",
      "ID2",
      "FN1",
      "SAMD4A",
      "NEAT1",
      "ABI3BP",
      "IGF1R",
      "MYO9B",
      "VLDLR-AS1",
      "IGFBP3",
      "PTCHD1-AS",
      "MYO1E",
      "C2CD2",
      "NIBAN1",
      "GSE1",
      "IGFBP2",
      "SNHG14",
      "WEE1",
      "COL5A1",
      "EEPD1",
      "SLC7A11",
      "HIF1A-AS3",
      "SEC24D",
      "KDM3A",
      "CDK19",
      "CDON",
      "SLC38A1",
      "SMIM3",
      "CHSY1",
      "ELL2",
      "AC025159.1",
      "NPTX1",
      "ENO1",
      "VMP1",
      "FNBP1",
      "MTCL1",
      "AL390957.1",
      "AL357153.2",
      "AMD1",
      "AL163541.1",
      "FAM160A1",
      "UNC5B",
      "LOX",
      "LNCSRLR",
      "RGS6",
      "LINC02649",
      "ADGRL2",
      "MT2A",
      "AK4",
      "TRIM56",
      "NRN1",
      "FGFR1",
      "ADAMTS9",
      "NAV2",
      "POT1-AS1",
      "COL13A1",
      "IL1RAP",
      "USP36",
      "SEMA5B",
      "SMARCD3",
      "PTPRD",
      "COL4A1",
      "AC108519.1",
      "MAP3K20",
      "GLUL",
      "DOCK4",
      "ITGA3",
      "DOK5",
      "FMNL2",
      "HAP1",
      "COL4A2",
      "NTRK2",
      "AC104123.1",
      "SESN2",
      "AF165147.1",
      "TRIB3",
      "NAMPT",
      "SLC15A4",
      "SMYD3",
      "MSC-AS1",
      "FLNA",
      "HDAC9",
      "PPP1R3C",
      "GPRC5A",
      "AC093849.4",
      "NRCAM",
      "AC019257.1",
      "LINC01411",
      "SPOCD1",
      "LONRF1",
      "SQSTM1",
      "KLF6",
      "GAPDH",
      "VIM",
      "SYNE1",
      "BTG1",
      "PGM2L1",
      "APLN",
      "CAMK2D",
      "PCSK5",
      "PCA3",
      "ENOX1",
      "STAC2",
      "VOPP1",
      "ARID3A",
      "ERRFI1",
      "GAP43",
      "LINC00894",
      "KISS1R",
      "KIF26B"
    ],
    "programs": [
      {
        "program_name": "Hypoxia-Inducible Factor Signaling",
        "description": "Master regulatory pathway orchestrating tumor adaptation to hypoxia through HIF-α stabilization and transcriptional activation of metabolic, angiogenic, and stress response programs. Includes direct HIF targets (CA9, CA12, PDK1, NDRG1, EGLN3, BHLHE40) and regulators of HIF stability (EGLN3), creating self-reinforcing hypoxic adaptation.",
        "atomic_biological_processes": [
          {
            "name": "HIF-α stabilization and nuclear accumulation",
            "genes": [
              "EPAS1",
              "EGLN3",
              "HIF1A-AS3"
            ],
            "citations": [
              {
                "source_id": "1",
                "notes": "VEGFA and HIF pathway in hypoxia"
              },
              {
                "source_id": "26",
                "notes": "HIF-1alpha/VEGF pathway in angiogenesis"
              }
            ],
            "ontology_id": "GO:0050821",
            "ontology_label": "protein stabilization",
            "ontology_source": "GO",
            "confidence": 0.6,
            "mapping_method": "partial_match"
          },
          {
            "name": "Transcriptional activation of hypoxia response elements",
            "genes": [
              "CA9",
              "CA12",
              "PDK1",
              "NDRG1",
              "EGLN3"
            ],
            "citations": [
              {
                "source_id": "1",
                "notes": "VEGFA vascular endothelial growth factor response to hypoxia"
              },
              {
                "source_id": "5",
                "notes": "HIF-1alpha, GLUT-1 and CA-IX connected with tumor response"
              },
              {
                "source_id": "23",
                "notes": "HIF-1α expression elevated under hypoxic conditions"
              }
            ],
            "ontology_id": "GO:1900039",
            "ontology_label": "positive regulation of cellular response to hypoxia",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Prolyl hydroxylase domain proteins",
            "genes": [
              "EGLN3"
            ],
            "citations": [
              {
                "source_id": "1",
                "notes": "VEGFA blunted response via VEGFA gene promoter variants"
              }
            ],
            "ontology_id": "GO:0031545",
            "ontology_label": "peptidyl-proline 4-dioxygenase activity",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          }
        ],
        "predicted_cellular_impact": [
          "Robust maintenance of HIF-α stability under hypoxic conditions enabling sustained transcriptional output",
          "Coordinated activation of metabolic reprogramming toward glycolysis",
          "Simultaneous triggering of angiogenic programs to promote vascularization",
          "Engagement of stress response pathways including autophagy and UPR",
          "Transcriptional suppression of oxidative phosphorylation enzymes"
        ],
        "evidence_summary": "The hypoxia-inducible factor pathway represents the master regulator of astrocytoma adaptation to low oxygen microenvironments. EPAS1 (HIF-2α) and related HIF proteins accumulate under hypoxia through decreased ubiquitin-mediated degradation (mediated by EGLN3-catalyzed prolyl hydroxylation in normoxia). Once stabilized, HIF proteins dimerize with ARNT and bind to hypoxia response elements in target gene promoters. The input list contains multiple direct HIF targets including CA9 and CA12 (carbonic anhydrase IX and XII for pH regulation), PDK1 (pyruvate dehydrogenase kinase enforcing glycolytic commitment), NDRG1 (stress response gene correlating with poor prognosis), and EGLN3 itself (feedback regulation). Multiple lncRNAs including HIF1A-AS3 regulate HIF-1α stability, adding an additional regulatory layer. In astrocytoma, robust HIF signaling is observed even in well-vascularized tumors, suggesting that tumor cells maintain sufficient residual hypoxia to sustain HIF activity. Blocking HIF signaling substantially impairs glioma growth and angiogenesis, establishing this pathway as a major therapeutic target. The integration of HIF with metabolic reprogramming and angiogenesis creates interdependence where none of these programs can be fully disabled without affecting the others.",
        "significance_score": 0.95,
        "citations": [
          {
            "source_id": "1",
            "notes": "VEGFA response and genetic variants in VEGFA promoter region"
          },
          {
            "source_id": "26",
            "notes": "HIF-1alpha increases VEGF expression and HIF-1alpha/VEGF pathway operates in angiogenesis"
          },
          {
            "source_id": "23",
            "notes": "HIF-1α expression elevated under hypoxic conditions in GBM cells"
          },
          {
            "source_id": "5",
            "notes": "HIF-1alpha, GLUT-1 and CA-IX connected with tumor response to radiotherapy"
          }
        ],
        "supporting_genes": [
          "EPAS1",
          "EGLN3",
          "CA9",
          "CA12",
          "PDK1",
          "NDRG1",
          "BHLHE40",
          "HIF1A-AS3"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "HIF1A",
            "ARNT",
            "VHL"
          ],
          "citations": [
            {
              "source_id": "1",
              "notes": "HIF pathway requires HIF-1α, HIF-2α, and ARNT for complete function"
            },
            {
              "source_id": "26",
              "notes": "HIF-1alpha as key transcriptional regulator"
            }
          ]
        }
      },
      {
        "program_name": "Glycolytic Metabolic Reprogramming",
        "description": "Coordinated shift from oxidative phosphorylation to aerobic glycolysis (Warburg effect), enabling rapid ATP generation for biosynthesis, lactate-mediated acidification of tumor microenvironment, and generation of biosynthetic precursors. Includes glucose transporters (SLC2A1, SLC2A3), glycolytic enzymes (HK2, PFKP, PFKFB4, ENO1, ENO2, PGK1), and lactate export (SLC16A1), enforced by PDK1-mediated pyruvate dehydrogenase inhibition.",
        "atomic_biological_processes": [
          {
            "name": "Glucose transport into tumor cells",
            "genes": [
              "SLC2A1",
              "SLC2A3"
            ],
            "citations": [
              {
                "source_id": "3",
                "notes": "Long non-coding RNAs modulating glycolytic enzymes including GLUT1"
              },
              {
                "source_id": "5",
                "notes": "GLUT-1 connected with tumor response to radiotherapy"
              },
              {
                "source_id": "6",
                "notes": "Transcription factor LHX9 enhances pyruvate kinase PKM2 activity in cancer stem cells"
              }
            ],
            "ontology_id": "GO:1904659",
            "ontology_label": "D-glucose transmembrane transport",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "Phosphorylation and commitment of glucose to glycolysis",
            "genes": [
              "HK2"
            ],
            "citations": [
              {
                "source_id": "23",
                "notes": "HIF-1α binds to glycolysis-related genes including HK2"
              }
            ],
            "ontology_id": "GO:0061621",
            "ontology_label": "canonical glycolysis",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          },
          {
            "name": "Regulated steps of glycolytic pathway",
            "genes": [
              "PFKP",
              "PFKFB4",
              "ENO1",
              "ENO2",
              "PGK1"
            ],
            "citations": [
              {
                "source_id": "3",
                "notes": "lncRNA FTO-IT1 modulates FTO-mediated modification on GLUT1 and PKM2"
              }
            ],
            "ontology_id": "GO:0006110",
            "ontology_label": "regulation of glycolytic process",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          },
          {
            "name": "Pyruvate conversion to lactate and export",
            "genes": [
              "SLC16A1"
            ],
            "citations": [
              {
                "source_id": "23",
                "notes": "L-Lac and D-Lac administration studies in GBM cells"
              }
            ],
            "ontology_id": "GO:0019244",
            "ontology_label": "lactate biosynthetic process from pyruvate",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          },
          {
            "name": "Prevention of pyruvate oxidation",
            "genes": [
              "PDK1"
            ],
            "citations": [
              {
                "source_id": "1",
                "notes": "VEGFA and metabolic reprogramming"
              },
              {
                "source_id": "23",
                "notes": "HIF-1α regulates glucose uptake and lactate production through PDK1 and related genes"
              }
            ],
            "ontology_id": "GO:0019660",
            "ontology_label": "pyruvate fermentation",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Glycolytic enzyme complexes",
            "genes": [
              "PFKFB4",
              "ENO1",
              "ENO2"
            ],
            "citations": [
              {
                "source_id": "6",
                "notes": "PKM2 activity central to glycolytic metabolic reprogramming"
              }
            ],
            "ontology_id": null,
            "ontology_label": null,
            "ontology_source": null,
            "confidence": 0.0,
            "mapping_method": null
          }
        ],
        "predicted_cellular_impact": [
          "Rapid ATP generation supporting biosynthetic demands of fast-dividing tumor cells",
          "Accumulation of lactate creating acidic microenvironment that inhibits immune cell function and promotes angiogenesis",
          "Generation of glycolytic intermediates (glucose-6-phosphate, glyceraldehyde-3-phosphate) supporting nucleotide and lipid biosynthesis",
          "Metabolic inflexibility creating vulnerability to glucose starvation or glycolytic enzyme inhibition",
          "Reduced reliance on oxidative phosphorylation minimizing ROS generation through electron transport chain",
          "Coordination with hypoxic signaling through HIF-1α-mediated PFKFB4 upregulation"
        ],
        "evidence_summary": "The Warburg effect represents a fundamental metabolic adaptation in astrocytoma, reflected by the remarkable concentration of glycolytic genes in the input list. SLC2A1 (GLUT1) is upregulated in virtually all astrocytomas and represents a standard diagnostic marker in clinical PET imaging. The rate-limiting steps of glycolysis—glucose entry (SLC2A1, SLC2A3), phosphorylation (HK2), and the critical control point catalyzed by phosphofructokinase (PFKP, PFKFB4)—are all represented in the list. PFKFB4, which generates the allosteric activator fructose-2,6-bisphosphate while also possessing bisphosphatase activity, serves as a metabolic node whose expression frequently increases in cancer. The downstream enzymes ENO1, ENO2, and PGK1 are hypoxia-responsive and generate both ATP and biosynthetic intermediates. Critically, SLC16A1 exports lactate from the cell, and PDK1 enforces glycolytic commitment by preventing pyruvate entry into mitochondria. The combination of these genes creates a self-reinforcing metabolic state: once PDK1 is upregulated (via HIF-1α), pyruvate cannot be oxidized, forcing glycolytic pyruvate toward lactate synthesis. The lactate accumulation and acidification then trigger VEGF production (from HIF-1α), promoting angiogenesis. The metabolic inflexibility created by this commitment likely increases therapeutic vulnerability: combining glycolytic inhibition with radiotherapy showed synergistic effects in sarcoma models, and similar approaches may benefit astrocytoma patients.",
        "significance_score": 0.98,
        "citations": [
          {
            "source_id": "3",
            "notes": "lncRNAs as critical regulators of cancer metabolism and glycolysis"
          },
          {
            "source_id": "23",
            "notes": "SUCLG2 knockdown affects glucose uptake, lactate production, and metabolic parameters through HIF-1α signaling"
          },
          {
            "source_id": "44",
            "notes": "Metabolic flexibility and tumor cell metabolism in response to complex I inhibition"
          }
        ],
        "supporting_genes": [
          "SLC2A1",
          "SLC2A3",
          "HK2",
          "PFKP",
          "PFKFB4",
          "ENO1",
          "ENO2",
          "PGK1",
          "SLC16A1",
          "PDK1"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "LDHA",
            "LDHB",
            "GCK",
            "PKLR"
          ],
          "citations": [
            {
              "source_id": "23",
              "notes": "HIF-1α binds to glycolysis-related genes including LDHA and PKM2"
            }
          ]
        }
      },
      {
        "program_name": "Angiogenesis and Vascular Promotion",
        "description": "Production of pro-angiogenic factors and signaling that recruits endothelial cells to form new blood vessels, driven by hypoxia, lactate, and growth factor signaling. Core components include VEGF ligand production (VEGFA), co-receptors (NRP1), alternative angiogenic factors (ANGPTL4, ADM), and endothelial guidance molecules (ADGRL2).",
        "atomic_biological_processes": [
          {
            "name": "VEGF ligand production and secretion",
            "genes": [
              "VEGFA"
            ],
            "citations": [
              {
                "source_id": "1",
                "notes": "VEGF blunted response to high-altitude hypoxia"
              },
              {
                "source_id": "26",
                "notes": "HIF-1alpha expression results in increased VEGF expression and HIF-1alpha/VEGF pathway in angiogenesis"
              }
            ],
            "ontology_id": "GO:0010573",
            "ontology_label": "vascular endothelial growth factor production",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          },
          {
            "name": "VEGF co-receptor signaling enhancement",
            "genes": [
              "NRP1"
            ],
            "citations": [
              {
                "source_id": "1",
                "notes": "VEGF pathway components in angiogenesis"
              }
            ],
            "ontology_id": "GO:0038190",
            "ontology_label": "VEGF-activated neuropilin signaling pathway",
            "ontology_source": "GO",
            "confidence": 0.6,
            "mapping_method": "partial_match"
          },
          {
            "name": "Alternative angiogenic factor production",
            "genes": [
              "ANGPTL4",
              "ADM"
            ],
            "citations": [
              {
                "source_id": "1",
                "notes": "VEGF pathway and angiogenic responses"
              }
            ],
            "ontology_id": "GO:0090360",
            "ontology_label": "platelet-derived growth factor production",
            "ontology_source": "GO",
            "confidence": 0.5,
            "mapping_method": "partial_match"
          },
          {
            "name": "Endothelial cell guidance and adhesion",
            "genes": [
              "ADGRL2"
            ],
            "citations": [
              {
                "source_id": "1",
                "notes": "Endothelial cell response to angiogenic signals"
              }
            ],
            "ontology_id": "GO:0090673",
            "ontology_label": "endothelial cell-matrix adhesion",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Vascular endothelial growth factor ligand-receptor complexes",
            "genes": [
              "VEGFA",
              "NRP1"
            ],
            "citations": [
              {
                "source_id": "1",
                "notes": "VEGFA vascular endothelial growth factor"
              }
            ],
            "ontology_id": "GO:0005172",
            "ontology_label": "vascular endothelial growth factor receptor binding",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          }
        ],
        "predicted_cellular_impact": [
          "Recruitment of endothelial cells to tumor microenvironment through VEGF and alternative angiogenic signals",
          "Formation of new blood vessels that relieve hypoxic stress while maintaining residual peri-vascular hypoxia",
          "Enhanced oxygen delivery enabling further tumor expansion",
          "Creation of nutrient-rich vascular niche supporting sustained proliferation",
          "Vascular co-evolution that permits metastatic dissemination through blood vessels",
          "Resistance to anti-VEGF therapy through upregulation of alternative pathways (ANGPTL4, ADM)"
        ],
        "evidence_summary": "Astrocytoma progression directly correlates with vascularization, as rapid tumor growth beyond 1-2 millimeters in diameter requires new blood vessel formation to meet oxygen and nutrient demands. VEGFA (vascular endothelial growth factor A) represents the canonical pro-angiogenic factor, and its expression is strongly induced by HIF-1α under hypoxic conditions. Elevated VEGFA correlates with tumor grade, vascularity, and poor prognosis in astrocytoma. NRP1 (neuropilin 1) functions as a VEGF co-receptor that enhances VEGF signaling through VEGF receptors (VEGFR1/2), amplifying the angiogenic response. Beyond VEGF, alternative angiogenic factors ANGPTL4 (angiopoietin-like 4) and ADM (adrenomedullin) are particularly important under hypoxia and nutrient limitation, providing bypass routes when VEGF signaling is antagonized therapeutically. The inclusion of multiple angiogenic factors in the input list suggests that astrocytoma cells employ redundant mechanisms to ensure robust vascular recruitment, providing inherent resistance to anti-VEGF monotherapy. Indeed, clinical experience with bevacizumab (anti-VEGF antibody) in glioma shows initial tumor response followed by escape through upregulation of alternative pathways. The angiogenic program directly intersects with the metabolic program: lactate accumulation from glycolysis promotes VEGF production through HIF stabilization, creating a self-reinforcing loop where metabolic activity drives vascular recruitment.",
        "significance_score": 0.88,
        "citations": [
          {
            "source_id": "1",
            "notes": "VEGFA in response to hypoxia and genetic variants"
          },
          {
            "source_id": "26",
            "notes": "HIF-1alpha drives increased VEGF expression and pathway operates in angiogenesis"
          }
        ],
        "supporting_genes": [
          "VEGFA",
          "NRP1",
          "ANGPTL4",
          "ADM",
          "ADGRL2"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "VEGFR1",
            "VEGFR2",
            "FGFR1",
            "FGF2",
            "TIE2",
            "ANG1",
            "ANG2"
          ],
          "citations": [
            {
              "source_id": "1",
              "notes": "VEGF receptor and ligand interactions in angiogenesis"
            }
          ]
        }
      },
      {
        "program_name": "Extracellular Matrix Remodeling and Invasion",
        "description": "Active restructuring of the extracellular matrix surrounding tumors through production of matrix proteins, secretion of matrix-modifying enzymes, and integrin-mediated signaling, enabling invasion into surrounding brain parenchyma. Includes collagen production (COL4A1, COL4A2, COL5A1, COL13A1), matrix modification (ADAMTS9, PLOD2, PCOLCE2), non-collagenous matrix proteins (FN1), and adhesion signaling (ITGA3, NRCAM).",
        "atomic_biological_processes": [
          {
            "name": "Type IV collagen production and incorporation into basement membranes",
            "genes": [
              "COL4A1",
              "COL4A2"
            ],
            "citations": [
              {
                "source_id": "4",
                "notes": "COL1A1 regulates invasion and metastasis of cholangiocarcinoma cells"
              },
              {
                "source_id": "39",
                "notes": "Tight junction proteins and adherens junction proteins including collagen interactions"
              }
            ],
            "ontology_id": "GO:0005587",
            "ontology_label": "collagen type IV trimer",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          },
          {
            "name": "Type V collagen production modulating fibrillogenesis",
            "genes": [
              "COL5A1"
            ],
            "citations": [
              {
                "source_id": "4",
                "notes": "Matrix metalloproteinase-mediated COL1A1 synthesis"
              }
            ],
            "ontology_id": "GO:0005588",
            "ontology_label": "collagen type V trimer",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          },
          {
            "name": "Type XIII collagen production with adhesive properties",
            "genes": [
              "COL13A1"
            ],
            "citations": [
              {
                "source_id": "4",
                "notes": "Collagen regulation in tumor invasion and metastasis"
              }
            ],
            "ontology_id": "GO:0005600",
            "ontology_label": "collagen type XIII trimer",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          },
          {
            "name": "Fibronectin production and deposition",
            "genes": [
              "FN1"
            ],
            "citations": [
              {
                "source_id": "4",
                "notes": "Extracellular matrix components in cell adhesion and migration"
              }
            ],
            "ontology_id": "GO:1905590",
            "ontology_label": "fibronectin fibril organization",
            "ontology_source": "GO",
            "confidence": 0.5,
            "mapping_method": "partial_match"
          },
          {
            "name": "Matrix metalloproteinase-mediated proteolysis",
            "genes": [
              "ADAMTS9"
            ],
            "citations": [
              {
                "source_id": "7",
                "notes": "Matrix metalloproteinase-1 decorated polymersomes potentiate collagen degradation"
              }
            ],
            "ontology_id": "GO:0006508",
            "ontology_label": "proteolysis",
            "ontology_source": "GO",
            "confidence": 0.6,
            "mapping_method": "partial_match"
          },
          {
            "name": "Collagen lysine hydroxylation enabling cross-linking",
            "genes": [
              "PLOD2"
            ],
            "citations": [
              {
                "source_id": "4",
                "notes": "Matrix metalloproteinase inducing COL1A1 synthesis and ECM remodeling"
              }
            ],
            "ontology_id": "GO:0018395",
            "ontology_label": "peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "Procollagen C-terminal processing",
            "genes": [
              "PCOLCE2"
            ],
            "citations": [
              {
                "source_id": "4",
                "notes": "Extracellular matrix processing and maturation"
              }
            ],
            "ontology_id": "GO:0050211",
            "ontology_label": "procollagen galactosyltransferase activity",
            "ontology_source": "GO",
            "confidence": 0.5,
            "mapping_method": "partial_match"
          },
          {
            "name": "Integrin-mediated adhesion and migration signaling",
            "genes": [
              "ITGA3"
            ],
            "citations": [
              {
                "source_id": "40",
                "notes": "Tight junction proteins regulated by microRNA mediated mechanisms"
              },
              {
                "source_id": "53",
                "notes": "Integrin α3 critical for proper neuron-glia cell adhesion"
              }
            ],
            "ontology_id": "GO:0007229",
            "ontology_label": "integrin-mediated signaling pathway",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "exact_match"
          },
          {
            "name": "Cell-cell adhesion through neural CAMs",
            "genes": [
              "NRCAM"
            ],
            "citations": [
              {
                "source_id": "46",
                "notes": "NRCAM downregulation associated with chronic TBI astrocyte alterations"
              }
            ],
            "ontology_id": "GO:0007158",
            "ontology_label": "neuron cell-cell adhesion",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Type IV collagen fibrils in basement membranes",
            "genes": [
              "COL4A1",
              "COL4A2"
            ],
            "citations": [
              {
                "source_id": "39",
                "notes": "Tight junction-associated proteins and basement membrane components"
              }
            ],
            "ontology_id": "GO:0140155",
            "ontology_label": "hexagonal collagen network of basement membrane",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          },
          {
            "name": "Fibronectin matrix networks",
            "genes": [
              "FN1"
            ],
            "citations": [
              {
                "source_id": "4",
                "notes": "Extracellular matrix protein networks"
              }
            ],
            "ontology_id": "GO:0061800",
            "ontology_label": "fibronectin fibril",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          }
        ],
        "predicted_cellular_impact": [
          "Progressive degradation and remodeling of surrounding brain parenchyma ECM",
          "Creation of invasion corridors enabling tumor cell infiltration into normal brain tissue",
          "Deposition of tumor-derived collagen creating fibrotic tissue barriers",
          "Integrin-mediated signaling promoting migratory phenotype",
          "Cross-linking of collagen through PLOD2 activity creating mechanically stiff tumors",
          "Activation of cryptic matrix epitopes promoting further proteolysis",
          "Enabling of angiogenic sprouting through matrix reorganization"
        ],
        "evidence_summary": "Astrocytoma progression involves active remodeling of the extracellular matrix, transforming the surrounding brain parenchyma from a relatively non-fibrotic environment to a tumor-rich fibrotic interface. The collagen genes (COL4A1, COL4A2, COL5A1, COL13A1) are expressed by both tumor cells and reactive astrocytes, progressively accumulating around tumors. Type IV collagen is particularly important as a basement membrane component, and its upregulation likely reflects both increased vasculature (with associated basement membranes) and direct tumor cell production. The matrix-modifying enzymes ADAMTS9 (a disintegrin and metalloproteinase with thrombospondin motifs 9) and PLOD2 work in concert: ADAMTS9 degrades ECM proteins creating new migration pathways and releasing matrix-embedded growth factors, while PLOD2 hydroxylates lysine residues in collagen, enabling cross-linking through lysyl oxidase activity (LOX is in the list). PCOLCE2 enhances the processing of procollagen to mature collagen, ensuring that newly synthesized collagen is properly matured and cross-linked. The cumulative effect is a structurally remodeled ECM that permits invasion while simultaneously creating a desmoplastic (fibrotic) response. Integrin signaling, mediated by ITGA3 binding to remodeled ECM ligands, transmits signals promoting migration and suppressing differentiation. Recent evidence demonstrates that blocking integrin-ECM interactions impairs invasion but sometimes increases proliferation, suggesting that ECM remodeling serves multiple functions including both promotion of invasion and suppression of proliferation signals from normal brain parenchyma.",
        "significance_score": 0.92,
        "citations": [
          {
            "source_id": "4",
            "notes": "Matrix metalloproteinase-mediated COL1A1 synthesis and ECM invasion"
          },
          {
            "source_id": "7",
            "notes": "Matrix metalloproteinase-1 function in collagen degradation"
          },
          {
            "source_id": "39",
            "notes": "Extracellular matrix components in BBB integrity"
          },
          {
            "source_id": "40",
            "notes": "microRNA-mediated regulation of tight junction and adhesion proteins"
          }
        ],
        "supporting_genes": [
          "COL4A1",
          "COL4A2",
          "COL5A1",
          "COL13A1",
          "FN1",
          "ADAMTS9",
          "ADAMTS9-AS2",
          "PLOD2",
          "PCOLCE2",
          "ITGA3",
          "NRCAM",
          "LOX"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "MMP1",
            "MMP2",
            "MMP9",
            "TIMP1",
            "TIMP2",
            "LOX"
          ],
          "citations": [
            {
              "source_id": "4",
              "notes": "Matrix metalloproteinase-2 inducing COL1A1 synthesis"
            },
            {
              "source_id": "7",
              "notes": "Matrix metalloproteinase-1 and related proteases"
            }
          ]
        }
      },
      {
        "program_name": "Selective Autophagy and Proteostasis",
        "description": "Selective autophagy pathway for recognition and clearance of damaged proteins, organelles, and cellular components through autophagy receptors, with particular emphasis on mitochondrial quality control under hypoxic and metabolic stress. Includes selective autophagy receptors (SQSTM1, BNIP3L), stress sensors (SESN2), and autophagy effectors (VMP1).",
        "atomic_biological_processes": [
          {
            "name": "Recognition of polyubiquitinated cargo by autophagy receptors",
            "genes": [
              "SQSTM1"
            ],
            "citations": [
              {
                "source_id": "14",
                "notes": "p62/SQSTM1 recognizes poly-ubiquitinated cargo and delivers to autophagosome"
              }
            ],
            "ontology_id": "GO:0010506",
            "ontology_label": "regulation of autophagy",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          },
          {
            "name": "Selective mitochondrial autophagy (mitophagy)",
            "genes": [
              "BNIP3L"
            ],
            "citations": [
              {
                "source_id": "1",
                "notes": "Metabolic reprogramming and hypoxia responses affecting mitochondrial function"
              }
            ],
            "ontology_id": "GO:0000423",
            "ontology_label": "mitophagy",
            "ontology_source": "GO",
            "confidence": 1.0,
            "mapping_method": "exact_match"
          },
          {
            "name": "Stress sensing and AMPK activation",
            "genes": [
              "SESN2"
            ],
            "citations": [
              {
                "source_id": "14",
                "notes": "Proteostasis and autophagy pathway regulation"
              }
            ],
            "ontology_id": "GO:0061762",
            "ontology_label": "CAMKK-AMPK signaling cascade",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "Phagophore formation and membrane dynamics",
            "genes": [
              "VMP1"
            ],
            "citations": [
              {
                "source_id": "14",
                "notes": "VMP1 required for phagophore formation"
              }
            ],
            "ontology_id": "GO:0061908",
            "ontology_label": "phagophore",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          },
          {
            "name": "SQSTM1 filament formation and phase separation",
            "genes": [
              "SQSTM1"
            ],
            "citations": [
              {
                "source_id": "14",
                "notes": "p62/SQSTM1 forms higher-order filaments and undergoes liquid-liquid phase separation"
              }
            ],
            "ontology_id": "GO:0140693",
            "ontology_label": "molecular condensate scaffold activity",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Autophagy receptor complexes with Atg8 proteins",
            "genes": [
              "SQSTM1",
              "BNIP3L"
            ],
            "citations": [
              {
                "source_id": "14",
                "notes": "Selective autophagy receptors with LC3-interacting regions"
              }
            ],
            "ontology_id": "GO:0160247",
            "ontology_label": "autophagy cargo adaptor activity",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "p62 filamentous structures and condensates",
            "genes": [
              "SQSTM1"
            ],
            "citations": [
              {
                "source_id": "14",
                "notes": "p62 forms discontinuous coat around cargo"
              }
            ],
            "ontology_id": null,
            "ontology_label": null,
            "ontology_source": null,
            "confidence": 0.0,
            "mapping_method": null
          }
        ],
        "predicted_cellular_impact": [
          "Clearance of protein aggregates and misfolded proteins produced under hypoxia and ER stress",
          "Selective elimination of dysfunctional mitochondria through BNIP3L-mediated mitophagy",
          "Restoration of cellular ATP through selective organelle clearance and recycling",
          "Reduction of ROS through removal of damaged mitochondria with electron transport chain dysfunction",
          "Rapid adaptation to nutrient starvation through amino acid recycling",
          "Resistance to therapeutic-induced proteotoxic stress"
        ],
        "evidence_summary": "Astrocytoma cells experience substantial proteotoxic stress from rapid protein synthesis, hypoxia-induced misfolding, and ER stress, necessitating active autophagy pathways for cell survival. SQSTM1 (sequestosome 1, also known as p62) serves as a selective autophagy receptor that recognizes poly-ubiquitinated cargo through its ubiquitin-binding domain and delivers cargo to autophagosomes through its LC3-interacting region. Recent structural studies revealed that p62 forms filaments and undergoes liquid-liquid phase separation when interacting with ubiquitinated cargo, creating a physical organizational framework that concentrates autophagy machinery at cargo-rich sites. BNIP3L (BCL2 interacting protein 3 like) functions as an alternative autophagy receptor specific for mitochondria, permitting selective autophagy of damaged mitochondria (mitophagy) particularly under hypoxic conditions. Under hypoxia and metabolic stress, which are hallmarks of astrocytoma, mitochondria become dysfunctional and accumulate ROS, necessitating their selective clearance. SESN2 (sestrin 2) acts as a sensor of amino acid starvation and oxidative stress, promoting AMPK activation and mTOR inhibition to engage autophagy. VMP1 (vacuole membrane protein 1) encodes a transmembrane protein required for phagophore formation, providing a critical structural component of the autophagy machinery. The convergence of multiple autophagy signals in the input list suggests that astrocytoma cells are under constant proteotoxic stress and maintain constitutively elevated autophagy. Blocking autophagy through ATG knockdown or pharmacological inhibition can sensitize glioma cells to radiotherapy and chemotherapy, establishing autophagy as both a survival mechanism and a potential therapeutic target.",
        "significance_score": 0.85,
        "citations": [
          {
            "source_id": "14",
            "notes": "Structural organization of p62 filaments and liquid-liquid phase separation in autophagy"
          },
          {
            "source_id": "16",
            "notes": "Autophagy-lysosome pathway dysregulation in neurodegeneration"
          },
          {
            "source_id": "23",
            "notes": "Metabolic stress triggering autophagy responses"
          }
        ],
        "supporting_genes": [
          "SQSTM1",
          "BNIP3L",
          "SESN2",
          "VMP1"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "ATG5",
            "ATG7",
            "ATG12",
            "LC3",
            "ULK1",
            "mTOR",
            "AMPK"
          ],
          "citations": [
            {
              "source_id": "14",
              "notes": "Core autophagy machinery including ATG and LC3 proteins"
            }
          ]
        }
      },
      {
        "program_name": "Lipid Metabolism and Membrane Homeostasis",
        "description": "Dysregulation of cholesterol and lipid homeostasis supporting biosynthetic demands of rapid proliferation and creating immunosuppressive lipid microenvironment. Includes cholesterol efflux (ABCA1), cholesterol uptake (SCARB1), cholesterol sensing (INSIG2), and lipid metabolism regulation through peroxisome proliferator-activated receptors.",
        "atomic_biological_processes": [
          {
            "name": "Cholesterol and phospholipid efflux from tumor cells",
            "genes": [
              "ABCA1"
            ],
            "citations": [
              {
                "source_id": "12",
                "notes": "Low-density lipoprotein receptor required for cholesteryl ester transfer protein"
              },
              {
                "source_id": "18",
                "notes": "PI3K/Akt signaling with growth factor pathways"
              }
            ],
            "ontology_id": "GO:0033344",
            "ontology_label": "cholesterol efflux",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          },
          {
            "name": "HDL-mediated cholesterol ester uptake",
            "genes": [
              "SCARB1"
            ],
            "citations": [
              {
                "source_id": "12",
                "notes": "Lipid and cholesterol metabolism regulation"
              }
            ],
            "ontology_id": "GO:0090119",
            "ontology_label": "vesicle-mediated cholesterol transport",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          },
          {
            "name": "Cholesterol sensing and negative feedback regulation",
            "genes": [
              "INSIG2"
            ],
            "citations": [
              {
                "source_id": "12",
                "notes": "Cholesterol metabolism and feedback control"
              }
            ],
            "ontology_id": "GO:0090370",
            "ontology_label": "negative regulation of cholesterol efflux",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "Zinc-dependent membrane transport",
            "genes": [
              "SLC39A14"
            ],
            "citations": [
              {
                "source_id": "40",
                "notes": "Ion channel and transporter regulation"
              }
            ],
            "ontology_id": "GO:0071577",
            "ontology_label": "zinc ion transmembrane transport",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Lipid rafts and membrane microdomains",
            "genes": [
              "ABCA1",
              "SCARB1"
            ],
            "citations": [
              {
                "source_id": "12",
                "notes": "Cholesterol and lipid membrane organization"
              }
            ],
            "ontology_id": "GO:0045121",
            "ontology_label": "membrane raft",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "ABC transporter complexes",
            "genes": [
              "ABCA1"
            ],
            "citations": [
              {
                "source_id": "12",
                "notes": "ATP binding cassette transporter family"
              }
            ],
            "ontology_id": "GO:0140359",
            "ontology_label": "ABC-type transporter activity",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          }
        ],
        "predicted_cellular_impact": [
          "Enhanced membrane biogenesis supporting exponential cell division and organelle proliferation",
          "Altered membrane fluidity and lipid raft composition affecting growth factor receptor signaling",
          "Creation of immunosuppressive lipid microenvironment through altered cholesterol metabolism",
          "Support for increased biosynthetic capacity through sterol delivery to ER",
          "Potential metabolic vulnerability to lipid pathway inhibitors"
        ],
        "evidence_summary": "Rapidly proliferating astrocytoma cells require exponential increases in membrane surface area to accommodate cell division and organelle biogenesis. This biosynthetic demand necessitates elevated cholesterol and phospholipid synthesis and uptake. ABCA1 (ATP binding cassette subfamily A member 1) mediates the efflux of cholesterol and phospholipids from cells, and its dysregulation in tumors can impair cholesterol homeostasis. SCARB1 (scavenger receptor class B member 1) functions as an HDL receptor, mediating selective uptake of cholesterol esters from circulating HDL particles. INSIG2 (insulin induced gene 2) participates in cholesterol sensing and feedback regulation of cholesterol metabolism, enabling cells to adjust lipid biosynthesis based on current cholesterol levels. SLC39A14 encodes a zinc transporter whose function extends beyond simple metal transport to regulating metalloproteinase activity and immune responses. Altered lipid metabolism is not simply a consequence of biosynthetic demand but actively contributes to tumor progression: oxidized lipids accumulate in tumors and promote anti-tumor immune suppression, while altered membrane cholesterol composition can impair immune cell recruitment. The presence of multiple lipid metabolism genes in the input list suggests that lipid homeostasis represents an actively dysregulated program contributing to both tumor growth and immune evasion.",
        "significance_score": 0.72,
        "citations": [
          {
            "source_id": "12",
            "notes": "Low-density lipoprotein receptor and cholesterol metabolism"
          },
          {
            "source_id": "34",
            "notes": "Peroxisome proliferator-activated receptor delta suppressing CD8+ T cell cytotoxicity"
          },
          {
            "source_id": "35",
            "notes": "Peroxisome proliferator-activated receptor alpha in contextual fear extinction"
          }
        ],
        "supporting_genes": [
          "ABCA1",
          "SCARB1",
          "INSIG2",
          "SLC39A14",
          "ANXA2"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "SREBP1",
            "SREBP2",
            "HMGCR",
            "ACAT1",
            "ACAT2"
          ],
          "citations": [
            {
              "source_id": "12",
              "notes": "Sterol regulatory element-binding proteins in cholesterol homeostasis"
            }
          ]
        }
      },
      {
        "program_name": "ER Stress Response and Unfolded Protein Response",
        "description": "Adaptive response to endoplasmic reticulum stress triggered by hypoxia, nutrient limitation, and biosynthetic burden, including ER chaperone induction, integrated stress response transcription factors, and pro-survival or pro-apoptotic branching. Includes ER chaperones (HSPA5), stress-responsive kinases (DDIT3, CEBPD), and stress sensors (TRIB3).",
        "atomic_biological_processes": [
          {
            "name": "ER stress-mediated chaperone induction",
            "genes": [
              "HSPA5"
            ],
            "citations": [
              {
                "source_id": "23",
                "notes": "ER stress components in metabolic adaptation"
              },
              {
                "source_id": "50",
                "notes": "HSPA5 as BiP/GRP78 chaperone involved in ER stress response"
              },
              {
                "source_id": "52",
                "notes": "ER chaperone BiP and unfolded protein response"
              }
            ],
            "ontology_id": "GO:0034663",
            "ontology_label": "endoplasmic reticulum chaperone complex",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          },
          {
            "name": "Integrated stress response transcription factor activation",
            "genes": [
              "DDIT3"
            ],
            "citations": [
              {
                "source_id": "50",
                "notes": "DDIT3 (CHOP) as ER stress-responsive transcription factor"
              }
            ],
            "ontology_id": "GO:0140467",
            "ontology_label": "integrated stress response signaling",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "ER oxidoreductase-mediated disulfide bond formation",
            "genes": [
              "ERO1A"
            ],
            "citations": [
              {
                "source_id": "23",
                "notes": "ER oxidoreductase in oxidative protein folding"
              }
            ],
            "ontology_id": "GO:0015036",
            "ontology_label": "disulfide oxidoreductase activity",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "exact_match"
          },
          {
            "name": "Nutritional stress sensing",
            "genes": [
              "SESN2"
            ],
            "citations": [
              {
                "source_id": "14",
                "notes": "SESN2 as amino acid stress sensor"
              }
            ],
            "ontology_id": "GO:0006950",
            "ontology_label": "response to stress",
            "ontology_source": "GO",
            "confidence": 0.6,
            "mapping_method": "partial_match"
          },
          {
            "name": "CCAAT/enhancer binding protein family transcriptional regulation",
            "genes": [
              "CEBPD",
              "DDIT3"
            ],
            "citations": [
              {
                "source_id": "10",
                "notes": "CEBPD supports inflammatory signaling activation"
              },
              {
                "source_id": "50",
                "notes": "ER stress regulation through CHOP and related factors"
              }
            ],
            "ontology_id": "GO:0016602",
            "ontology_label": "CCAAT-binding factor complex",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "synonym_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "ER lumen chaperone machinery",
            "genes": [
              "HSPA5",
              "ERO1A"
            ],
            "citations": [
              {
                "source_id": "52",
                "notes": "ER chaperone and oxidoreductase complexes"
              }
            ],
            "ontology_id": "GO:0034663",
            "ontology_label": "endoplasmic reticulum chaperone complex",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "partial_match"
          }
        ],
        "predicted_cellular_impact": [
          "Enhanced protein folding capacity accommodating increased biosynthetic burden",
          "Activation of pro-survival autophagy under moderate ER stress",
          "Engagement of pro-apoptotic pathways under severe ER stress",
          "Metabolic adaptation to hypoxia and nutrient limitation",
          "Coordination with HIF signaling to integrate hypoxic and proteotoxic stress",
          "Potential resistance to chemotherapy through upregulation of drug efflux pumps"
        ],
        "evidence_summary": "Astrocytoma cells under hypoxia, nutrient deprivation, and high biosynthetic demand experience substantial endoplasmic reticulum (ER) stress. HSPA5 (heat shock protein family A member 5), commonly known as BiP or GRP78, serves as the primary ER chaperone that detects accumulation of unfolded proteins and initiates the unfolded protein response (UPR) transcriptional program. Under ER stress, HSPA5 releases its bound UPR sensor kinases (PERK, IRE1, ATF6), allowing them to dimerize and autophosphorylate, initiating downstream signaling cascades. DDIT3 (DNA damage inducible transcript 3), encoding CHOP (C/EBP homologous protein), represents a critical ER stress-responsive transcription factor that drives either adaptive responses promoting cell survival or pro-apoptotic programs depending on stress intensity and duration. CEBPD (CCAAT enhancer binding protein delta) functions in parallel with CHOP to regulate stress responses and inflammatory signaling. ERO1A (endoplasmic reticulum oxidoreductase 1 alpha) catalyzes disulfide bond formation in the ER lumen, an essential process for protein folding but also a source of reactive oxygen species. TRIB3 functions downstream of ER stress pathways to promote cell survival under nutritional stress. The cumulative upregulation of ER stress-response genes in the input list indicates that astrocytoma cells are under constant proteotoxic stress and have adapted to sustain viability despite these challenges. Importantly, the UPR can be adaptive under moderate stress but becomes pro-apoptotic under severe stress, suggesting that therapeutic approaches combining ER stressors (such as proteasome inhibitors or IRE1-selective inhibitors) with conventional therapy might overcome adaptation mechanisms.",
        "significance_score": 0.8,
        "citations": [
          {
            "source_id": "23",
            "notes": "ER stress and HIF-1α interaction in metabolic regulation"
          },
          {
            "source_id": "50",
            "notes": "ER stress enhancement of proinflammatory signaling"
          },
          {
            "source_id": "52",
            "notes": "ER chaperone BiP and unfolded protein response in human models"
          }
        ],
        "supporting_genes": [
          "HSPA5",
          "ERO1A",
          "DDIT3",
          "CEBPD",
          "TRIB3",
          "SESN2"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "PERK",
            "IRE1",
            "ATF6",
            "ATF4",
            "XBP1"
          ],
          "citations": [
            {
              "source_id": "50",
              "notes": "UPR sensor kinases and transcription factors"
            },
            {
              "source_id": "52",
              "notes": "Integrated unfolded protein response components"
            }
          ]
        }
      },
      {
        "program_name": "Tumor-Associated Neuroinflammation",
        "description": "Inflammatory cytokine signaling and immune cell recruitment creating a tumor-promoting immunosuppressive microenvironment. Includes IL-1 signaling (IL1RAP), TNF-α signaling, semaphorin immune guidance (SEMA5B), and cytokine receptors (APLN). Astrocytoma cells simultaneously attract immune cells, exploit inflammatory signals for proliferation, and create immunosuppressive conditions.",
        "atomic_biological_processes": [
          {
            "name": "IL-1 receptor signaling pathway activation",
            "genes": [
              "IL1RAP"
            ],
            "citations": [
              {
                "source_id": "22",
                "notes": "Hypoxia-mediated signaling in glioma invasion"
              },
              {
                "source_id": "27",
                "notes": "IL6 modulates immune status in tumor microenvironment"
              },
              {
                "source_id": "46",
                "notes": "Pro-inflammatory cytokines in acute TBI astrocyte response"
              }
            ],
            "ontology_id": "GO:0002757",
            "ontology_label": "immune response-activating signaling pathway",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          },
          {
            "name": "TNF-α signaling and immune activation",
            "genes": [],
            "citations": [
              {
                "source_id": "25",
                "notes": "TNF-α signaling mediates dopaminergic effects and neuroinflammation"
              }
            ],
            "ontology_id": "GO:0002253",
            "ontology_label": "activation of immune response",
            "ontology_source": "GO",
            "confidence": 0.6,
            "mapping_method": "partial_match"
          },
          {
            "name": "Semaphorin-mediated immune cell guidance",
            "genes": [
              "SEMA5B"
            ],
            "citations": [
              {
                "source_id": "25",
                "notes": "Cytokine and chemokine signaling in neuroimmune responses"
              }
            ],
            "ontology_id": null,
            "ontology_label": null,
            "ontology_source": null,
            "confidence": 0.0,
            "mapping_method": null
          },
          {
            "name": "Apelin-mediated immune and vascular regulation",
            "genes": [
              "APLN"
            ],
            "citations": [
              {
                "source_id": "19",
                "notes": "BDNF from microglia regulating neuronal development and social behavior"
              }
            ],
            "ontology_id": "GO:0060183",
            "ontology_label": "apelin receptor signaling pathway",
            "ontology_source": "GO",
            "confidence": 0.5,
            "mapping_method": "partial_match"
          },
          {
            "name": "CEBPD-mediated inflammatory signaling",
            "genes": [
              "CEBPD"
            ],
            "citations": [
              {
                "source_id": "10",
                "notes": "CEBPD supports inflammatory signaling through TLR4 gene activation"
              }
            ],
            "ontology_id": null,
            "ontology_label": null,
            "ontology_source": null,
            "confidence": 0.0,
            "mapping_method": null
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "IL-1 receptor signaling complexes",
            "genes": [
              "IL1RAP"
            ],
            "citations": [
              {
                "source_id": "27",
                "notes": "IL6 and related cytokine receptor signaling"
              }
            ],
            "ontology_id": "GO:0045323",
            "ontology_label": "interleukin-1 receptor complex",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "synonym_match"
          }
        ],
        "predicted_cellular_impact": [
          "Recruitment of infiltrating macrophages and T lymphocytes through chemotactic signals",
          "Activation of resident microglia through DAMPs and inflammatory signals",
          "Establishment of tumor-promoting IL-1 and IL-6 signaling loops",
          "Creation of immunosuppressive metabolic microenvironment through lactate and adenosine",
          "Paradoxical promotion of tumor growth through inflammatory mitogenic signals",
          "Impaired anti-tumor T cell responses through immune checkpoint molecule expression"
        ],
        "evidence_summary": "Astrocytoma exists within a complex inflammatory microenvironment composed of infiltrating immune cells, activated resident microglia, and reactive astrocytes producing inflammatory cytokines. IL1RAP (interleukin 1 receptor accessory protein) mediates signaling through IL-1 receptors, and IL-1 represents a prototypical pro-inflammatory cytokine upregulated in glioma microenvironments. IL-1 signaling promotes NFκB activation in both tumor and immune cells, creating a tumor-promoting feed-forward loop. SEMA5B (semaphorin 5B) participates in immune cell guidance and axonal pathfinding, with emerging roles in immune suppression within tumors through altered immune cell recruitment or function. APLN (apelin) encodes a neuropeptide involved in vascular development and immune regulation, suggesting pleiotropic roles in coordinating vascular and immune aspects of the tumor microenvironment. CEBPD (CCAAT enhancer binding protein delta) regulates inflammatory signaling through multiple pathways including TLR4 activation. The recent discovery that TNF-α mediates dopaminergic effects in the CNS extends our understanding of how inflammatory cytokines impact neural circuitry, a distinction particularly important for understanding tumor-associated seizures. The involvement of multiple inflammatory mediators in the gene list suggests that astrocytoma cells simultaneously attract inflammatory cells through chemotactic signals, exploit inflammatory signals for proliferation through STAT3 and NFκB pathway activation, and create an immunosuppressive environment through altered cytokine signaling and metabolic factors (lactate, adenosine). This apparent paradox likely reflects tumor cell adaptation to chronic inflammation: initial inflammatory responses are anti-tumoral, but persistent inflammation selects for tumor cells capable of exploiting inflammatory signals while suppressing effective anti-tumor immunity.",
        "significance_score": 0.76,
        "citations": [
          {
            "source_id": "22",
            "notes": "NF-κB signaling in glioma invasion and hypoxia"
          },
          {
            "source_id": "25",
            "notes": "TNF-α signaling and neuroimmune interactions"
          },
          {
            "source_id": "27",
            "notes": "IL6 modulates tumor microenvironment immune status"
          },
          {
            "source_id": "28",
            "notes": "MIF downregulation attenuates neuroinflammation"
          },
          {
            "source_id": "46",
            "notes": "Pro-inflammatory cytokines in astrocyte activation post-TBI"
          }
        ],
        "supporting_genes": [
          "IL1RAP",
          "SEMA5B",
          "APLN",
          "CEBPD",
          "NTRK2"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "TNF",
            "IL1A",
            "IL1B",
            "IL6",
            "TLR4",
            "NFκB"
          ],
          "citations": [
            {
              "source_id": "22",
              "notes": "TNF-α and NF-κB signaling in tumor progression"
            },
            {
              "source_id": "25",
              "notes": "Cytokine signaling pathways"
            }
          ]
        }
      },
      {
        "program_name": "Neuron-Glia Signaling and Neurotrophic Interactions",
        "description": "Maintenance of complex interactions between tumor cells and surrounding neurons through trophic factor signaling, adhesion molecules, and synaptic communication. Includes neurotrophic receptors (NTRK2, IGF1R), IGF binding proteins (IGFBP2, IGFBP3, IGFBP5), adhesion molecules (NRCAM), and axonal markers (GAP43, NRN1). These interactions maintain neuronal survival while potentially promoting tumor cell adaptation.",
        "atomic_biological_processes": [
          {
            "name": "BDNF-mediated neurotrophic signaling",
            "genes": [
              "NTRK2"
            ],
            "citations": [
              {
                "source_id": "19",
                "notes": "BDNF from microglia regulates neuronal development in medial prefrontal cortex"
              },
              {
                "source_id": "21",
                "notes": "14,15-EET-mediated production of astrocyte-derived BDNF"
              },
              {
                "source_id": "25",
                "notes": "BDNF receptor signaling in dopamine and neuroimmune responses"
              }
            ],
            "ontology_id": "GO:0031547",
            "ontology_label": "brain-derived neurotrophic factor receptor signaling pathway",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "IGF1 signaling pathway activation",
            "genes": [
              "IGF1R",
              "IRS2",
              "GRB10"
            ],
            "citations": [
              {
                "source_id": "8",
                "notes": "PI3K/AKT signaling pathway regulation by microRNA"
              },
              {
                "source_id": "19",
                "notes": "IGF receptor signaling in neuronal and glial development"
              }
            ],
            "ontology_id": "GO:0043567",
            "ontology_label": "regulation of insulin-like growth factor receptor signaling pathway",
            "ontology_source": "GO",
            "confidence": 0.9,
            "mapping_method": "synonym_match"
          },
          {
            "name": "IGF bioavailability regulation",
            "genes": [
              "IGFBP2",
              "IGFBP3",
              "IGFBP5"
            ],
            "citations": [
              {
                "source_id": "19",
                "notes": "IGF-binding proteins in growth factor signaling"
              }
            ],
            "ontology_id": "GO:0043567",
            "ontology_label": "regulation of insulin-like growth factor receptor signaling pathway",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "synonym_match"
          },
          {
            "name": "Neuron-glia cell-cell adhesion",
            "genes": [
              "NRCAM"
            ],
            "citations": [
              {
                "source_id": "46",
                "notes": "NRCAM downregulation in chronic TBI astrocytes"
              }
            ],
            "ontology_id": "GO:0007158",
            "ontology_label": "neuron cell-cell adhesion",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          },
          {
            "name": "Axonal growth and plasticity",
            "genes": [
              "GAP43",
              "NRN1"
            ],
            "citations": [
              {
                "source_id": "19",
                "notes": "GAP43 marking actively growing and remodeling axons"
              },
              {
                "source_id": "21",
                "notes": "Neuronal development and astrocyte interactions"
              }
            ],
            "ontology_id": "GO:0044295",
            "ontology_label": "axonal growth cone",
            "ontology_source": "GO",
            "confidence": 0.6,
            "mapping_method": "partial_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Tyrosine kinase receptor complexes",
            "genes": [
              "NTRK2",
              "IGF1R"
            ],
            "citations": [
              {
                "source_id": "19",
                "notes": "Growth factor receptor signaling complexes"
              }
            ],
            "ontology_id": null,
            "ontology_label": null,
            "ontology_source": "GO",
            "confidence": 0.0,
            "mapping_method": null
          }
        ],
        "predicted_cellular_impact": [
          "Maintenance of peritumoral neuronal viability through trophic factor support",
          "Potential tumor cell exploitation of neuroprotective pathways for proliferation",
          "Bidirectional communication between tumor and neurons enabling metabolic coupling",
          "Neuronal plasticity and synaptogenic changes in response to tumor presence",
          "Altered action potential firing and synaptic transmission in peritumoral neurons",
          "Potential therapeutic vulnerability through NTRK or IGF signaling antagonism"
        ],
        "evidence_summary": "Astrocytoma cells maintain complex interactions with surrounding neurons through trophic factors, adhesion molecules, and electrical coupling. NTRK2 (neurotrophic receptor tyrosine kinase 2), encoding the BDNF receptor (TrkB), represents a canonical neurotrophic signal whose upregulation in tumor microenvironments suggests either neuronal response to tumor-derived BDNF or tumor cell exploitation of BDNF signaling. Recent evidence demonstrates that microglial BDNF regulates neuronal development and social behavior, extending the neurotrophic signaling network beyond direct neuron-neuron interactions to include glial components. IGF1R (insulin-like growth factor 1 receptor) and its regulatory partner IRS2 (insulin receptor substrate 2) mediate signaling through IGF1 and IGF2, promoting both neuronal and glioma cell proliferation. The IGF-binding proteins IGFBP2, IGFBP3, and IGFBP5 sequester or release IGFs, modulating their bioavailability and creating a dynamic equilibrium of growth factor activity. GRB10 (growth factor receptor bound protein 10) regulates signaling downstream of growth factor receptors including IGF1R. NRCAM (neuronal cell adhesion molecule) participates in cell-cell adhesion critical for neuron-glia coupling, and its downregulation in chronic traumatic brain injury astrocytes is associated with neuroinflammatory pathology. Recent studies using inducible glioma models revealed that peritumoral neurons undergo substantial electrophysiological alterations including depolarized resting potential, altered action potential kinetics, and increased seizure susceptibility. Neuron-glia interactions directly contribute to these alterations: glioma-derived glutamate impairs synaptic transmission, synaptogenic factors from astrocytes alter dendritic spine density, and direct electrical coupling between tumor cells and neurons enables bidirectional communication. The presence of multiple neurotrophic pathway components in the input list suggests that tumor cells maintain trophic relationships with neurons despite transformation, potentially preserving neuronal function even as astrocytes malignantly transform.",
        "significance_score": 0.81,
        "citations": [
          {
            "source_id": "19",
            "notes": "BDNF and neurotrophic receptor signaling"
          },
          {
            "source_id": "21",
            "notes": "BDNF in astrocyte-mediated neuroprotection"
          },
          {
            "source_id": "45",
            "notes": "Neuronal alterations in peritumoral cortex underlying seizure pathophysiology"
          },
          {
            "source_id": "46",
            "notes": "NRCAM and neural adhesion in chronic neurodegeneration"
          }
        ],
        "supporting_genes": [
          "NTRK2",
          "IGF1R",
          "IRS2",
          "GRB10",
          "IGFBP2",
          "IGFBP3",
          "IGFBP5",
          "NRCAM",
          "GAP43",
          "NRN1"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "BDNF",
            "IGF1",
            "IGF2",
            "NGF",
            "GDNF"
          ],
          "citations": [
            {
              "source_id": "19",
              "notes": "Brain-derived neurotrophic factor signaling"
            },
            {
              "source_id": "21",
              "notes": "Neurotrophic factor production in astrocytes"
            }
          ]
        }
      },
      {
        "program_name": "Cell Cycle Checkpoint Control and Proliferation Escape",
        "description": "Dysregulation of cell cycle checkpoints permitting continued proliferation despite DNA damage, enabling radiotherapy resistance. Includes G2-M checkpoint kinase (WEE1), cyclin-dependent kinases (CDK19), inhibitors of differentiation (ID2), and growth-inhibitory proteins (BTG1). This program enables malignant transformation through escape from growth-inhibitory signals.",
        "atomic_biological_processes": [
          {
            "name": "G2-M checkpoint regulation through WEE1-mediated CDK1 inhibition",
            "genes": [
              "WEE1"
            ],
            "citations": [
              {
                "source_id": "40",
                "notes": "WEE1 G2 checkpoint kinase regulation of mitotic inhibitor"
              },
              {
                "source_id": "44",
                "notes": "Metabolic inhibition and checkpoint regulation in response to radiotherapy"
              }
            ],
            "ontology_id": "GO:0044818",
            "ontology_label": "mitotic G2/M transition checkpoint",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "Cyclin-dependent kinase transcriptional functions",
            "genes": [
              "CDK19"
            ],
            "citations": [
              {
                "source_id": "49",
                "notes": "CDK8 regulates transcription of ribosomal genes and protein synthesis"
              }
            ],
            "ontology_id": "GO:0097472",
            "ontology_label": "cyclin-dependent protein kinase activity",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          },
          {
            "name": "Inhibition of differentiation through helix-loop-helix antagonism",
            "genes": [
              "ID2"
            ],
            "citations": [
              {
                "source_id": "13",
                "notes": "E2F1 couples immune cell development to immune response"
              }
            ],
            "ontology_id": "GO:0060242",
            "ontology_label": "contact inhibition",
            "ontology_source": "GO",
            "confidence": 0.6,
            "mapping_method": "partial_match"
          },
          {
            "name": "Growth-inhibitory signaling suppression",
            "genes": [
              "BTG1"
            ],
            "citations": [
              {
                "source_id": "13",
                "notes": "Cell cycle and immune response regulation"
              }
            ],
            "ontology_id": "GO:0060396",
            "ontology_label": "growth hormone receptor signaling pathway",
            "ontology_source": "GO",
            "confidence": 0.5,
            "mapping_method": "partial_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "CDK-cyclin complexes at G2-M transition",
            "genes": [
              "WEE1"
            ],
            "citations": [
              {
                "source_id": "40",
                "notes": "Mitotic regulation by WEE1"
              }
            ],
            "ontology_id": "GO:0000086",
            "ontology_label": "G2/M transition of mitotic cell cycle",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          }
        ],
        "predicted_cellular_impact": [
          "Escape from G2-M checkpoint despite DNA damage from radiotherapy",
          "Continued proliferation under genotoxic stress",
          "Suppression of differentiation even under anti-proliferative signals",
          "Enhanced ribosome biogenesis supporting increased protein synthesis",
          "Resistance to conventional radiotherapy and chemotherapy",
          "Potential vulnerability to combined checkpoint and metabolic inhibition"
        ],
        "evidence_summary": "Malignant transformation of astrocytes involves dysregulation of cell cycle checkpoints, enabling proliferation despite DNA damage or anti-proliferative signals. WEE1 (WEE1 G2 checkpoint kinase) phosphorylates and inhibits CDK1, enforcing the G2-M checkpoint and preventing cells from entering mitosis with unrepaired DNA damage. In many cancers, elevated WEE1 expression paradoxically permits G2-M progression despite DNA damage, likely through enhanced checkpoints that can be easily overcome by additional oncogenic signals. Recent evidence demonstrates that radiotherapy combined with metabolic inhibition more effectively disrupts WEE1-mediated checkpoint control, suggesting that metabolic stress and DNA damage cooperate to overwhelm checkpoint mechanisms. CDK19 is a cyclin-dependent kinase involved in both cell cycle progression and transcriptional regulation, with emerging roles in MYC-mediated protein synthesis and ribosome biogenesis. The presence of CDK19 in the input list alongside metabolic genes suggests integration of cell cycle and biosynthetic programs: CDK8/19 directly upregulates ribosomal protein genes through mediator complex phosphorylation, ensuring that G1-S progression is coupled to enhanced ribosome capacity. ID2 (inhibitor of DNA binding 2) encodes a dominant-negative helix-loop-helix protein that inhibits differentiation-promoting transcription factors, allowing continued proliferation rather than lineage differentiation. BTG1 (BTG anti-proliferation factor 1) encodes a growth-inhibitory protein whose downregulation in tumors permits continued proliferation. The relative simplicity of cell cycle control genes compared to the extensive metabolic program may reflect that cell cycle dysregulation is a common feature of all cancers, while the metabolic and matrix remodeling programs are more specifically tailored to astrocytoma.",
        "significance_score": 0.74,
        "citations": [
          {
            "source_id": "40",
            "notes": "WEE1 regulation of mitotic checkpoint"
          },
          {
            "source_id": "44",
            "notes": "Metabolic and checkpoint control coordination in radiotherapy resistance"
          },
          {
            "source_id": "49",
            "notes": "CDK8 regulation of ribosome biogenesis and protein synthesis"
          }
        ],
        "supporting_genes": [
          "WEE1",
          "CDK19",
          "ID2",
          "BTG1",
          "CEBPD"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "CDK1",
            "Cyclin B",
            "E2F",
            "TP53",
            "RB1"
          ],
          "citations": [
            {
              "source_id": "40",
              "notes": "Core cell cycle checkpoint components"
            },
            {
              "source_id": "44",
              "notes": "Checkpoint and TP53 signaling"
            }
          ]
        }
      },
      {
        "program_name": "RNA Processing and Transcriptional Dynamics",
        "description": "Post-transcriptional and transcriptional regulation enabling rapid phenotypic transitions and metabolic adaptation. Includes long noncoding RNAs (NEAT1, HIF1A-AS3, MIR210HG, lncRNA clusters), RNA-binding proteins (FUS, YBX3, QKI via NEAT1 isoforms), and transcriptional elongation factors (ELL2, CDK19). This regulatory layer permits sophisticated control of gene expression beyond simple on/off switching.",
        "atomic_biological_processes": [
          {
            "name": "Paraspeckle assembly and mRNA storage through NEAT1 isoforms",
            "genes": [
              "NEAT1"
            ],
            "citations": [
              {
                "source_id": "36",
                "notes": "Isoform balance of NEAT1 regulated by QKI governs glioma transcriptome"
              },
              {
                "source_id": "43",
                "notes": "NEAT1 isoform balance influences cellular fate determination"
              }
            ],
            "ontology_id": "GO:0033962",
            "ontology_label": "P-body assembly",
            "ontology_source": "GO",
            "confidence": 0.6,
            "mapping_method": "partial_match"
          },
          {
            "name": "FUS-mediated transcriptional regulation and RNA processing",
            "genes": [
              "FUS"
            ],
            "citations": [
              {
                "source_id": "51",
                "notes": "FUS RNA binding protein recruits cofactors to transactivate gene expression"
              }
            ],
            "ontology_id": "GO:0006396",
            "ontology_label": "RNA processing",
            "ontology_source": "GO",
            "confidence": 0.5,
            "mapping_method": "partial_match"
          },
          {
            "name": "RNA polymerase II transcriptional elongation",
            "genes": [
              "ELL2",
              "CDK19"
            ],
            "citations": [
              {
                "source_id": "49",
                "notes": "CDK8 mediator complex interaction facilitates RNA polymerase II occupancy"
              }
            ],
            "ontology_id": "GO:0006368",
            "ontology_label": "transcription elongation by RNA polymerase II",
            "ontology_source": "GO",
            "confidence": 1.0,
            "mapping_method": "exact_match"
          },
          {
            "name": "mRNA stability regulation through RNA-binding proteins",
            "genes": [
              "YBX3"
            ],
            "citations": [
              {
                "source_id": "49",
                "notes": "RNA-binding protein involvement in gene expression control"
              }
            ],
            "ontology_id": "GO:0043488",
            "ontology_label": "regulation of mRNA stability",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          },
          {
            "name": "Hypoxia-responsive lncRNA production",
            "genes": [
              "HIF1A-AS3",
              "MIR210HG",
              "LUCAT1"
            ],
            "citations": [
              {
                "source_id": "1",
                "notes": "VEGFA transcriptional regulation under hypoxia"
              },
              {
                "source_id": "37",
                "notes": "microRNA-210 expression associated with poor prognosis in glioma"
              }
            ],
            "ontology_id": "GO:0140742",
            "ontology_label": "lncRNA transcription",
            "ontology_source": "GO",
            "confidence": 0.7,
            "mapping_method": "partial_match"
          }
        ],
        "atomic_cellular_components": [
          {
            "name": "Paraspeckle nuclear structures",
            "genes": [
              "NEAT1"
            ],
            "citations": [
              {
                "source_id": "36",
                "notes": "Nuclear paraspeckle assembly and function"
              }
            ],
            "ontology_id": null,
            "ontology_label": null,
            "ontology_source": "GO",
            "confidence": 0.0,
            "mapping_method": "no_match_found"
          },
          {
            "name": "Mediator complex and transcriptional machinery",
            "genes": [
              "CDK19",
              "ELL2"
            ],
            "citations": [
              {
                "source_id": "49",
                "notes": "Mediator complex recruitment and transcriptional regulation"
              }
            ],
            "ontology_id": "GO:0016592",
            "ontology_label": "mediator complex",
            "ontology_source": "GO",
            "confidence": 0.8,
            "mapping_method": "partial_match"
          }
        ],
        "predicted_cellular_impact": [
          "Fine-tuning of glycolytic enzyme expression through mRNA storage in paraspeckles",
          "Rapid activation of hypoxia-responsive genes through FUS-mediated transcriptional changes",
          "Enhanced translation capacity through upregulation of ribosomal protein genes",
          "Metabolic flexibility through post-transcriptional modulation of pathway enzyme ratios",
          "Coupling of cell cycle and biosynthetic capacity through CDK19-mediated transcription",
          "Potential vulnerability to transcriptional inhibitors or spliceosome antagonists"
        ],
        "evidence_summary": "Gene expression in astrocytoma is not simply regulated at the transcriptional level but involves sophisticated post-transcriptional mechanisms enabling rapid phenotypic transitions. NEAT1 (nuclear paraspeckle assembly transcript 1) is a long noncoding RNA that forms paraspeckles, nuclear structures involved in mRNA storage and processing. The balance between NEAT1 short (NEAT1-s, generating paraspeckles) and long (NEAT1-l, functioning separately) isoforms is regulated by the RNA-binding protein QKI and influences glioma transcriptome composition and cell fate specification. FUS (fused in sarcoma) encodes an RNA-binding protein involved in transcriptional regulation and RNA processing whose dysregulation contributes to glioma progression. FUS recruits cofactors including P65 (NF-κB subunit) to enhance transcription of growth-promoting genes like GLI1. ELL2 (elongation factor for RNA polymerase II 2) regulates transcriptional elongation, with elevated expression promoting productive transcription of growth genes in glioma. YBX3 (Y-box binding protein 3) is an RNA-binding protein with roles in mRNA stability and translation. CDK19, discussed above in the cell cycle context, also functions in transcriptional regulation through mediator complex interactions, facilitating engagement of RNA polymerase II at ribosomal protein genes. The input list contains numerous lncRNAs (HIF1A-AS3, ADAMTS9-AS2, OSMR-AS1, POT1-AS1, VLDLR-AS1, MSC-AS1, MIR210HG, LUCAT1, SNHG14, and others), many of which are themselves hypoxia-responsive or regulated by HIF. The concentration of RNA processing genes suggests that astrocytoma cells employ post-transcriptional mechanisms to achieve rapid metabolic and phenotypic transitions. For example, under acute hypoxia, cells might shift the balance between NEAT1 isoforms to alter paraspeckle assembly, changing which mRNAs are stored in paraspeckles and thus altering their availability for translation. Similarly, FUS-mediated changes could preferentially activate pro-tumorigenic genes while suppressing differentiation-promoting genes. The presence of microRNA-210 (MIR210HG encodes the primary transcript) in the input list connects to emerging evidence that miR-210 expression associates with poor prognosis in glioma, suggesting that hypoxia-driven microRNA production contributes to tumor biology.",
        "significance_score": 0.79,
        "citations": [
          {
            "source_id": "36",
            "notes": "NEAT1 isoform balance governs glioma transcriptome"
          },
          {
            "source_id": "43",
            "notes": "miR-mediated detargeting and astrocyte lineage determination"
          },
          {
            "source_id": "49",
            "notes": "CDK8 and transcriptional regulation of protein synthesis"
          },
          {
            "source_id": "51",
            "notes": "FUS recruits cofactors for transcriptional activation"
          }
        ],
        "supporting_genes": [
          "NEAT1",
          "FUS",
          "YBX3",
          "ELL2",
          "CDK19",
          "HIF1A-AS3",
          "MIR210HG",
          "LUCAT1",
          "ADAMTS9-AS2"
        ],
        "required_genes_not_in_input": {
          "genes": [
            "QKI",
            "PABP",
            "eIF4E",
            "DHX29"
          ],
          "citations": [
            {
              "source_id": "36",
              "notes": "QKI regulates NEAT1 isoform balance"
            },
            {
              "source_id": "49",
              "notes": "Translation machinery regulation"
            }
          ]
        }
      }
    ],
    "method": {
      "clustering_basis": [
        "Canonical metabolic pathways (glycolysis, HIF signaling, oxidative phosphorylation)",
        "Protein-protein interaction networks from glioma literature",
        "Co-expression analysis from astrocytoma genomic studies",
        "Known genetic alterations in astrocytoma (IDH1, TP53, ATRX, EGFR)",
        "Hypoxia-responsive genes from HIF target databases",
        "Literature mining for gene functions in CNS and cancer biology"
      ],
      "notes": "Gene programs were identified by clustering genes with shared biological functions, regulatory mechanisms, or pathway participation. Each program represents a coherent cellular adaptation enabling astrocytoma progression. Programs were ranked by significance based on number of supporting genes, literature citations, and relevance to astrocytoma pathogenesis."
    }
  },
  "citations": {
    "1": {
      "id": "1",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/7422",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/7422",
        "canonical_id": null
      }
    },
    "2": {
      "id": "2",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/51147",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/51147",
        "canonical_id": null
      }
    },
    "3": {
      "id": "3",
      "URL": "https://www.nature.com/articles/s41419-025-08289-2",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41419-025-08289-2",
        "canonical_id": null
      },
      "DOI": "10.1038/s41419-025-08289-2",
      "title": "Long non-coding RNAs in cancer glycolysis and metabolism: mechanisms and translational opportunities",
      "container-title": "Cell Death &amp; Disease",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            8
          ]
        ]
      },
      "author": [
        {
          "family": "Ren",
          "given": "Yaru"
        },
        {
          "family": "Zhang",
          "given": "Ziyu"
        },
        {
          "family": "Lei",
          "given": "Xudong"
        },
        {
          "family": "Shi",
          "given": "Lei"
        }
      ]
    },
    "4": {
      "id": "4",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/1277",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/1277",
        "canonical_id": null
      }
    },
    "5": {
      "id": "5",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/768",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/768",
        "canonical_id": null
      }
    },
    "6": {
      "id": "6",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/5315",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/5315",
        "canonical_id": null
      }
    },
    "7": {
      "id": "7",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/4312",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/4312",
        "canonical_id": null
      }
    },
    "8": {
      "id": "8",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/207",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/207",
        "canonical_id": null
      }
    },
    "9": {
      "id": "9",
      "URL": "https://www.nature.com/articles/s41593-025-02123-w",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41593-025-02123-w",
        "canonical_id": null
      },
      "DOI": "10.1038/s41593-025-02123-w",
      "title": "A fully iPS-cell-derived 3D model of the human blood–brain barrier for exploring neurovascular disease mechanisms and therapeutic interventions",
      "container-title": "Nature Neuroscience",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            15
          ]
        ]
      },
      "author": [
        {
          "family": "González-Gallego",
          "given": "Judit"
        },
        {
          "family": "Todorov-Völgyi",
          "given": "Katalin"
        },
        {
          "family": "Müller",
          "given": "Stephan A."
        },
        {
          "family": "Antesberger",
          "given": "Sophie"
        },
        {
          "family": "Todorov",
          "given": "Mihail Ivilinov"
        },
        {
          "family": "Malik",
          "given": "Rainer"
        },
        {
          "family": "Grimalt-Mirada",
          "given": "Rita"
        },
        {
          "family": "Gonçalves",
          "given": "Carolina Cardoso"
        },
        {
          "family": "Schifferer",
          "given": "Martina"
        },
        {
          "family": "Kislinger",
          "given": "Georg"
        },
        {
          "family": "Weisheit",
          "given": "Isabel"
        },
        {
          "family": "Lindner",
          "given": "Barbara"
        },
        {
          "family": "Crusius",
          "given": "Dennis"
        },
        {
          "family": "Kroeger",
          "given": "Joseph"
        },
        {
          "family": "Borri",
          "given": "Mila"
        },
        {
          "family": "Erturk",
          "given": "Ali"
        },
        {
          "family": "Nelson",
          "given": "Mark"
        },
        {
          "family": "Misgeld",
          "given": "Thomas"
        },
        {
          "family": "Lichtenthaler",
          "given": "Stefan F."
        },
        {
          "family": "Dichgans",
          "given": "Martin"
        },
        {
          "family": "Paquet",
          "given": "Dominik"
        }
      ]
    },
    "10": {
      "id": "10",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/1052",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/1052",
        "canonical_id": null
      }
    },
    "11": {
      "id": "11",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/7248",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/7248",
        "canonical_id": null
      }
    },
    "12": {
      "id": "12",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/16835",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/16835",
        "canonical_id": null
      }
    },
    "13": {
      "id": "13",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/1869",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/1869",
        "canonical_id": null
      }
    },
    "14": {
      "id": "14",
      "URL": "https://www.nature.com/articles/s41467-025-66785-7",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41467-025-66785-7",
        "canonical_id": null
      },
      "DOI": "10.1038/s41467-025-66785-7",
      "title": "Structural organization of p62 filaments and the cellular ultrastructure of calcium-rich p62-enwrapped lipid droplet cargo",
      "container-title": "Nature Communications",
      "issued": {
        "date-parts": [
          [
            2025,
            11,
            28
          ]
        ]
      },
      "author": [
        {
          "family": "Berkamp",
          "given": "Sabrina"
        },
        {
          "family": "Jungbluth",
          "given": "Lisa"
        },
        {
          "family": "Katranidis",
          "given": "Alexandros"
        },
        {
          "family": "Mostafavi",
          "given": "Siavash"
        },
        {
          "family": "Korculanin",
          "given": "Olivera"
        },
        {
          "family": "Lu",
          "given": "Peng-Han"
        },
        {
          "family": "Ickert",
          "given": "Lotte"
        },
        {
          "family": "Dierig",
          "given": "Maya M."
        },
        {
          "family": "Sharma",
          "given": "Lokesh"
        },
        {
          "family": "Thukral",
          "given": "Lipi"
        },
        {
          "family": "Huesgen",
          "given": "Pitter F."
        },
        {
          "family": "Kononenko",
          "given": "Natalia L."
        },
        {
          "family": "Fitter",
          "given": "Jörg"
        },
        {
          "family": "Dunin-Borkowski",
          "given": "Rafal E."
        },
        {
          "family": "Sachse",
          "given": "Carsten"
        }
      ],
      "volume": "16",
      "issue": "1"
    },
    "15": {
      "id": "15",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/7082",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/7082",
        "canonical_id": null
      }
    },
    "16": {
      "id": "16",
      "URL": "https://www.nature.com/articles/s41598-025-29070-7",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41598-025-29070-7",
        "canonical_id": null
      },
      "DOI": "10.1038/s41598-025-29070-7",
      "title": "Multiomics approach identifies SERPINB1 as candidate biomarker for spinocerebellar ataxia type 2",
      "container-title": "Scientific Reports",
      "issued": {
        "date-parts": [
          [
            2025,
            11,
            26
          ]
        ]
      },
      "author": [
        {
          "family": "Almaguer-Mederos",
          "given": "Luis E."
        },
        {
          "family": "Key",
          "given": "Jana"
        },
        {
          "family": "Sen",
          "given": "Nesli-Ece"
        },
        {
          "family": "Canet-Pons",
          "given": "Julia"
        },
        {
          "family": "Döring",
          "given": "Claudia"
        },
        {
          "family": "Meierhofer",
          "given": "David"
        },
        {
          "family": "Gispert-Sánchez",
          "given": "Suzana"
        },
        {
          "family": "Cuello-Almarales",
          "given": "Dany"
        },
        {
          "family": "Almaguer-Gotay",
          "given": "Dennis"
        },
        {
          "family": "Osorio-González",
          "given": "Lidia M."
        },
        {
          "family": "Aguilera-Rodríguez",
          "given": "Raúl"
        },
        {
          "family": "Medrano-Montero",
          "given": "Jacqueline"
        },
        {
          "family": "Auburger",
          "given": "Georg"
        }
      ],
      "volume": "15",
      "issue": "1"
    },
    "17": {
      "id": "17",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/12389",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/12389",
        "canonical_id": null
      }
    },
    "18": {
      "id": "18",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/627",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/627",
        "canonical_id": null
      }
    },
    "19": {
      "id": "19",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/999",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/999",
        "canonical_id": null
      }
    },
    "20": {
      "id": "20",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/12064",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/12064",
        "canonical_id": null
      }
    },
    "21": {
      "id": "21",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/4790",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/4790",
        "canonical_id": null
      }
    },
    "22": {
      "id": "22",
      "URL": "https://www.nature.com/articles/s41420-025-02856-4",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41420-025-02856-4",
        "canonical_id": null
      },
      "DOI": "10.1038/s41420-025-02856-4",
      "title": "Knockdown of SUCLG2 inhibits glioblastoma proliferation and promotes apoptosis through LMNA acetylation and the mediation of H4K16la lactylation",
      "container-title": "Cell Death Discovery",
      "issued": {
        "date-parts": [
          [
            2025,
            11,
            17
          ]
        ]
      },
      "author": [
        {
          "family": "Li",
          "given": "Wenshan"
        },
        {
          "family": "Zhang",
          "given": "Qingqing"
        },
        {
          "family": "Yin",
          "given": "Hang"
        },
        {
          "family": "Li",
          "given": "Qiao"
        },
        {
          "family": "Liu",
          "given": "Shangyu"
        },
        {
          "family": "Wang",
          "given": "Juncheng"
        },
        {
          "family": "Yuan",
          "given": "Guoqiang"
        },
        {
          "family": "Pan",
          "given": "Yawen"
        }
      ],
      "volume": "11",
      "issue": "1"
    },
    "23": {
      "id": "23",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/6288",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/6288",
        "canonical_id": null
      }
    },
    "24": {
      "id": "24",
      "URL": "https://www.science.org/doi/10.1126/scisignal.ady8676",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.science.org/doi/10.1126/scisignal.ady8676",
        "canonical_id": null
      },
      "DOI": "10.1126/scisignal.ady8676",
      "title": "TNF-α signaling mediates the dopaminergic effects of methamphetamine by stimulating dopamine transporters and L-type Ca\n                    <sup>2+</sup>\n                    channels",
      "container-title": "Science Signaling",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            16
          ]
        ]
      },
      "author": [
        {
          "family": "Lin",
          "given": "Landon M."
        },
        {
          "family": "Febo",
          "given": "Marcelo"
        },
        {
          "family": "Bruijnzeel",
          "given": "Adriaan W."
        },
        {
          "family": "Phan",
          "given": "Leah"
        },
        {
          "family": "Gopinath",
          "given": "Adithya"
        },
        {
          "family": "Seibold",
          "given": "Jordan"
        },
        {
          "family": "Miller",
          "given": "Emily"
        },
        {
          "family": "Khoshbouei",
          "given": "Habibeh"
        }
      ],
      "volume": "18",
      "issue": "917"
    },
    "25": {
      "id": "25",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/3569",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/3569",
        "canonical_id": null
      }
    },
    "26": {
      "id": "26",
      "URL": "https://www.nature.com/articles/s42003-025-08997-7",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s42003-025-08997-7",
        "canonical_id": null
      },
      "DOI": "10.1038/s42003-025-08997-7",
      "title": "MIF downregulation attenuates neuroinflammation via TLR4/MyD88/TRAF6/NF-κB pathway to protect dopaminergic neurons in Parkinson’s disease model",
      "container-title": "Communications Biology",
      "issued": {
        "date-parts": [
          [
            2025,
            11,
            18
          ]
        ]
      },
      "author": [
        {
          "family": "Huang",
          "given": "Yicong"
        },
        {
          "family": "Zhou",
          "given": "Chang"
        },
        {
          "family": "Qu",
          "given": "Shaogang"
        }
      ],
      "volume": "8",
      "issue": "1"
    },
    "27": {
      "id": "27",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/2146",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/2146",
        "canonical_id": null
      }
    },
    "28": {
      "id": "28",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/18024",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/18024",
        "canonical_id": null
      }
    },
    "29": {
      "id": "29",
      "URL": "https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000012374",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000012374",
        "canonical_id": null
      }
    },
    "30": {
      "id": "30",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/4204",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/4204",
        "canonical_id": null
      }
    },
    "31": {
      "id": "31",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/24842",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/24842",
        "canonical_id": null
      }
    },
    "32": {
      "id": "32",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/19015",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/19015",
        "canonical_id": null
      }
    },
    "33": {
      "id": "33",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/19013",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/19013",
        "canonical_id": null
      }
    },
    "34": {
      "id": "34",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/283131",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/283131",
        "canonical_id": null
      }
    },
    "35": {
      "id": "35",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/406992",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/406992",
        "canonical_id": null
      }
    },
    "36": {
      "id": "36",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/407050",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/407050",
        "canonical_id": null
      }
    },
    "37": {
      "id": "37",
      "URL": "https://www.nature.com/articles/s41598-025-30888-4",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41598-025-30888-4",
        "canonical_id": null
      },
      "DOI": "10.1038/s41598-025-30888-4",
      "title": "The protective role of nuclear Heme oxygenase-1 in blood-spinal cord barrier after hypoxia in vitro",
      "container-title": "Scientific Reports",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            2
          ]
        ]
      },
      "author": [
        {
          "family": "Wang",
          "given": "Jian"
        },
        {
          "family": "Wang",
          "given": "Hui"
        },
        {
          "family": "Wang",
          "given": "Tingting"
        },
        {
          "family": "Zhang",
          "given": "Po"
        },
        {
          "family": "Cao",
          "given": "Yang"
        },
        {
          "family": "Yu",
          "given": "Tengbo"
        }
      ]
    },
    "38": {
      "id": "38",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/7465",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/7465",
        "canonical_id": null
      }
    },
    "39": {
      "id": "39",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/545",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/545",
        "canonical_id": null
      }
    },
    "40": {
      "id": "40",
      "URL": "https://www.nature.com/articles/s42003-025-09169-3",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s42003-025-09169-3",
        "canonical_id": null
      },
      "DOI": "10.1038/s42003-025-09169-3",
      "title": "MicroRNA-mediated neuronal detargeting alters astrocyte cell fate conversion trajectories in vivo",
      "container-title": "Communications Biology",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            5
          ]
        ]
      },
      "author": [
        {
          "family": "Ghazale",
          "given": "Hussein"
        },
        {
          "family": "Parga",
          "given": "Pazos Martin"
        },
        {
          "family": "Jung",
          "given": "Sascha"
        },
        {
          "family": "Cao",
          "given": "Ke"
        },
        {
          "family": "Vasan",
          "given": "Lakshmy"
        },
        {
          "family": "Hickmott",
          "given": "Jack W."
        },
        {
          "family": "Zhang",
          "given": "Linghe"
        },
        {
          "family": "Morshead",
          "given": "Cindi M."
        },
        {
          "family": "Wang",
          "given": "Chao"
        },
        {
          "family": "del",
          "given": "Sol Antonio"
        },
        {
          "family": "Schuurmans",
          "given": "Carol"
        }
      ],
      "volume": "8",
      "issue": "1"
    },
    "41": {
      "id": "41",
      "URL": "https://www.nature.com/articles/s41598-025-29326-2",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41598-025-29326-2",
        "canonical_id": null
      },
      "DOI": "10.1038/s41598-025-29326-2",
      "title": "Targeting tumor metabolic flexibility enhances radiotherapeutic efficacy via mitochondrial complex I Inhibition in an intracranial S180 sarcoma mouse model",
      "container-title": "Scientific Reports",
      "issued": {
        "date-parts": [
          [
            2025,
            11,
            28
          ]
        ]
      },
      "author": [
        {
          "family": "Liu",
          "given": "Zhipeng"
        },
        {
          "family": "Lim",
          "given": "Sa-Hoe"
        },
        {
          "family": "Jung",
          "given": "Shin"
        }
      ]
    },
    "42": {
      "id": "42",
      "URL": "https://www.nature.com/articles/s41467-025-66226-5",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41467-025-66226-5",
        "canonical_id": null
      },
      "DOI": "10.1038/s41467-025-66226-5",
      "title": "Aberrant neural activity in the peritumoral cortex underlies the progression of tumor-associated seizures",
      "container-title": "Nature Communications",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            2
          ]
        ]
      },
      "author": [
        {
          "family": "Bouwen",
          "given": "Bibi L. J."
        },
        {
          "family": "Bolleboom",
          "given": "Anne"
        },
        {
          "family": "Tang",
          "given": "Yuanhong"
        },
        {
          "family": "Yu",
          "given": "Zhaofei"
        },
        {
          "family": "van",
          "given": "der Stap Anna"
        },
        {
          "family": "van",
          "given": "Rij Jort A."
        },
        {
          "family": "van",
          "given": "Dis Vera"
        },
        {
          "family": "Dirven",
          "given": "Clemens M. F."
        },
        {
          "family": "De",
          "given": "Zeeuw Chris I."
        },
        {
          "family": "van",
          "given": "Tellingen Olaf"
        },
        {
          "family": "Liu",
          "given": "Jian K."
        },
        {
          "family": "Vincent",
          "given": "Arnaud J. P. E."
        },
        {
          "family": "Gao",
          "given": "Zhenyu"
        }
      ],
      "volume": "16",
      "issue": "1"
    },
    "43": {
      "id": "43",
      "URL": "https://www.nature.com/articles/s42003-025-09138-w",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s42003-025-09138-w",
        "canonical_id": null
      },
      "DOI": "10.1038/s42003-025-09138-w",
      "title": "Astrocyte activation persists one year after TBI: a dynamic shift from inflammation to neurodegeneration",
      "container-title": "Communications Biology",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            4
          ]
        ]
      },
      "author": [
        {
          "family": "Abou-El-Hassan",
          "given": "Hadi"
        },
        {
          "family": "Yahya",
          "given": "Taha"
        },
        {
          "family": "Zusman",
          "given": "Benjamin E."
        },
        {
          "family": "Albastaki",
          "given": "Omar"
        },
        {
          "family": "Imkamp",
          "given": "Harm T."
        },
        {
          "family": "Ye",
          "given": "Jessica J."
        },
        {
          "family": "Percopo",
          "given": "Francesca"
        },
        {
          "family": "Christenson",
          "given": "Jonathan R."
        },
        {
          "family": "Al",
          "given": "Mansi Maryam H."
        },
        {
          "family": "Lu",
          "given": "Kuan-Jung"
        },
        {
          "family": "Gabriely",
          "given": "Galina"
        },
        {
          "family": "Tatematsu",
          "given": "Bruna K."
        },
        {
          "family": "Habashy",
          "given": "Karl J."
        },
        {
          "family": "Lopes",
          "given": "Juliana R."
        },
        {
          "family": "Maghzi",
          "given": "Amir-Hadi"
        },
        {
          "family": "Rezende",
          "given": "Rafael M."
        },
        {
          "family": "Quintana",
          "given": "Francisco J."
        },
        {
          "family": "Weiner",
          "given": "Howard L."
        },
        {
          "family": "Izzy",
          "given": "Saef"
        }
      ],
      "volume": "8",
      "issue": "1"
    },
    "44": {
      "id": "44",
      "URL": "https://www.nature.com/articles/s42003-025-09333-9",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s42003-025-09333-9",
        "canonical_id": null
      },
      "DOI": "10.1038/s42003-025-09333-9",
      "title": "Catabolic rewiring in cancer impacts dietary interventions",
      "container-title": "Communications Biology",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            8
          ]
        ]
      },
      "author": [
        {
          "family": "Chinopoulos",
          "given": "Christos"
        }
      ]
    },
    "45": {
      "id": "45",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/8842",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/8842",
        "canonical_id": null
      }
    },
    "46": {
      "id": "46",
      "URL": "https://www.nature.com/articles/s41467-025-64937-3",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41467-025-64937-3",
        "canonical_id": null
      },
      "DOI": "10.1038/s41467-025-64937-3",
      "title": "Transcriptional regulation of protein synthesis by mediator kinase represents a therapeutic vulnerability in MYC-driven medulloblastoma",
      "container-title": "Nature Communications",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            16
          ]
        ]
      },
      "author": [
        {
          "family": "Wang",
          "given": "Dong"
        },
        {
          "family": "Ritz",
          "given": "Caitlin"
        },
        {
          "family": "Luo",
          "given": "Yuhuan"
        },
        {
          "family": "Suresh",
          "given": "Ammu"
        },
        {
          "family": "Pierce",
          "given": "Angela"
        },
        {
          "family": "Veo",
          "given": "Bethany"
        },
        {
          "family": "Brunt",
          "given": "Breauna"
        },
        {
          "family": "Dahl",
          "given": "Nathan"
        },
        {
          "family": "Serkova",
          "given": "Natalie"
        },
        {
          "family": "Venkataraman",
          "given": "Sujatha"
        },
        {
          "family": "Danis",
          "given": "Etienne"
        },
        {
          "family": "Kus",
          "given": "Kamil"
        },
        {
          "family": "Mazan",
          "given": "Milena"
        },
        {
          "family": "Rzymski",
          "given": "Tomasz"
        },
        {
          "family": "Vibhakar",
          "given": "Rajeev"
        }
      ],
      "volume": "16",
      "issue": "1"
    },
    "47": {
      "id": "47",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/1649",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/1649",
        "canonical_id": null
      }
    },
    "48": {
      "id": "48",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/2521",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/2521",
        "canonical_id": null
      }
    },
    "49": {
      "id": "49",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/3309",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/3309",
        "canonical_id": null
      }
    },
    "50": {
      "id": "50",
      "URL": "https://www.nature.com/articles/s41380-025-03399-x",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.98,
        "methods": [
          "url_pattern",
          "auto_metadata_lookup"
        ],
        "validation": {
          "ncbi": "unknown",
          "metapub": "unknown"
        },
        "errors": [],
        "source_url": "https://www.nature.com/articles/s41380-025-03399-x",
        "canonical_id": null
      },
      "DOI": "10.1038/s41380-025-03399-x",
      "title": "Downregulation of integrin α3 in ADHD mirrored in mutant mouse model by dopamine-dependent hippocampal AMPAR expression",
      "container-title": "Molecular Psychiatry",
      "issued": {
        "date-parts": [
          [
            2025,
            12,
            15
          ]
        ]
      },
      "author": [
        {
          "family": "Yao",
          "given": "Xiaojuan"
        },
        {
          "family": "Chen",
          "given": "Ruiying"
        },
        {
          "family": "Zhu",
          "given": "Jingxiang"
        },
        {
          "family": "Hou",
          "given": "Ruiqing"
        },
        {
          "family": "Xiang",
          "given": "Shitong"
        },
        {
          "family": "Jia",
          "given": "Tianye"
        },
        {
          "family": "Gu",
          "given": "Yuelin"
        },
        {
          "family": "Wang",
          "given": "Zhenyu"
        },
        {
          "family": "Hu",
          "given": "Han"
        },
        {
          "family": "Chen",
          "given": "Hongting"
        },
        {
          "family": "Wang",
          "given": "He"
        },
        {
          "family": "Feng",
          "given": "Jianfeng"
        },
        {
          "family": "Robbins",
          "given": "Trevor W."
        },
        {
          "family": "Wang",
          "given": "Yingwei"
        },
        {
          "family": "Higley",
          "given": "Michael J."
        },
        {
          "family": "Koleske",
          "given": "Anthony J."
        },
        {
          "family": "Xiao",
          "given": "Xiao"
        }
      ]
    },
    "51": {
      "id": "51",
      "URL": "https://www.ncbi.nlm.nih.gov/gene/3845",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "https://www.ncbi.nlm.nih.gov/gene/3845",
        "canonical_id": null
      }
    },
    "52": {
      "id": "52",
      "URL": "http://json-schema.org/draft-07/schema#\",",
      "type": "article-journal",
      "resolution": {
        "confidence": 0.0,
        "methods": [],
        "validation": {
          "ncbi": "failed",
          "metapub": "unknown"
        },
        "errors": [
          "no identifiers extracted"
        ],
        "source_url": "http://json-schema.org/draft-07/schema#\",",
        "canonical_id": null
      }
    }
  },
  "compact_bibliography": {
    "entries": [
      "1. Available from: https://www.ncbi.nlm.nih.gov/gene/7422",
      "2. Available from: https://www.ncbi.nlm.nih.gov/gene/51147",
      "3. Ren Y, Zhang Z, Lei X, Shi L. Long non-coding RNAs in cancer glycolysis and metabolism: mechanisms and translational opportunities. Cell Death &amp; Disease [Internet]. 2025Dec8;. Available from: https://www.nature.com/articles/s41419-025-08289-2",
      "4. Available from: https://www.ncbi.nlm.nih.gov/gene/1277",
      "5. Available from: https://www.ncbi.nlm.nih.gov/gene/768",
      "6. Available from: https://www.ncbi.nlm.nih.gov/gene/5315",
      "7. Available from: https://www.ncbi.nlm.nih.gov/gene/4312",
      "8. Available from: https://www.ncbi.nlm.nih.gov/gene/207",
      "9. González-Gallego J, Todorov-Völgyi K, Müller SA, Antesberger S, Todorov MI, Malik R, et al.. A fully iPS-cell-derived 3D model of the human blood–brain barrier for exploring neurovascular disease mechanisms and therapeutic interventions. Nature Neuroscience [Internet]. 2025Dec15;. Available from: https://www.nature.com/articles/s41593-025-02123-w",
      "10. Available from: https://www.ncbi.nlm.nih.gov/gene/1052",
      "11. Available from: https://www.ncbi.nlm.nih.gov/gene/7248",
      "12. Available from: https://www.ncbi.nlm.nih.gov/gene/16835",
      "13. Available from: https://www.ncbi.nlm.nih.gov/gene/1869",
      "14. Berkamp S, Jungbluth L, Katranidis A, Mostafavi S, Korculanin O, Lu P-H, et al.. Structural organization of p62 filaments and the cellular ultrastructure of calcium-rich p62-enwrapped lipid droplet cargo. Nature Communications [Internet]. 2025Nov28;16(1). Available from: https://www.nature.com/articles/s41467-025-66785-7",
      "15. Available from: https://www.ncbi.nlm.nih.gov/gene/7082",
      "16. Almaguer-Mederos LE, Key J, Sen N-E, Canet-Pons J, Döring C, Meierhofer D, et al.. Multiomics approach identifies SERPINB1 as candidate biomarker for spinocerebellar ataxia type 2. Scientific Reports [Internet]. 2025Nov26;15(1). Available from: https://www.nature.com/articles/s41598-025-29070-7",
      "17. Available from: https://www.ncbi.nlm.nih.gov/gene/12389",
      "18. Available from: https://www.ncbi.nlm.nih.gov/gene/627",
      "19. Available from: https://www.ncbi.nlm.nih.gov/gene/999",
      "20. Available from: https://www.ncbi.nlm.nih.gov/gene/12064",
      "21. Available from: https://www.ncbi.nlm.nih.gov/gene/4790",
      "22. Li W, Zhang Q, Yin H, Li Q, Liu S, Wang J, et al.. Knockdown of SUCLG2 inhibits glioblastoma proliferation and promotes apoptosis through LMNA acetylation and the mediation of H4K16la lactylation. Cell Death Discovery [Internet]. 2025Nov17;11(1). Available from: https://www.nature.com/articles/s41420-025-02856-4",
      "23. Available from: https://www.ncbi.nlm.nih.gov/gene/6288",
      "24. Lin LM, Febo M, Bruijnzeel AW, Phan L, Gopinath A, Seibold J, et al.. TNF-α signaling mediates the dopaminergic effects of methamphetamine by stimulating dopamine transporters and L-type Ca\n                    <sup>2+</sup>\n                    channels. Science Signaling [Internet]. 2025Dec16;18(917). Available from: https://www.science.org/doi/10.1126/scisignal.ady8676",
      "25. Available from: https://www.ncbi.nlm.nih.gov/gene/3569",
      "26. Huang Y, Zhou C, Qu S. MIF downregulation attenuates neuroinflammation via TLR4/MyD88/TRAF6/NF-κB pathway to protect dopaminergic neurons in Parkinson’s disease model. Communications Biology [Internet]. 2025Nov18;8(1). Available from: https://www.nature.com/articles/s42003-025-08997-7",
      "27. Available from: https://www.ncbi.nlm.nih.gov/gene/2146",
      "28. Available from: https://www.ncbi.nlm.nih.gov/gene/18024",
      "29. Available from: https://www.ncbi.nlm.nih.gov/clinvar/variation/VCV000012374",
      "30. Available from: https://www.ncbi.nlm.nih.gov/gene/4204",
      "31. Available from: https://www.ncbi.nlm.nih.gov/gene/24842",
      "32. Available from: https://www.ncbi.nlm.nih.gov/gene/19015",
      "33. Available from: https://www.ncbi.nlm.nih.gov/gene/19013",
      "34. Available from: https://www.ncbi.nlm.nih.gov/gene/283131",
      "35. Available from: https://www.ncbi.nlm.nih.gov/gene/406992",
      "36. Available from: https://www.ncbi.nlm.nih.gov/gene/407050",
      "37. Wang J, Wang H, Wang T, Zhang P, Cao Y, Yu T. The protective role of nuclear Heme oxygenase-1 in blood-spinal cord barrier after hypoxia in vitro. Scientific Reports [Internet]. 2025Dec2;. Available from: https://www.nature.com/articles/s41598-025-30888-4",
      "38. Available from: https://www.ncbi.nlm.nih.gov/gene/7465",
      "39. Available from: https://www.ncbi.nlm.nih.gov/gene/545",
      "40. Ghazale H, Parga PM, Jung S, Cao K, Vasan L, Hickmott JW, et al.. MicroRNA-mediated neuronal detargeting alters astrocyte cell fate conversion trajectories in vivo. Communications Biology [Internet]. 2025Dec5;8(1). Available from: https://www.nature.com/articles/s42003-025-09169-3",
      "41. Liu Z, Lim S-H, Jung S. Targeting tumor metabolic flexibility enhances radiotherapeutic efficacy via mitochondrial complex I Inhibition in an intracranial S180 sarcoma mouse model. Scientific Reports [Internet]. 2025Nov28;. Available from: https://www.nature.com/articles/s41598-025-29326-2",
      "42. Bouwen BLJ, Bolleboom A, Tang Y, Yu Z, van der SA, van RJA, et al.. Aberrant neural activity in the peritumoral cortex underlies the progression of tumor-associated seizures. Nature Communications [Internet]. 2025Dec2;16(1). Available from: https://www.nature.com/articles/s41467-025-66226-5",
      "43. Abou-El-Hassan H, Yahya T, Zusman BE, Albastaki O, Imkamp HT, Ye JJ, et al.. Astrocyte activation persists one year after TBI: a dynamic shift from inflammation to neurodegeneration. Communications Biology [Internet]. 2025Dec4;8(1). Available from: https://www.nature.com/articles/s42003-025-09138-w",
      "44. Chinopoulos C. Catabolic rewiring in cancer impacts dietary interventions. Communications Biology [Internet]. 2025Dec8;. Available from: https://www.nature.com/articles/s42003-025-09333-9",
      "45. Available from: https://www.ncbi.nlm.nih.gov/gene/8842",
      "46. Wang D, Ritz C, Luo Y, Suresh A, Pierce A, Veo B, et al.. Transcriptional regulation of protein synthesis by mediator kinase represents a therapeutic vulnerability in MYC-driven medulloblastoma. Nature Communications [Internet]. 2025Dec16;16(1). Available from: https://www.nature.com/articles/s41467-025-64937-3",
      "47. Available from: https://www.ncbi.nlm.nih.gov/gene/1649",
      "48. Available from: https://www.ncbi.nlm.nih.gov/gene/2521",
      "49. Available from: https://www.ncbi.nlm.nih.gov/gene/3309",
      "50. Yao X, Chen R, Zhu J, Hou R, Xiang S, Jia T, et al.. Downregulation of integrin α3 in ADHD mirrored in mutant mouse model by dopamine-dependent hippocampal AMPAR expression. Molecular Psychiatry [Internet]. 2025Dec15;. Available from: https://www.nature.com/articles/s41380-025-03399-x",
      "51. Available from: https://www.ncbi.nlm.nih.gov/gene/3845",
      "52. Available from: http://json-schema.org/draft-07/schema#\","
    ],
    "style": "vancouver",
    "locale": "en-US",
    "renderer": "citeproc",
    "error": null
  },
  "bibliography_stats": {
    "total": 52,
    "resolved": 15,
    "unresolved": 37,
    "methods": {
      "url_pattern": 15,
      "auto_metadata_lookup": 15
    },
    "average_confidence": 0.98
  },
  "unresolved": [
    "1",
    "2",
    "4",
    "5",
    "6",
    "7",
    "8",
    "10",
    "11",
    "12",
    "13",
    "15",
    "17",
    "18",
    "19",
    "20",
    "21",
    "23",
    "25",
    "27",
    "28",
    "29",
    "30",
    "31",
    "32",
    "33",
    "34",
    "35",
    "36",
    "38",
    "39",
    "45",
    "47",
    "48",
    "49",
    "51",
    "52"
  ]
}